Version: 2017-09-28
Format: classname (Label) [#subclasses][accuracy]

1. [NCIT:C2852](markdown/NCIT_C2852.md) (Adenocarcinoma) [573][52.89%]
1. [NCIT:C2853](markdown/NCIT_C2853.md) (Papillary Adenocarcinoma) [35][53.30%]
1. [NCIT:C2855](markdown/NCIT_C2855.md) (Adenoma) [162][51.79%]
1. [NCIT:C2862](markdown/NCIT_C2862.md) (Primary Myelofibrosis) [2][53.49%]
1. [NCIT:C2879](markdown/NCIT_C2879.md) (Neoplasm of the Diffuse Neuroendocrine System) [16][55.56%]
1. [NCIT:C2894](markdown/NCIT_C2894.md) (Benign Colon Neoplasm) [6][57.14%]
1. [NCIT:C2895](markdown/NCIT_C2895.md) (Benign Ovarian Neoplasm) [30][55.56%]
1. [NCIT:C2896](markdown/NCIT_C2896.md) (Benign Skin Neoplasm) [79][62.50%]
1. [NCIT:C2898](markdown/NCIT_C2898.md) (Bile Duct Neoplasm) [107][75.00%]
1. [NCIT:C2907](markdown/NCIT_C2907.md) (Brain Neoplasm) [234][75.00%]
1. [NCIT:C2912](markdown/NCIT_C2912.md) (Burkitt Lymphoma) [33][54.38%]
1. [NCIT:C2915](markdown/NCIT_C2915.md) (Carcinoid Tumor) [42][54.55%]
1. [NCIT:C2916](markdown/NCIT_C2916.md) (Carcinoma) [1857][52.26%]
1. [NCIT:C2917](markdown/NCIT_C2917.md) (Carcinoma In Situ) [95][53.85%]
1. [NCIT:C2919](markdown/NCIT_C2919.md) (Prostate Adenocarcinoma) [12][53.75%]
1. [NCIT:C2920](markdown/NCIT_C2920.md) (Malignant Skin Neoplasm) [211][66.67%]
1. [NCIT:C2921](markdown/NCIT_C2921.md) (Skin Basal Cell Carcinoma) [26][55.88%]
1. [NCIT:C2924](markdown/NCIT_C2924.md) (Ductal Breast Carcinoma In Situ) [3][55.77%]
1. [NCIT:C2926](markdown/NCIT_C2926.md) (Non-Small Cell Lung Carcinoma) [61][53.40%]
1. [NCIT:C2927](markdown/NCIT_C2927.md) (Papillary Carcinoma) [73][52.77%]
1. [NCIT:C2929](markdown/NCIT_C2929.md) (Squamous Cell Carcinoma) [223][52.77%]
1. [NCIT:C2930](markdown/NCIT_C2930.md) (Transitional Cell Carcinoma) [62][52.53%]
1. [NCIT:C2935](markdown/NCIT_C2935.md) (Cerebellar Neoplasm) [37][62.50%]
1. [NCIT:C2937](markdown/NCIT_C2937.md) (Intraventricular Brain Neoplasm) [9][66.67%]
1. [NCIT:C2942](markdown/NCIT_C2942.md) (Bile Duct Adenoma) [4][53.20%]
1. [NCIT:C2946](markdown/NCIT_C2946.md) (Chondrosarcoma) [20][56.25%]
1. [NCIT:C2947](markdown/NCIT_C2947.md) (Chordoma) [4][53.49%]
1. [NCIT:C2948](markdown/NCIT_C2948.md) (Choriocarcinoma) [14][66.67%]
1. [NCIT:C2953](markdown/NCIT_C2953.md) (Colon Neoplasm) [80][75.00%]
1. [NCIT:C2955](markdown/NCIT_C2955.md) (Colorectal Carcinoma) [123][53.75%]
1. [NCIT:C2960](markdown/NCIT_C2960.md) (Condyloma Acuminatum) [7][53.20%]
1. [NCIT:C2970](markdown/NCIT_C2970.md) (Adenoid Cystic Carcinoma) [27][53.00%]
1. [NCIT:C2971](markdown/NCIT_C2971.md) (Cystadenocarcinoma) [16][52.89%]
1. [NCIT:C2972](markdown/NCIT_C2972.md) (Cystadenoma) [26][54.55%]
1. [NCIT:C2973](markdown/NCIT_C2973.md) (Mucinous Cystadenoma) [4][53.85%]
1. [NCIT:C2974](markdown/NCIT_C2974.md) (Papillary Cystadenoma) [8][53.85%]
1. [NCIT:C2977](markdown/NCIT_C2977.md) (Phyllodes Tumor) [11][54.55%]
1. [NCIT:C2995](markdown/NCIT_C2995.md) (Duodenal Neoplasm) [19][75.00%]
1. [NCIT:C2996](markdown/NCIT_C2996.md) (Dysgerminoma) [5][52.40%]
1. [NCIT:C3010](markdown/NCIT_C3010.md) (Endocrine Neoplasm) [424][51.96%]
1. [NCIT:C3011](markdown/NCIT_C3011.md) (Yolk Sac Tumor) [13][52.53%]
1. [NCIT:C3017](markdown/NCIT_C3017.md) (Ependymoma) [14][53.75%]
1. [NCIT:C3041](markdown/NCIT_C3041.md) (Fibroma) [24][56.25%]
1. [NCIT:C3042](markdown/NCIT_C3042.md) (Fibromatosis) [9][55.56%]
1. [NCIT:C3043](markdown/NCIT_C3043.md) (Fibrosarcoma) [19][53.85%]
1. [NCIT:C3048](markdown/NCIT_C3048.md) (Gallbladder Neoplasm) [72][75.00%]
1. [NCIT:C3049](markdown/NCIT_C3049.md) (Ganglioneuroma) [6][53.20%]
1. [NCIT:C3050](markdown/NCIT_C3050.md) (Gastrin-Producing Neuroendocrine Tumor) [4][53.30%]
1. [NCIT:C3055](markdown/NCIT_C3055.md) (Giant Cell Tumor) [11][51.96%]
1. [NCIT:C3056](markdown/NCIT_C3056.md) (Angiofollicular Lymphoid Hyperplasia) [3][55.00%]
1. [NCIT:C3058](markdown/NCIT_C3058.md) (Glioblastoma) [35][54.38%]
1. [NCIT:C3059](markdown/NCIT_C3059.md) (Glioma) [216][55.00%]
1. [NCIT:C3060](markdown/NCIT_C3060.md) (Glomus Tumor) [11][57.14%]
1. [NCIT:C3061](markdown/NCIT_C3061.md) (Jugulotympanic Paraganglioma) [3][53.40%]
1. [NCIT:C3062](markdown/NCIT_C3062.md) (Pancreatic Glucagon-Producing Neuroendocrine Tumor) [2][55.26%]
1. [NCIT:C3082](markdown/NCIT_C3082.md) (Heavy Chain Disease) [3][53.30%]
1. [NCIT:C3084](markdown/NCIT_C3084.md) (Hemangioendothelioma) [15][56.25%]
1. [NCIT:C3085](markdown/NCIT_C3085.md) (Hemangioma) [53][55.00%]
1. [NCIT:C3086](markdown/NCIT_C3086.md) (Cavernous Hemangioma) [8][54.55%]
1. [NCIT:C3088](markdown/NCIT_C3088.md) (Angiosarcoma) [35][53.49%]
1. [NCIT:C3099](markdown/NCIT_C3099.md) (Hepatocellular Carcinoma) [35][56.35%]
1. [NCIT:C3107](markdown/NCIT_C3107.md) (Langerhans Cell Histiocytosis) [10][55.00%]
1. [NCIT:C3139](markdown/NCIT_C3139.md) (Infratentorial Neoplasm) [72][66.67%]
1. [NCIT:C3157](markdown/NCIT_C3157.md) (Leiomyoma) [50][53.33%]
1. [NCIT:C3158](markdown/NCIT_C3158.md) (Leiomyosarcoma) [51][54.46%]
1. [NCIT:C3161](markdown/NCIT_C3161.md) (Leukemia) [208][51.79%]
1. [NCIT:C3163](markdown/NCIT_C3163.md) (Chronic Lymphocytic Leukemia) [13][54.00%]
1. [NCIT:C3164](markdown/NCIT_C3164.md) (Acute Basophilic Leukemia) [2][53.67%]
1. [NCIT:C3167](markdown/NCIT_C3167.md) (Acute Lymphoblastic Leukemia) [36][53.49%]
1. [NCIT:C3168](markdown/NCIT_C3168.md) (Childhood Acute Lymphoblastic Leukemia) [10][53.58%]
1. [NCIT:C3170](markdown/NCIT_C3170.md) (Acute Megakaryoblastic Leukemia) [2][54.00%]
1. [NCIT:C3171](markdown/NCIT_C3171.md) (Acute Myeloid Leukemia) [87][52.77%]
1. [NCIT:C3172](markdown/NCIT_C3172.md) (Myeloid Leukemia) [100][52.53%]
1. [NCIT:C3174](markdown/NCIT_C3174.md) (Chronic Myelogenous Leukemia, BCR-ABL1 Positive) [9][53.58%]
1. [NCIT:C3178](markdown/NCIT_C3178.md) (Chronic Myelomonocytic Leukemia) [4][54.74%]
1. [NCIT:C3181](markdown/NCIT_C3181.md) (Prolymphocytic Leukemia) [7][53.49%]
1. [NCIT:C3182](markdown/NCIT_C3182.md) (Acute Promyelocytic Leukemia with PML-RARA) [4][54.00%]
1. [NCIT:C3183](markdown/NCIT_C3183.md) (T Acute Lymphoblastic Leukemia) [4][55.37%]
1. [NCIT:C3192](markdown/NCIT_C3192.md) (Lipoma) [41][55.56%]
1. [NCIT:C3193](markdown/NCIT_C3193.md) (Lipomatosis) [6][54.17%]
1. [NCIT:C3194](markdown/NCIT_C3194.md) (Liposarcoma) [24][53.33%]
1. [NCIT:C3208](markdown/NCIT_C3208.md) (Lymphoma) [610][52.40%]
1. [NCIT:C3209](markdown/NCIT_C3209.md) (Follicular Lymphoma) [42][53.67%]
1. [NCIT:C3211](markdown/NCIT_C3211.md) (Non-Hodgkin Lymphoma) [464][52.53%]
1. [NCIT:C3212](markdown/NCIT_C3212.md) (Lymphoplasmacytic Lymphoma) [10][54.38%]
1. [NCIT:C3222](markdown/NCIT_C3222.md) (Medulloblastoma) [21][53.33%]
1. [NCIT:C3224](markdown/NCIT_C3224.md) (Melanoma) [74][58.33%]
1. [NCIT:C3230](markdown/NCIT_C3230.md) (Meningioma) [37][60.00%]
1. [NCIT:C3234](markdown/NCIT_C3234.md) (Mesothelioma) [48][60.00%]
1. [NCIT:C3242](markdown/NCIT_C3242.md) (Plasma Cell Myeloma) [4][53.67%]
1. [NCIT:C3246](markdown/NCIT_C3246.md) (Mycosis Fungoides) [6][54.38%]
1. [NCIT:C3247](markdown/NCIT_C3247.md) (Myelodysplastic Syndrome) [23][52.77%]
1. [NCIT:C3249](markdown/NCIT_C3249.md) (Acute Myeloid Leukemia without Maturation) [2][54.00%]
1. [NCIT:C3250](markdown/NCIT_C3250.md) (Acute Myeloid Leukemia with Maturation) [2][53.92%]
1. [NCIT:C3252](markdown/NCIT_C3252.md) (Benign Granular Cell Tumor) [7][52.26%]
1. [NCIT:C3264](markdown/NCIT_C3264.md) (Embryonal Neoplasm) [180][51.13%]
1. [NCIT:C3267](markdown/NCIT_C3267.md) (Wilms Tumor) [19][52.89%]
1. [NCIT:C3269](markdown/NCIT_C3269.md) (Schwannoma) [6][53.49%]
1. [NCIT:C3270](markdown/NCIT_C3270.md) (Neuroblastoma) [24][53.49%]
1. [NCIT:C3272](markdown/NCIT_C3272.md) (Neurofibroma) [11][54.84%]
1. [NCIT:C3288](markdown/NCIT_C3288.md) (Oligodendroglioma) [9][54.53%]
1. [NCIT:C3296](markdown/NCIT_C3296.md) (Osteoma) [3][54.17%]
1. [NCIT:C3302](markdown/NCIT_C3302.md) (Extramammary Paget Disease) [5][53.33%]
1. [NCIT:C3308](markdown/NCIT_C3308.md) (Paraganglioma) [39][55.00%]
1. [NCIT:C3309](markdown/NCIT_C3309.md) (Extra-Adrenal Paraganglioma) [23][54.55%]
1. [NCIT:C3314](markdown/NCIT_C3314.md) (Parotid Gland Neoplasm) [21][85.36%]
1. [NCIT:C3326](markdown/NCIT_C3326.md) (Adrenal Gland Pheochromocytoma) [10][54.08%]
1. [NCIT:C3328](markdown/NCIT_C3328.md) (Pineal Region Neoplasm) [16][62.50%]
1. [NCIT:C3329](markdown/NCIT_C3329.md) (Pituitary Gland Adenoma) [23][53.40%]
1. [NCIT:C3330](markdown/NCIT_C3330.md) (Pituitary Gland Neoplasm) [44][60.00%]
1. [NCIT:C3332](markdown/NCIT_C3332.md) (Pleural Neoplasm) [28][75.00%]
1. [NCIT:C3336](markdown/NCIT_C3336.md) (Polycythemia Vera) [2][53.49%]
1. [NCIT:C3350](markdown/NCIT_C3350.md) (Rectal Neoplasm) [59][75.00%]
1. [NCIT:C3358](markdown/NCIT_C3358.md) (Rhabdomyoma) [9][52.89%]
1. [NCIT:C3359](markdown/NCIT_C3359.md) (Rhabdomyosarcoma) [34][53.67%]
1. [NCIT:C3363](markdown/NCIT_C3363.md) (Sebaceous Gland Neoplasm) [10][57.14%]
1. [NCIT:C3377](markdown/NCIT_C3377.md) (Soft Tissue Neoplasm) [564][53.87%]
1. [NCIT:C3379](markdown/NCIT_C3379.md) (Somatostatin-Producing Neuroendocrine Tumor) [7][53.84%]
1. [NCIT:C3381](markdown/NCIT_C3381.md) (Spinal Cord Neoplasm) [28][75.00%]
1. [NCIT:C3392](markdown/NCIT_C3392.md) (Sublingual Gland Neoplasm) [4][85.36%]
1. [NCIT:C3393](markdown/NCIT_C3393.md) (Submandibular Gland Neoplasm) [10][85.36%]
1. [NCIT:C3397](markdown/NCIT_C3397.md) (Supratentorial Neoplasm) [114][66.67%]
1. [NCIT:C3398](markdown/NCIT_C3398.md) (Sweat Gland Neoplasm) [61][62.50%]
1. [NCIT:C3402](markdown/NCIT_C3402.md) (Tenosynovial Giant Cell Tumor) [2][53.00%]
1. [NCIT:C3403](markdown/NCIT_C3403.md) (Teratoma) [43][55.00%]
1. [NCIT:C3411](markdown/NCIT_C3411.md) (Thymoma) [26][55.56%]
1. [NCIT:C3422](markdown/NCIT_C3422.md) (Trophoblastic Tumor) [25][66.67%]
1. [NCIT:C3434](markdown/NCIT_C3434.md) (Uterine Corpus Leiomyoma) [8][54.08%]
1. [NCIT:C3457](markdown/NCIT_C3457.md) (B-Cell Non-Hodgkin Lymphoma) [269][52.89%]
1. [NCIT:C3460](markdown/NCIT_C3460.md) (Grade 3 Follicular Lymphoma) [8][54.74%]
1. [NCIT:C3461](markdown/NCIT_C3461.md) (Immunoblastic Lymphoma) [9][54.67%]
1. [NCIT:C3465](markdown/NCIT_C3465.md) (Grade 1 Follicular Lymphoma) [6][54.80%]
1. [NCIT:C3466](markdown/NCIT_C3466.md) (T-Cell Non-Hodgkin Lymphoma) [113][52.89%]
1. [NCIT:C3467](markdown/NCIT_C3467.md) (Primary Cutaneous T-Cell Non-Hodgkin Lymphoma) [18][53.49%]
1. [NCIT:C3468](markdown/NCIT_C3468.md) (Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma) [97][53.20%]
1. [NCIT:C3473](markdown/NCIT_C3473.md) (Choroid Plexus Neoplasm) [7][54.17%]
1. [NCIT:C3474](markdown/NCIT_C3474.md) (Granular Cell Tumor) [20][52.12%]
1. [NCIT:C3480](markdown/NCIT_C3480.md) (Lobular Hemangioma) [3][53.85%]
1. [NCIT:C3482](markdown/NCIT_C3482.md) (Metastatic Carcinoma) [52][52.53%]
1. [NCIT:C3483](markdown/NCIT_C3483.md) (Chronic Leukemia) [36][51.96%]
1. [NCIT:C3490](markdown/NCIT_C3490.md) (Lip Carcinoma) [13][52.77%]
1. [NCIT:C3491](markdown/NCIT_C3491.md) (Cecum Carcinoma) [2][54.00%]
1. [NCIT:C3493](markdown/NCIT_C3493.md) (Squamous Cell Lung Carcinoma) [13][54.87%]
1. [NCIT:C3499](markdown/NCIT_C3499.md) (Atrial Myxoma) [2][53.67%]
1. [NCIT:C3502](markdown/NCIT_C3502.md) (Thyroid Gland Follicular Adenoma) [2][55.25%]
1. [NCIT:C3510](markdown/NCIT_C3510.md) (Cutaneous Melanoma) [36][55.00%]
1. [NCIT:C3512](markdown/NCIT_C3512.md) (Lung Adenocarcinoma) [19][55.06%]
1. [NCIT:C3513](markdown/NCIT_C3513.md) (Esophageal Carcinoma) [47][52.89%]
1. [NCIT:C3517](markdown/NCIT_C3517.md) (Mixed Cellularity Classical Hodgkin Lymphoma) [8][54.74%]
1. [NCIT:C3518](markdown/NCIT_C3518.md) (Nodular Sclerosis Classical Hodgkin Lymphoma) [4][54.87%]
1. [NCIT:C3520](markdown/NCIT_C3520.md) (Myeloid Sarcoma) [6][52.12%]
1. [NCIT:C3525](markdown/NCIT_C3525.md) (Malignant Parotid Gland Neoplasm) [11][68.69%]
1. [NCIT:C3526](markdown/NCIT_C3526.md) (Malignant Submandibular Gland Neoplasm) [8][68.69%]
1. [NCIT:C3527](markdown/NCIT_C3527.md) (Malignant Sublingual Gland Neoplasm) [2][68.69%]
1. [NCIT:C3530](markdown/NCIT_C3530.md) (Malignant Palate Neoplasm) [3][75.00%]
1. [NCIT:C3536](markdown/NCIT_C3536.md) (Malignant Ampulla of Vater Neoplasm) [27][66.67%]
1. [NCIT:C3544](markdown/NCIT_C3544.md) (Malignant Glottis Neoplasm) [2][75.00%]
1. [NCIT:C3545](markdown/NCIT_C3545.md) (Malignant Supraglottis Neoplasm) [2][75.00%]
1. [NCIT:C3546](markdown/NCIT_C3546.md) (Malignant Subglottis Neoplasm) [2][75.00%]
1. [NCIT:C3547](markdown/NCIT_C3547.md) (Malignant Pleural Neoplasm) [21][62.50%]
1. [NCIT:C3548](markdown/NCIT_C3548.md) (Malignant Cardiac Neoplasm) [22][62.50%]
1. [NCIT:C3549](markdown/NCIT_C3549.md) (Malignant Mediastinal Neoplasm) [23][66.67%]
1. [NCIT:C3556](markdown/NCIT_C3556.md) (Malignant Uterine Corpus Neoplasm) [54][75.00%]
1. [NCIT:C3558](markdown/NCIT_C3558.md) (Malignant Epididymal Neoplasm) [2][75.00%]
1. [NCIT:C3561](markdown/NCIT_C3561.md) (Malignant Accessory Urethral Gland Neoplasm) [3][53.87%]
1. [NCIT:C3563](markdown/NCIT_C3563.md) (Malignant Lacrimal Gland Neoplasm) [6][66.67%]
1. [NCIT:C3568](markdown/NCIT_C3568.md) (Malignant Brain Neoplasm) [92][62.50%]
1. [NCIT:C3569](markdown/NCIT_C3569.md) (Malignant Cerebellar Neoplasm) [23][58.33%]
1. [NCIT:C3570](markdown/NCIT_C3570.md) (Malignant Brain Stem Neoplasm) [6][58.33%]
1. [NCIT:C3571](markdown/NCIT_C3571.md) (Malignant Cranial Nerve Neoplasm) [6][66.67%]
1. [NCIT:C3572](markdown/NCIT_C3572.md) (Malignant Spinal Cord Neoplasm) [6][62.50%]
1. [NCIT:C3573](markdown/NCIT_C3573.md) (Malignant Pineal Region Neoplasm) [4][58.33%]
1. [NCIT:C3575](markdown/NCIT_C3575.md) (Malignant Endocrine Neoplasm) [153][52.12%]
1. [NCIT:C3576](markdown/NCIT_C3576.md) (Malignant Thoracic Neoplasm) [223][66.67%]
1. [NCIT:C3577](markdown/NCIT_C3577.md) (Metastatic Malignant Neoplasm in the Lung) [4][58.33%]
1. [NCIT:C3580](markdown/NCIT_C3580.md) (Metastatic Malignant Neoplasm in the Bone) [5][58.33%]
1. [NCIT:C3584](markdown/NCIT_C3584.md) (Stage III Hodgkin Lymphoma) [5][54.17%]
1. [NCIT:C3592](markdown/NCIT_C3592.md) (Benign Tongue Neoplasm) [2][52.53%]
1. [NCIT:C3595](markdown/NCIT_C3595.md) (Benign Nasopharyngeal Neoplasm) [3][55.00%]
1. [NCIT:C3597](markdown/NCIT_C3597.md) (Benign Pharyngeal Neoplasm) [8][55.56%]
1. [NCIT:C3598](markdown/NCIT_C3598.md) (Benign Esophageal Neoplasm) [7][60.00%]
1. [NCIT:C3599](markdown/NCIT_C3599.md) (Benign Gastric Neoplasm) [6][60.00%]
1. [NCIT:C3600](markdown/NCIT_C3600.md) (Benign Small Intestinal Neoplasm) [3][60.00%]
1. [NCIT:C3601](markdown/NCIT_C3601.md) (Benign Laryngeal Neoplasm) [6][55.56%]
1. [NCIT:C3603](markdown/NCIT_C3603.md) (Benign Pleural Neoplasm) [2][52.26%]
1. [NCIT:C3604](markdown/NCIT_C3604.md) (Benign Mediastinal Neoplasm) [10][52.26%]
1. [NCIT:C3605](markdown/NCIT_C3605.md) (Benign Cardiac Neoplasm) [20][52.40%]
1. [NCIT:C3607](markdown/NCIT_C3607.md) (Benign Cervical Neoplasm) [9][56.25%]
1. [NCIT:C3608](markdown/NCIT_C3608.md) (Benign Uterine Corpus Neoplasm) [18][55.56%]
1. [NCIT:C3609](markdown/NCIT_C3609.md) (Benign Uterine Neoplasm) [29][57.14%]
1. [NCIT:C3610](markdown/NCIT_C3610.md) (Benign Vaginal Neoplasm) [5][57.14%]
1. [NCIT:C3611](markdown/NCIT_C3611.md) (Benign Vulvar Neoplasm) [12][57.14%]
1. [NCIT:C3613](markdown/NCIT_C3613.md) (Benign Prostate Neoplasm) [4][56.25%]
1. [NCIT:C3616](markdown/NCIT_C3616.md) (Benign Renal Pelvis Neoplasm) [2][52.77%]
1. [NCIT:C3617](markdown/NCIT_C3617.md) (Benign Ureter Neoplasm) [4][52.26%]
1. [NCIT:C3618](markdown/NCIT_C3618.md) (Benign Bladder Neoplasm) [4][52.12%]
1. [NCIT:C3619](markdown/NCIT_C3619.md) (Benign Urethral Neoplasm) [4][52.12%]
1. [NCIT:C3624](markdown/NCIT_C3624.md) (Benign Retinal Neoplasm) [4][60.00%]
1. [NCIT:C3627](markdown/NCIT_C3627.md) (Benign Spinal Cord Neoplasm) [3][66.67%]
1. [NCIT:C3628](markdown/NCIT_C3628.md) (Benign Thyroid Gland Neoplasm) [3][55.00%]
1. [NCIT:C3629](markdown/NCIT_C3629.md) (Benign Adrenal Gland Neoplasm) [9][60.00%]
1. [NCIT:C3630](markdown/NCIT_C3630.md) (Benign Parathyroid Gland Neoplasm) [7][55.00%]
1. [NCIT:C3631](markdown/NCIT_C3631.md) (Benign Pineal Region Neoplasm) [2][58.33%]
1. [NCIT:C3633](markdown/NCIT_C3633.md) (Intracranial Hemangioma) [3][53.85%]
1. [NCIT:C3634](markdown/NCIT_C3634.md) (Retinal Hemangioma) [2][53.33%]
1. [NCIT:C3635](markdown/NCIT_C3635.md) (Intra-Abdominal Hemangioma) [2][54.55%]
1. [NCIT:C3640](markdown/NCIT_C3640.md) (Stage 0 Skin Cancer) [3][53.40%]
1. [NCIT:C3641](markdown/NCIT_C3641.md) (Stage 0 Breast Cancer AJCC v6 and v7) [7][53.58%]
1. [NCIT:C3679](markdown/NCIT_C3679.md) (Oxyphilic Adenocarcinoma) [3][53.10%]
1. [NCIT:C3680](markdown/NCIT_C3680.md) (Cribriform Carcinoma) [9][52.53%]
1. [NCIT:C3686](markdown/NCIT_C3686.md) (Salivary Gland Monomorphic Adenoma) [5][53.33%]
1. [NCIT:C3687](markdown/NCIT_C3687.md) (Renal Papillary Adenoma) [2][54.17%]
1. [NCIT:C3692](markdown/NCIT_C3692.md) (Undifferentiated Carcinoma) [37][54.55%]
1. [NCIT:C3693](markdown/NCIT_C3693.md) (Carcinomatosis) [6][52.66%]
1. [NCIT:C3696](markdown/NCIT_C3696.md) (Subependymal Giant Cell Astrocytoma) [3][54.24%]
1. [NCIT:C3697](markdown/NCIT_C3697.md) (Myxopapillary Ependymoma) [2][53.67%]
1. [NCIT:C3708](markdown/NCIT_C3708.md) (Germ Cell Tumor) [164][62.50%]
1. [NCIT:C3709](markdown/NCIT_C3709.md) (Epithelial Neoplasm) [2675][51.79%]
1. [NCIT:C3712](markdown/NCIT_C3712.md) (Squamous Papilloma) [15][53.40%]
1. [NCIT:C3713](markdown/NCIT_C3713.md) (Papillomatosis) [7][55.56%]
1. [NCIT:C3714](markdown/NCIT_C3714.md) (Epithelioid Sarcoma) [7][53.49%]
1. [NCIT:C3716](markdown/NCIT_C3716.md) (Primitive Neuroectodermal Tumor) [58][56.94%]
1. [NCIT:C3720](markdown/NCIT_C3720.md) (Anaplastic Large Cell Lymphoma) [28][53.75%]
1. [NCIT:C3721](markdown/NCIT_C3721.md) (Lymphomatoid Papulosis) [5][53.84%]
1. [NCIT:C3723](markdown/NCIT_C3723.md) (Lymphatic Vessel Neoplasm) [18][57.14%]
1. [NCIT:C3726](markdown/NCIT_C3726.md) (Adenomyoma) [2][53.20%]
1. [NCIT:C3727](markdown/NCIT_C3727.md) (Adenosquamous Carcinoma) [31][52.53%]
1. [NCIT:C3729](markdown/NCIT_C3729.md) (Malignant Mixed Neoplasm) [80][51.96%]
1. [NCIT:C3730](markdown/NCIT_C3730.md) (Mixed Mesodermal (Mullerian) Tumor) [51][56.25%]
1. [NCIT:C3732](markdown/NCIT_C3732.md) (Pulmonary Blastoma) [2][54.38%]
1. [NCIT:C3737](markdown/NCIT_C3737.md) (Mesenchymal Chondrosarcoma) [4][54.17%]
1. [NCIT:C3738](markdown/NCIT_C3738.md) (Osteoclastic Giant Cell-Rich Tumor of Bone) [6][52.53%]
1. [NCIT:C3739](markdown/NCIT_C3739.md) (Benign Fibrous Histiocytoma) [7][52.53%]
1. [NCIT:C3743](markdown/NCIT_C3743.md) (Fibroepithelial Neoplasm) [22][55.56%]
1. [NCIT:C3744](markdown/NCIT_C3744.md) (Breast Fibroadenoma) [5][53.57%]
1. [NCIT:C3746](markdown/NCIT_C3746.md) (Small Cell Sarcoma) [9][56.25%]
1. [NCIT:C3747](markdown/NCIT_C3747.md) (Angioleiomyoma) [3][54.17%]
1. [NCIT:C3748](markdown/NCIT_C3748.md) (Leiomyomatosis) [4][53.30%]
1. [NCIT:C3749](markdown/NCIT_C3749.md) (Alveolar Rhabdomyosarcoma) [3][53.84%]
1. [NCIT:C3750](markdown/NCIT_C3750.md) (Alveolar Soft Part Sarcoma) [7][53.67%]
1. [NCIT:C3751](markdown/NCIT_C3751.md) (Smooth Muscle Neoplasm) [108][55.00%]
1. [NCIT:C3752](markdown/NCIT_C3752.md) (Embryonal Carcinoma) [10][54.55%]
1. [NCIT:C3753](markdown/NCIT_C3753.md) (Germinoma) [2][60.82%]
1. [NCIT:C3758](markdown/NCIT_C3758.md) (Hepatocellular Adenoma) [3][53.30%]
1. [NCIT:C3759](markdown/NCIT_C3759.md) (Oncocytic Adenoma) [2][54.55%]
1. [NCIT:C3760](markdown/NCIT_C3760.md) (Hidrocystoma) [2][53.49%]
1. [NCIT:C3762](markdown/NCIT_C3762.md) (Adenomatoid Tumor) [8][61.39%]
1. [NCIT:C3764](markdown/NCIT_C3764.md) (Adenomatous Polyp) [10][52.66%]
1. [NCIT:C3766](markdown/NCIT_C3766.md) (Clear Cell Adenocarcinoma) [24][53.00%]
1. [NCIT:C3768](markdown/NCIT_C3768.md) (Acinar Cell Carcinoma) [6][55.56%]
1. [NCIT:C3769](markdown/NCIT_C3769.md) (Endometrioid Adenocarcinoma) [19][53.30%]
1. [NCIT:C3770](markdown/NCIT_C3770.md) (Pancreatic Neuroendocrine Carcinoma) [4][54.24%]
1. [NCIT:C3771](markdown/NCIT_C3771.md) (Lobular Breast Carcinoma) [9][54.00%]
1. [NCIT:C3772](markdown/NCIT_C3772.md) (Mucoepidermoid Carcinoma) [27][60.00%]
1. [NCIT:C3773](markdown/NCIT_C3773.md) (Neuroendocrine Carcinoma) [97][52.89%]
1. [NCIT:C3774](markdown/NCIT_C3774.md) (Signet Ring Cell Carcinoma) [18][53.33%]
1. [NCIT:C3775](markdown/NCIT_C3775.md) (Adnexal Carcinoma) [34][52.89%]
1. [NCIT:C3776](markdown/NCIT_C3776.md) (Mucinous Cystadenocarcinoma) [5][55.88%]
1. [NCIT:C3777](markdown/NCIT_C3777.md) (Papillary Cystadenocarcinoma) [2][53.30%]
1. [NCIT:C3778](markdown/NCIT_C3778.md) (Serous Cystadenocarcinoma) [3][55.56%]
1. [NCIT:C3779](markdown/NCIT_C3779.md) (Giant Cell Carcinoma) [4][53.40%]
1. [NCIT:C3780](markdown/NCIT_C3780.md) (Large Cell Carcinoma) [59][52.66%]
1. [NCIT:C3781](markdown/NCIT_C3781.md) (Verrucous Carcinoma) [15][53.84%]
1. [NCIT:C3782](markdown/NCIT_C3782.md) (Cervical Intraepithelial Neoplasia) [13][52.53%]
1. [NCIT:C3783](markdown/NCIT_C3783.md) (Serous Cystadenoma) [8][53.57%]
1. [NCIT:C3784](markdown/NCIT_C3784.md) (Basal Cell Neoplasm) [32][51.96%]
1. [NCIT:C3785](markdown/NCIT_C3785.md) (Intraductal Papilloma) [5][53.85%]
1. [NCIT:C3786](markdown/NCIT_C3786.md) (Mesothelial Neoplasm) [49][66.67%]
1. [NCIT:C3787](markdown/NCIT_C3787.md) (Neuroepithelial Neoplasm) [307][66.67%]
1. [NCIT:C3788](markdown/NCIT_C3788.md) (Ganglioglioma) [2][54.08%]
1. [NCIT:C3789](markdown/NCIT_C3789.md) (Olfactory Neuroblastoma) [3][54.60%]
1. [NCIT:C3790](markdown/NCIT_C3790.md) (Ganglioneuroblastoma) [10][53.20%]
1. [NCIT:C3792](markdown/NCIT_C3792.md) (Squamous Cell Neoplasm) [279][56.25%]
1. [NCIT:C3793](markdown/NCIT_C3793.md) (Inverted Papilloma) [8][53.85%]
1. [NCIT:C3794](markdown/NCIT_C3794.md) (Sex Cord-Stromal Tumor) [10][53.85%]
1. [NCIT:C3796](markdown/NCIT_C3796.md) (Gliosarcoma) [6][55.06%]
1. [NCIT:C3798](markdown/NCIT_C3798.md) (Malignant Peripheral Nerve Sheath Tumor) [18][54.00%]
1. [NCIT:C3799](markdown/NCIT_C3799.md) (Angiofibroma) [5][53.00%]
1. [NCIT:C3800](markdown/NCIT_C3800.md) (Epithelioid Hemangioendothelioma) [8][53.84%]
1. [NCIT:C3801](markdown/NCIT_C3801.md) (Hemangioblastoma) [4][54.17%]
1. [NCIT:C3803](markdown/NCIT_C3803.md) (Blue Nevus) [2][53.20%]
1. [NCIT:C3808](markdown/NCIT_C3808.md) (Rhabdoid Tumor) [6][55.56%]
1. [NCIT:C3809](markdown/NCIT_C3809.md) (Neuroendocrine Neoplasm) [309][56.25%]
1. [NCIT:C3813](markdown/NCIT_C3813.md) (Metastatic Malignant Neoplasm in the Brain) [5][56.25%]
1. [NCIT:C3842](markdown/NCIT_C3842.md) (Urothelial Papilloma) [9][54.16%]
1. [NCIT:C3844](markdown/NCIT_C3844.md) (Gallbladder Carcinoma) [39][53.00%]
1. [NCIT:C3850](markdown/NCIT_C3850.md) (Pancreatic Carcinoma) [38][52.77%]
1. [NCIT:C3860](markdown/NCIT_C3860.md) (Extrahepatic Bile Duct Carcinoma) [30][53.20%]
1. [NCIT:C3861](markdown/NCIT_C3861.md) (Ependymal Tumor of Brain) [9][53.20%]
1. [NCIT:C3863](markdown/NCIT_C3863.md) (Intraductal Breast Papilloma) [4][53.30%]
1. [NCIT:C3864](markdown/NCIT_C3864.md) (Colon Adenoma) [8][53.20%]
1. [NCIT:C3867](markdown/NCIT_C3867.md) (Fallopian Tube Carcinoma) [16][52.66%]
1. [NCIT:C3868](markdown/NCIT_C3868.md) (Gastrointestinal Stromal Tumor) [28][53.20%]
1. [NCIT:C3871](markdown/NCIT_C3871.md) (Nasopharyngeal Carcinoma) [34][53.75%]
1. [NCIT:C3872](markdown/NCIT_C3872.md) (Ovarian Brenner Tumor) [3][52.89%]
1. [NCIT:C3873](markdown/NCIT_C3873.md) (Ovarian Germ Cell Tumor) [40][58.33%]
1. [NCIT:C3874](markdown/NCIT_C3874.md) (Pancreatic Cystadenocarcinoma) [2][53.92%]
1. [NCIT:C3879](markdown/NCIT_C3879.md) (Thyroid Gland Medullary Carcinoma) [7][54.53%]
1. [NCIT:C3898](markdown/NCIT_C3898.md) (Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue) [22][54.38%]
1. [NCIT:C3903](markdown/NCIT_C3903.md) (Mixed Glioma) [14][53.10%]
1. [NCIT:C3908](markdown/NCIT_C3908.md) (Ampulla of Vater Carcinoma) [26][52.77%]
1. [NCIT:C3915](markdown/NCIT_C3915.md) (Small Cell Carcinoma) [32][53.49%]
1. [NCIT:C3916](markdown/NCIT_C3916.md) (Parathyroid Gland Adenoma) [6][54.67%]
1. [NCIT:C3917](markdown/NCIT_C3917.md) (Vaginal Carcinoma) [18][52.77%]
1. [NCIT:C3918](markdown/NCIT_C3918.md) (Extragonadal Germ Cell Tumor) [61][60.00%]
1. [NCIT:C3938](markdown/NCIT_C3938.md) (Turcot Syndrome) [2][56.74%]
1. [NCIT:C3995](markdown/NCIT_C3995.md) (Stage IV Breast Cancer AJCC v6 and v7) [7][53.57%]
1. [NCIT:C3999](markdown/NCIT_C3999.md) (Recurrent Esophageal Carcinoma) [2][53.00%]
1. [NCIT:C4001](markdown/NCIT_C4001.md) (Inflammatory Breast Carcinoma) [2][54.00%]
1. [NCIT:C4004](markdown/NCIT_C4004.md) (Gastric Adenocarcinoma) [16][53.67%]
1. [NCIT:C4007](markdown/NCIT_C4007.md) (Small Intestinal Lymphoma) [14][52.89%]
1. [NCIT:C4009](markdown/NCIT_C4009.md) (Non-Functioning Pituitary Gland Neoplasm) [5][53.20%]
1. [NCIT:C4012](markdown/NCIT_C4012.md) (Stage IV Non-Small Cell Lung Cancer AJCC v7) [3][53.58%]
1. [NCIT:C4015](markdown/NCIT_C4015.md) (Metastatic Malignant Neoplasm in the Central Nervous System) [13][58.33%]
1. [NCIT:C4016](markdown/NCIT_C4016.md) (Malignant Bone Neoplasm) [85][66.67%]
1. [NCIT:C4017](markdown/NCIT_C4017.md) (Ductal Breast Carcinoma) [21][54.24%]
1. [NCIT:C4024](markdown/NCIT_C4024.md) (Esophageal Squamous Cell Carcinoma) [14][54.38%]
1. [NCIT:C4025](markdown/NCIT_C4025.md) (Esophageal Adenocarcinoma) [9][54.53%]
1. [NCIT:C4028](markdown/NCIT_C4028.md) (Cervical Squamous Cell Carcinoma, Not Otherwise Specified) [10][54.31%]
1. [NCIT:C4029](markdown/NCIT_C4029.md) (Cervical Adenocarcinoma) [13][54.08%]
1. [NCIT:C4030](markdown/NCIT_C4030.md) (Urothelial Carcinoma) [52][53.20%]
1. [NCIT:C4031](markdown/NCIT_C4031.md) (Bladder Squamous Cell Carcinoma) [10][53.49%]
1. [NCIT:C4032](markdown/NCIT_C4032.md) (Bladder Adenocarcinoma) [6][53.75%]
1. [NCIT:C4033](markdown/NCIT_C4033.md) (Clear Cell Renal Cell Carcinoma) [6][54.16%]
1. [NCIT:C4035](markdown/NCIT_C4035.md) (Thyroid Gland Papillary Carcinoma) [10][55.77%]
1. [NCIT:C4036](markdown/NCIT_C4036.md) (Myelodysplastic Syndrome with Ring Sideroblasts) [2][54.00%]
1. [NCIT:C4043](markdown/NCIT_C4043.md) (Hypopharyngeal Squamous Cell Carcinoma) [6][53.75%]
1. [NCIT:C4044](markdown/NCIT_C4044.md) (Laryngeal Squamous Cell Carcinoma) [9][54.60%]
1. [NCIT:C4045](markdown/NCIT_C4045.md) (Childhood Oligodendroglioma) [2][54.74%]
1. [NCIT:C4047](markdown/NCIT_C4047.md) (Pilocytic Astrocytoma) [5][54.80%]
1. [NCIT:C4048](markdown/NCIT_C4048.md) (Childhood Pilocytic Astrocytoma) [2][54.87%]
1. [NCIT:C4049](markdown/NCIT_C4049.md) (Anaplastic Ependymoma) [2][54.31%]
1. [NCIT:C4050](markdown/NCIT_C4050.md) (Oligoastrocytoma) [3][54.31%]
1. [NCIT:C4052](markdown/NCIT_C4052.md) (Vulvar Squamous Cell Carcinoma) [6][53.49%]
1. [NCIT:C4060](markdown/NCIT_C4060.md) (Ovarian Cystadenoma) [5][53.84%]
1. [NCIT:C4063](markdown/NCIT_C4063.md) (Myomatous Neoplasm) [159][52.12%]
1. [NCIT:C4074](markdown/NCIT_C4074.md) (Centroblastic Lymphoma) [7][54.74%]
1. [NCIT:C4089](markdown/NCIT_C4089.md) (Polyposis) [3][62.50%]
1. [NCIT:C4090](markdown/NCIT_C4090.md) (Malignant Giant Cell Neoplasm) [13][60.00%]
1. [NCIT:C4092](markdown/NCIT_C4092.md) (Benign Epithelial Neoplasm) [181][55.56%]
1. [NCIT:C4102](markdown/NCIT_C4102.md) (Papillary Squamous Cell Carcinoma) [26][53.49%]
1. [NCIT:C4104](markdown/NCIT_C4104.md) (Metastatic Squamous Cell Carcinoma) [2][53.00%]
1. [NCIT:C4105](markdown/NCIT_C4105.md) (Keratinizing Squamous Cell Carcinoma) [23][53.57%]
1. [NCIT:C4107](markdown/NCIT_C4107.md) (Nasopharyngeal Type Undifferentiated Carcinoma) [19][53.00%]
1. [NCIT:C4113](markdown/NCIT_C4113.md) (Tricholemmoma) [2][53.75%]
1. [NCIT:C4115](markdown/NCIT_C4115.md) (Transitional Cell Papilloma) [11][53.30%]
1. [NCIT:C4116](markdown/NCIT_C4116.md) (Stage 0 Transitional Cell Carcinoma) [13][53.10%]
1. [NCIT:C4118](markdown/NCIT_C4118.md) (Inverted Transitional Cell Papilloma) [5][53.40%]
1. [NCIT:C4120](markdown/NCIT_C4120.md) (Sarcomatoid Transitional Cell Carcinoma) [4][57.50%]
1. [NCIT:C4121](markdown/NCIT_C4121.md) (Basaloid Carcinoma) [12][52.66%]
1. [NCIT:C4122](markdown/NCIT_C4122.md) (Papillary Transitional Cell Carcinoma) [8][53.20%]
1. [NCIT:C4123](markdown/NCIT_C4123.md) (Adenocarcinoma In Situ) [26][53.40%]
1. [NCIT:C4124](markdown/NCIT_C4124.md) (Metastatic Adenocarcinoma) [13][53.10%]
1. [NCIT:C4126](markdown/NCIT_C4126.md) (Intestinal-Type Adenocarcinoma) [6][53.30%]
1. [NCIT:C4127](markdown/NCIT_C4127.md) (Diffuse Type Adenocarcinoma) [3][53.10%]
1. [NCIT:C4129](markdown/NCIT_C4129.md) (Bile Duct Mucinous Cystic Neoplasm) [7][57.14%]
1. [NCIT:C4130](markdown/NCIT_C4130.md) (Bile Duct Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma) [2][53.84%]
1. [NCIT:C4133](markdown/NCIT_C4133.md) (Tubular Adenoma) [9][53.85%]
1. [NCIT:C4135](markdown/NCIT_C4135.md) (Multiple Adenomatous Polyps) [2][52.77%]
1. [NCIT:C4137](markdown/NCIT_C4137.md) (Solid Carcinoma) [7][55.00%]
1. [NCIT:C4139](markdown/NCIT_C4139.md) (Combined Carcinoid and Adenocarcinoma) [2][52.53%]
1. [NCIT:C4142](markdown/NCIT_C4142.md) (Villous Adenocarcinoma) [2][53.00%]
1. [NCIT:C4143](markdown/NCIT_C4143.md) (Tubulovillous Adenoma) [8][53.85%]
1. [NCIT:C4146](markdown/NCIT_C4146.md) (Chromophobe Renal Cell Carcinoma) [2][54.46%]
1. [NCIT:C4159](markdown/NCIT_C4159.md) (Lipoadenoma) [2][57.14%]
1. [NCIT:C4168](markdown/NCIT_C4168.md) (Apocrine Adenoma) [2][53.75%]
1. [NCIT:C4169](markdown/NCIT_C4169.md) (Apocrine Carcinoma) [4][56.00%]
1. [NCIT:C4171](markdown/NCIT_C4171.md) (Papillary Hidradenoma) [2][53.49%]
1. [NCIT:C4178](markdown/NCIT_C4178.md) (Borderline Papillary Cystadenoma) [2][53.20%]
1. [NCIT:C4179](markdown/NCIT_C4179.md) (Papillary Cystic Neoplasm) [12][57.14%]
1. [NCIT:C4180](markdown/NCIT_C4180.md) (Papillary Serous Cystadenoma) [2][53.20%]
1. [NCIT:C4182](markdown/NCIT_C4182.md) (Serous Surface Papillary Carcinoma) [3][54.76%]
1. [NCIT:C4188](markdown/NCIT_C4188.md) (Comedocarcinoma) [3][52.40%]
1. [NCIT:C4194](markdown/NCIT_C4194.md) (Invasive Ductal Carcinoma, Not Otherwise Specified) [2][56.04%]
1. [NCIT:C4197](markdown/NCIT_C4197.md) (Acinar Cell Neoplasm) [10][52.77%]
1. [NCIT:C4199](markdown/NCIT_C4199.md) (Epithelial-Myoepithelial Carcinoma) [2][54.55%]
1. [NCIT:C4216](markdown/NCIT_C4216.md) (Sympathetic Paraganglioma) [15][53.20%]
1. [NCIT:C4217](markdown/NCIT_C4217.md) (Parasympathetic Paraganglioma) [7][53.20%]
1. [NCIT:C4219](markdown/NCIT_C4219.md) (Malignant Extra-Adrenal Paraganglioma) [4][53.33%]
1. [NCIT:C4220](markdown/NCIT_C4220.md) (Malignant Adrenal Gland Pheochromocytoma) [2][54.46%]
1. [NCIT:C4222](markdown/NCIT_C4222.md) (Glomangioma) [2][55.56%]
1. [NCIT:C4228](markdown/NCIT_C4228.md) (Regressing Melanoma) [2][57.14%]
1. [NCIT:C4237](markdown/NCIT_C4237.md) (Spindle Cell Melanoma) [2][57.48%]
1. [NCIT:C4242](markdown/NCIT_C4242.md) (Benign Soft Tissue Neoplasm) [145][56.62%]
1. [NCIT:C4246](markdown/NCIT_C4246.md) (Atypical Fibroxanthoma) [2][57.14%]
1. [NCIT:C4247](markdown/NCIT_C4247.md) (Undifferentiated Pleomorphic Sarcoma) [8][54.16%]
1. [NCIT:C4248](markdown/NCIT_C4248.md) (Lipomatous Neoplasm) [81][57.14%]
1. [NCIT:C4250](markdown/NCIT_C4250.md) (Well Differentiated Liposarcoma) [2][54.46%]
1. [NCIT:C4263](markdown/NCIT_C4263.md) (Low Grade Endometrioid Stromal Sarcoma) [4][54.00%]
1. [NCIT:C4274](markdown/NCIT_C4274.md) (Benign Phyllodes Tumor) [2][53.85%]
1. [NCIT:C4275](markdown/NCIT_C4275.md) (Malignant Phyllodes Tumor) [3][53.30%]
1. [NCIT:C4286](markdown/NCIT_C4286.md) (Immature Teratoma) [6][54.17%]
1. [NCIT:C4290](markdown/NCIT_C4290.md) (Mixed Germ Cell Tumor) [6][52.02%]
1. [NCIT:C4298](markdown/NCIT_C4298.md) (Epithelioid Hemangioma) [3][53.57%]
1. [NCIT:C4303](markdown/NCIT_C4303.md) (Myxoid Chondrosarcoma) [2][55.88%]
1. [NCIT:C4318](markdown/NCIT_C4318.md) (Gliomatosis Cerebri) [4][54.24%]
1. [NCIT:C4320](markdown/NCIT_C4320.md) (Protoplasmic Astrocytoma) [2][54.53%]
1. [NCIT:C4321](markdown/NCIT_C4321.md) (Gemistocytic Astrocytoma) [3][54.38%]
1. [NCIT:C4322](markdown/NCIT_C4322.md) (Fibrillary Astrocytoma) [2][54.46%]
1. [NCIT:C4323](markdown/NCIT_C4323.md) (Pleomorphic Xanthoastrocytoma) [2][54.08%]
1. [NCIT:C4325](markdown/NCIT_C4325.md) (Giant Cell Glioblastoma) [3][55.06%]
1. [NCIT:C4326](markdown/NCIT_C4326.md) (Anaplastic Oligodendroglioma) [5][54.60%]
1. [NCIT:C4336](markdown/NCIT_C4336.md) (Malignant Granular Cell Tumor) [2][52.26%]
1. [NCIT:C4337](markdown/NCIT_C4337.md) (Mantle Cell Lymphoma) [14][54.16%]
1. [NCIT:C4340](markdown/NCIT_C4340.md) (Peripheral T-Cell Lymphoma, Not Otherwise Specified) [4][54.24%]
1. [NCIT:C4341](markdown/NCIT_C4341.md) (Marginal Zone Lymphoma) [39][53.75%]
1. [NCIT:C4342](markdown/NCIT_C4342.md) (Intravascular Large B-Cell Lymphoma) [4][54.38%]
1. [NCIT:C4343](markdown/NCIT_C4343.md) (Aleukemic Lymphoid Leukemia) [3][52.89%]
1. [NCIT:C4345](markdown/NCIT_C4345.md) (Myeloproliferative Neoplasm) [20][52.26%]
1. [NCIT:C4347](markdown/NCIT_C4347.md) (Childhood Cerebral Astrocytoma) [3][53.67%]
1. [NCIT:C4348](markdown/NCIT_C4348.md) (Non-Functioning Pituitary Gland Adenoma) [4][53.49%]
1. [NCIT:C4349](markdown/NCIT_C4349.md) (Colon Adenocarcinoma) [11][54.46%]
1. [NCIT:C4354](markdown/NCIT_C4354.md) (Benign Eyelid Neoplasm) [3][60.00%]
1. [NCIT:C4360](markdown/NCIT_C4360.md) (Lacrimal Gland Neoplasm) [9][75.00%]
1. [NCIT:C4374](markdown/NCIT_C4374.md) (Pancreatic Cystadenoma) [3][53.67%]
1. [NCIT:C4381](markdown/NCIT_C4381.md) (Ovarian Epithelial Tumor) [87][56.25%]
1. [NCIT:C4396](markdown/NCIT_C4396.md) (Malignant Adrenal Medulla Neoplasm) [6][75.00%]
1. [NCIT:C4397](markdown/NCIT_C4397.md) (Carcinoma ex Pleomorphic Adenoma) [6][53.67%]
1. [NCIT:C4410](markdown/NCIT_C4410.md) (Malignant Minor Salivary Gland Neoplasm) [9][75.00%]
1. [NCIT:C4433](markdown/NCIT_C4433.md) (Cecum Neoplasm) [9][68.06%]
1. [NCIT:C4436](markdown/NCIT_C4436.md) (Cholangiocarcinoma) [32][53.84%]
1. [NCIT:C4437](markdown/NCIT_C4437.md) (Liver Sarcoma) [5][53.30%]
1. [NCIT:C4440](markdown/NCIT_C4440.md) (Benign Gallbladder Neoplasm) [5][58.33%]
1. [NCIT:C4441](markdown/NCIT_C4441.md) (Extrahepatic Bile Duct Neoplasm) [57][66.67%]
1. [NCIT:C4447](markdown/NCIT_C4447.md) (Benign Retroperitoneal Neoplasm) [10][66.67%]
1. [NCIT:C4450](markdown/NCIT_C4450.md) (Large Cell Lung Carcinoma) [13][53.84%]
1. [NCIT:C4454](markdown/NCIT_C4454.md) (Benign Lung Neoplasm) [15][52.53%]
1. [NCIT:C4455](markdown/NCIT_C4455.md) (Lung Adenoma) [5][53.58%]
1. [NCIT:C4456](markdown/NCIT_C4456.md) (Malignant Mesothelioma) [30][52.12%]
1. [NCIT:C4463](markdown/NCIT_C4463.md) (Skin Appendage Neoplasm) [108][66.67%]
1. [NCIT:C4475](markdown/NCIT_C4475.md) (Dermal Neoplasm) [65][75.00%]
1. [NCIT:C4479](markdown/NCIT_C4479.md) (Cutaneous Neural Neoplasm) [2][75.00%]
1. [NCIT:C4480](markdown/NCIT_C4480.md) (Cutaneous Smooth Muscle Neoplasm) [3][54.17%]
1. [NCIT:C4489](markdown/NCIT_C4489.md) (Skin Angiosarcoma) [2][54.00%]
1. [NCIT:C4501](markdown/NCIT_C4501.md) (Malignant Lipomatous Neoplasm) [25][56.25%]
1. [NCIT:C4502](markdown/NCIT_C4502.md) (Benign Lipomatous Neoplasm) [51][56.25%]
1. [NCIT:C4503](markdown/NCIT_C4503.md) (Hereditary Breast Carcinoma) [2][52.77%]
1. [NCIT:C4505](markdown/NCIT_C4505.md) (Benign Breast Neoplasm) [18][66.67%]
1. [NCIT:C4508](markdown/NCIT_C4508.md) (Ovarian Seromucinous Tumor) [5][53.10%]
1. [NCIT:C4510](markdown/NCIT_C4510.md) (Benign Ovarian Epithelial Tumor) [23][53.30%]
1. [NCIT:C4514](markdown/NCIT_C4514.md) (Malignant Ovarian Germ Cell Tumor) [34][52.26%]
1. [NCIT:C4515](markdown/NCIT_C4515.md) (Ovarian Choriocarcinoma) [6][63.64%]
1. [NCIT:C4517](markdown/NCIT_C4517.md) (Benign Fallopian Tube Neoplasm) [6][57.14%]
1. [NCIT:C4521](markdown/NCIT_C4521.md) (Vaginal Intraepithelial Neoplasia) [3][55.56%]
1. [NCIT:C4523](markdown/NCIT_C4523.md) (Stage 0 Testicular Cancer) [3][52.77%]
1. [NCIT:C4525](markdown/NCIT_C4525.md) (Kidney Sarcoma) [5][52.77%]
1. [NCIT:C4533](markdown/NCIT_C4533.md) (Malignant Choroid Plexus Neoplasm) [2][53.40%]
1. [NCIT:C4534](markdown/NCIT_C4534.md) (Spinal Cord Glioma) [8][52.77%]
1. [NCIT:C4536](markdown/NCIT_C4536.md) (Pituitary Gland Carcinoma) [4][54.38%]
1. [NCIT:C4537](markdown/NCIT_C4537.md) (Optic Nerve Glioma) [3][53.57%]
1. [NCIT:C4565](markdown/NCIT_C4565.md) (Benign Thoracic Neoplasm) [51][52.12%]
1. [NCIT:C4567](markdown/NCIT_C4567.md) (Malignant Pericardial Neoplasm) [4][60.00%]
1. [NCIT:C4571](markdown/NCIT_C4571.md) (Malignant Respiratory Tract Neoplasm) [129][75.00%]
1. [NCIT:C4572](markdown/NCIT_C4572.md) (Malignant Intestinal Neoplasm) [222][75.00%]
1. [NCIT:C4573](markdown/NCIT_C4573.md) (Malignant Skin Appendage Neoplasm) [44][60.00%]
1. [NCIT:C4574](markdown/NCIT_C4574.md) (Malignant Dermal Neoplasm) [22][62.50%]
1. [NCIT:C4575](markdown/NCIT_C4575.md) (Malignant Great Vessel Neoplasm) [7][57.14%]
1. [NCIT:C4577](markdown/NCIT_C4577.md) (Malignant Cerebral Neoplasm) [12][58.33%]
1. [NCIT:C4581](markdown/NCIT_C4581.md) (Metastatic Malignant Neoplasm in the Large Intestine) [2][58.33%]
1. [NCIT:C4583](markdown/NCIT_C4583.md) (Metastatic Malignant Neoplasm in the Peritoneum) [2][60.00%]
1. [NCIT:C4586](markdown/NCIT_C4586.md) (Metastatic Malignant Neoplasm in the Eye) [2][62.50%]
1. [NCIT:C4596](markdown/NCIT_C4596.md) (Penile Intraepithelial Neoplasia) [4][53.33%]
1. [NCIT:C4598](markdown/NCIT_C4598.md) (Benign Gingival Neoplasm) [2][52.53%]
1. [NCIT:C4600](markdown/NCIT_C4600.md) (Benign Salivary Gland Neoplasm) [27][62.50%]
1. [NCIT:C4604](markdown/NCIT_C4604.md) (Benign Oropharyngeal Neoplasm) [2][55.00%]
1. [NCIT:C4607](markdown/NCIT_C4607.md) (Benign Myocardial Neoplasm) [2][52.66%]
1. [NCIT:C4608](markdown/NCIT_C4608.md) (Benign Endocardial Neoplasm) [5][75.00%]
1. [NCIT:C4609](markdown/NCIT_C4609.md) (Benign Intestinal Neoplasm) [20][62.50%]
1. [NCIT:C4610](markdown/NCIT_C4610.md) (Benign Colorectal Neoplasm) [15][58.33%]
1. [NCIT:C4611](markdown/NCIT_C4611.md) (Benign Anal Neoplasm) [4][60.00%]
1. [NCIT:C4612](markdown/NCIT_C4612.md) (Benign Pancreatic Neoplasm) [8][60.00%]
1. [NCIT:C4613](markdown/NCIT_C4613.md) (Benign Exocrine Pancreas Neoplasm) [7][58.33%]
1. [NCIT:C4615](markdown/NCIT_C4615.md) (Benign Skin Appendage Neoplasm) [51][58.33%]
1. [NCIT:C4621](markdown/NCIT_C4621.md) (Benign Endocrine Neoplasm) [14][54.55%]
1. [NCIT:C4627](markdown/NCIT_C4627.md) (Malignant Central Nervous System Neoplasm) [223][75.00%]
1. [NCIT:C4628](markdown/NCIT_C4628.md) (Malignant Neoplasm of the Meninges) [9][66.67%]
1. [NCIT:C4630](markdown/NCIT_C4630.md) (Low Grade Cervical Intraepithelial Neoplasia) [3][53.85%]
1. [NCIT:C4634](markdown/NCIT_C4634.md) (Cutaneous Fibroblastic Neoplasm) [8][56.25%]
1. [NCIT:C4636](markdown/NCIT_C4636.md) (Gastric Lymphoma) [7][52.89%]
1. [NCIT:C4637](markdown/NCIT_C4637.md) (Intestinal Neuroendocrine Tumor G1) [10][53.92%]
1. [NCIT:C4642](markdown/NCIT_C4642.md) (Brain Glioblastoma) [9][54.60%]
1. [NCIT:C4646](markdown/NCIT_C4646.md) (Gestational Choriocarcinoma) [2][63.64%]
1. [NCIT:C4651](markdown/NCIT_C4651.md) (Pericardial Neoplasm) [12][75.00%]
1. [NCIT:C4663](markdown/NCIT_C4663.md) (Splenic Marginal Zone Lymphoma) [2][54.60%]
1. [NCIT:C4664](markdown/NCIT_C4664.md) (T-Cell Large Granular Lymphocyte Leukemia) [3][54.31%]
1. [NCIT:C4665](markdown/NCIT_C4665.md) (Plasma Cell Neoplasm) [14][53.10%]
1. [NCIT:C4670](markdown/NCIT_C4670.md) (Breast Sarcoma) [8][52.66%]
1. [NCIT:C4671](markdown/NCIT_C4671.md) (Breast Lymphoma) [8][52.77%]
1. [NCIT:C4676](markdown/NCIT_C4676.md) (Skull Base Neoplasm) [47][75.00%]
1. [NCIT:C4683](markdown/NCIT_C4683.md) (Dermatofibrosarcoma Protuberans) [2][53.40%]
1. [NCIT:C4684](markdown/NCIT_C4684.md) (Nasal Type Extranodal NK/T-Cell Lymphoma) [9][54.87%]
1. [NCIT:C4699](markdown/NCIT_C4699.md) (Gestational Trophoblastic Tumor) [11][62.50%]
1. [NCIT:C4711](markdown/NCIT_C4711.md) (Borderline Cystadenoma) [4][53.57%]
1. [NCIT:C4712](markdown/NCIT_C4712.md) (Adenocarcinoma with Metaplasia) [4][53.00%]
1. [NCIT:C4727](markdown/NCIT_C4727.md) (Post-Transplant Lymphoproliferative Disorder) [18][57.14%]
1. [NCIT:C4737](markdown/NCIT_C4737.md) (Enteropathy-Associated T-Cell Lymphoma) [6][54.46%]
1. [NCIT:C4742](markdown/NCIT_C4742.md) (Benign Squamous Cell Neoplasm) [18][53.57%]
1. [NCIT:C4747](markdown/NCIT_C4747.md) (Neuronal and Mixed Neuronal-Glial Tumors) [17][55.56%]
1. [NCIT:C4748](markdown/NCIT_C4748.md) (Malignant Melanotic Peripheral Nerve Sheath Tumor) [2][54.16%]
1. [NCIT:C4752](markdown/NCIT_C4752.md) (T-Cell Prolymphocytic Leukemia) [3][55.13%]
1. [NCIT:C4755](markdown/NCIT_C4755.md) (Chondrogenic Neoplasm) [32][64.29%]
1. [NCIT:C4758](markdown/NCIT_C4758.md) (Metastatic Malignant Neoplasm in the Liver) [4][57.14%]
1. [NCIT:C4762](markdown/NCIT_C4762.md) (Malignant Major Salivary Gland Neoplasm) [45][51.13%]
1. [NCIT:C4768](markdown/NCIT_C4768.md) (Malignant Olfactory Nerve Neoplasm) [4][62.50%]
1. [NCIT:C4769](markdown/NCIT_C4769.md) (Malignant Pituitary Gland Neoplasm) [6][57.14%]
1. [NCIT:C4770](markdown/NCIT_C4770.md) (Benign Parotid Gland Neoplasm) [7][58.33%]
1. [NCIT:C4771](markdown/NCIT_C4771.md) (Benign Major Salivary Gland Neoplasm) [10][60.00%]
1. [NCIT:C4773](markdown/NCIT_C4773.md) (Benign Appendix Neoplasm) [2][60.00%]
1. [NCIT:C4774](markdown/NCIT_C4774.md) (Benign Rectal Neoplasm) [2][57.14%]
1. [NCIT:C4776](markdown/NCIT_C4776.md) (Benign Extrahepatic Bile Duct Neoplasm) [6][60.00%]
1. [NCIT:C4777](markdown/NCIT_C4777.md) (Benign Male Reproductive System Neoplasm) [12][57.14%]
1. [NCIT:C4778](markdown/NCIT_C4778.md) (Benign Kidney Neoplasm) [12][52.40%]
1. [NCIT:C4779](markdown/NCIT_C4779.md) (Benign Ciliary Body Neoplasm) [3][58.33%]
1. [NCIT:C4780](markdown/NCIT_C4780.md) (Benign Eye Neoplasm) [19][62.50%]
1. [NCIT:C4781](markdown/NCIT_C4781.md) (Benign Brain Neoplasm) [24][62.50%]
1. [NCIT:C4783](markdown/NCIT_C4783.md) (Borderline Ovarian Epithelial Tumor) [18][54.55%]
1. [NCIT:C4787](markdown/NCIT_C4787.md) (Benign Digestive System Neoplasm) [60][62.50%]
1. [NCIT:C4788](markdown/NCIT_C4788.md) (Malignant Nervous System Neoplasm) [264][75.00%]
1. [NCIT:C4793](markdown/NCIT_C4793.md) (Colon Lymphoma) [8][53.10%]
1. [NCIT:C4794](markdown/NCIT_C4794.md) (Lung Lymphoma) [3][52.89%]
1. [NCIT:C4801](markdown/NCIT_C4801.md) (Optic Nerve Neoplasm) [4][62.50%]
1. [NCIT:C4803](markdown/NCIT_C4803.md) (Duodenal Carcinoma) [3][53.40%]
1. [NCIT:C4810](markdown/NCIT_C4810.md) (Malignant Sweat Gland Neoplasm) [29][58.33%]
1. [NCIT:C4815](markdown/NCIT_C4815.md) (Thyroid Gland Carcinoma) [43][52.89%]
1. [NCIT:C4817](markdown/NCIT_C4817.md) (Ewing Sarcoma) [11][54.08%]
1. [NCIT:C4819](markdown/NCIT_C4819.md) (Skin Squamous Cell Carcinoma) [15][53.30%]
1. [NCIT:C4822](markdown/NCIT_C4822.md) (Malignant Glioma) [66][53.33%]
1. [NCIT:C4824](markdown/NCIT_C4824.md) (Tongue Carcinoma) [5][53.10%]
1. [NCIT:C4830](markdown/NCIT_C4830.md) (Ureter Urothelial Carcinoma) [5][53.58%]
1. [NCIT:C4832](markdown/NCIT_C4832.md) (Retroperitoneal Sarcoma) [6][54.55%]
1. [NCIT:C4833](markdown/NCIT_C4833.md) (Oral Cavity Squamous Cell Carcinoma) [22][53.49%]
1. [NCIT:C4834](markdown/NCIT_C4834.md) (Primary Bone Osteosarcoma) [17][53.58%]
1. [NCIT:C4835](markdown/NCIT_C4835.md) (Ewing Sarcoma of Bone) [3][54.46%]
1. [NCIT:C4839](markdown/NCIT_C4839.md) (Esophageal Intraepithelial Neoplasia) [13][54.55%]
1. [NCIT:C4840](markdown/NCIT_C4840.md) (Esophageal Low Grade Intraepithelial Neoplasia) [2][53.57%]
1. [NCIT:C4843](markdown/NCIT_C4843.md) (Biliary Intraepithelial Neoplasia) [7][53.30%]
1. [NCIT:C4845](markdown/NCIT_C4845.md) (Pancreatic Intraepithelial Neoplasia) [5][53.67%]
1. [NCIT:C4855](markdown/NCIT_C4855.md) (Laryngeal Carcinoma) [34][53.00%]
1. [NCIT:C4860](markdown/NCIT_C4860.md) (Lung Sarcoma) [2][52.89%]
1. [NCIT:C4861](markdown/NCIT_C4861.md) (Acute Monocytic Leukemia) [3][53.67%]
1. [NCIT:C4862](markdown/NCIT_C4862.md) (Ovarian Sex Cord-Stromal Tumor) [7][53.33%]
1. [NCIT:C4863](markdown/NCIT_C4863.md) (Prostate Carcinoma) [28][52.66%]
1. [NCIT:C4866](markdown/NCIT_C4866.md) (Vulvar Carcinoma) [46][52.53%]
1. [NCIT:C4867](markdown/NCIT_C4867.md) (Malignant Soft Tissue Neoplasm) [301][62.50%]
1. [NCIT:C4869](markdown/NCIT_C4869.md) (Brain Stem Neoplasm) [24][62.50%]
1. [NCIT:C4872](markdown/NCIT_C4872.md) (Breast Carcinoma) [115][52.66%]
1. [NCIT:C4874](markdown/NCIT_C4874.md) (Cerebral Neoplasm) [24][62.50%]
1. [NCIT:C4877](markdown/NCIT_C4877.md) (Rectosigmoid Neoplasm) [16][75.00%]
1. [NCIT:C4878](markdown/NCIT_C4878.md) (Lung Carcinoma) [105][52.89%]
1. [NCIT:C4879](markdown/NCIT_C4879.md) (Benign Sweat Gland Neoplasm) [28][53.20%]
1. [NCIT:C4880](markdown/NCIT_C4880.md) (Benign Bone Neoplasm) [18][62.50%]
1. [NCIT:C4882](markdown/NCIT_C4882.md) (Benign Muscle Neoplasm) [63][52.53%]
1. [NCIT:C4883](markdown/NCIT_C4883.md) (Malignant Muscle Neoplasm) [89][56.25%]
1. [NCIT:C4884](markdown/NCIT_C4884.md) (Benign Neck Neoplasm) [28][56.25%]
1. [NCIT:C4890](markdown/NCIT_C4890.md) (Malignant Digestive System Neoplasm) [730][75.00%]
1. [NCIT:C4893](markdown/NCIT_C4893.md) (Benign Urinary System Neoplasm) [30][51.96%]
1. [NCIT:C4895](markdown/NCIT_C4895.md) (Benign Adrenal Medulla Neoplasm) [2][57.14%]
1. [NCIT:C4905](markdown/NCIT_C4905.md) (Skin Hemangioma) [4][53.33%]
1. [NCIT:C4906](markdown/NCIT_C4906.md) (Parathyroid Gland Carcinoma) [4][55.26%]
1. [NCIT:C4908](markdown/NCIT_C4908.md) (Ovarian Carcinoma) [21][53.20%]
1. [NCIT:C4910](markdown/NCIT_C4910.md) (Colon Carcinoma) [37][53.84%]
1. [NCIT:C4911](markdown/NCIT_C4911.md) (Gastric Carcinoma) [43][52.89%]
1. [NCIT:C4912](markdown/NCIT_C4912.md) (Bladder Carcinoma) [57][52.66%]
1. [NCIT:C4914](markdown/NCIT_C4914.md) (Skin Carcinoma) [98][52.66%]
1. [NCIT:C4915](markdown/NCIT_C4915.md) (Embryonal Tumor with Multilayered Rosettes, C19MC-Altered) [5][53.33%]
1. [NCIT:C4917](markdown/NCIT_C4917.md) (Small Cell Lung Carcinoma) [2][55.66%]
1. [NCIT:C4925](markdown/NCIT_C4925.md) (Malignant Germ Cell Tumor) [90][55.36%]
1. [NCIT:C4934](markdown/NCIT_C4934.md) (Benign Female Reproductive System Neoplasm) [109][58.33%]
1. [NCIT:C4937](markdown/NCIT_C4937.md) (Recurrent Hodgkin Lymphoma) [7][52.77%]
1. [NCIT:C4942](markdown/NCIT_C4942.md) (Stage 0 Pharyngeal Cancer) [7][53.40%]
1. [NCIT:C4944](markdown/NCIT_C4944.md) (Sella Turcica Neoplasm) [45][66.67%]
1. [NCIT:C4949](markdown/NCIT_C4949.md) (Liver Lymphoma) [4][53.49%]
1. [NCIT:C4950](markdown/NCIT_C4950.md) (Colon Non-Hodgkin Lymphoma) [5][53.20%]
1. [NCIT:C4951](markdown/NCIT_C4951.md) (Cerebral Astrocytoma) [5][53.58%]
1. [NCIT:C4952](markdown/NCIT_C4952.md) (Primary Brain Neoplasm) [46][66.67%]
1. [NCIT:C4954](markdown/NCIT_C4954.md) (Malignant Primary Brain Neoplasm) [18][60.00%]
1. [NCIT:C4955](markdown/NCIT_C4955.md) (Benign Cerebellar Neoplasm) [2][58.33%]
1. [NCIT:C4961](markdown/NCIT_C4961.md) (Malignant Peripheral Nervous System Neoplasm) [31][75.00%]
1. [NCIT:C4962](markdown/NCIT_C4962.md) (Malignant Thymus Neoplasm) [35][62.50%]
1. [NCIT:C4963](markdown/NCIT_C4963.md) (Benign Supratentorial Neoplasm) [14][60.00%]
1. [NCIT:C4964](markdown/NCIT_C4964.md) (Malignant Supratentorial Neoplasm) [38][60.00%]
1. [NCIT:C4965](markdown/NCIT_C4965.md) (Benign Infratentorial Neoplasm) [5][60.00%]
1. [NCIT:C4966](markdown/NCIT_C4966.md) (Malignant Infratentorial Neoplasm) [35][60.00%]
1. [NCIT:C4967](markdown/NCIT_C4967.md) (Adult Acute Lymphoblastic Leukemia) [5][53.58%]
1. [NCIT:C4972](markdown/NCIT_C4972.md) (Nerve Sheath Neoplasm) [66][51.96%]
1. [NCIT:C4973](markdown/NCIT_C4973.md) (Perineurioma) [2][59.09%]
1. [NCIT:C4975](markdown/NCIT_C4975.md) (Primary Brain Stem Neoplasm) [19][60.00%]
1. [NCIT:C4978](markdown/NCIT_C4978.md) (Malignant Colorectal Neoplasm) [161][66.67%]
1. [NCIT:C4982](markdown/NCIT_C4982.md) (Aleukemic Leukemia) [6][51.96%]
1. [NCIT:C4983](markdown/NCIT_C4983.md) (Aleukemic Leukemia Cutis) [2][53.33%]
1. [NCIT:C4989](markdown/NCIT_C4989.md) (Childhood Leukemia) [34][51.96%]
1. [NCIT:C5006](markdown/NCIT_C5006.md) (Stage IV Follicular Lymphoma) [3][54.60%]
1. [NCIT:C5007](markdown/NCIT_C5007.md) (Recurrent Follicular Lymphoma) [3][54.53%]
1. [NCIT:C5008](markdown/NCIT_C5008.md) (Recurrent Burkitt Lymphoma) [2][54.46%]
1. [NCIT:C5027](markdown/NCIT_C5027.md) (Malignant Testicular Non-Seminomatous Germ Cell Tumor) [3][53.10%]
1. [NCIT:C5028](markdown/NCIT_C5028.md) (Verrucous Lesion) [10][53.33%]
1. [NCIT:C5029](markdown/NCIT_C5029.md) (Extrahepatic Bile Duct Sarcoma) [4][53.57%]
1. [NCIT:C5084](markdown/NCIT_C5084.md) (Stage IV Burkitt Lymphoma) [2][54.46%]
1. [NCIT:C5097](markdown/NCIT_C5097.md) (Brain Stem Glioblastoma) [2][54.87%]
1. [NCIT:C5103](markdown/NCIT_C5103.md) (Recurrent Pharyngeal Carcinoma) [8][53.00%]
1. [NCIT:C5105](markdown/NCIT_C5105.md) (Colorectal Adenocarcinoma) [33][54.38%]
1. [NCIT:C5111](markdown/NCIT_C5111.md) (Benign Intracranial Neoplasm) [30][66.67%]
1. [NCIT:C5114](markdown/NCIT_C5114.md) (Malignant Intracranial Neoplasm) [94][66.67%]
1. [NCIT:C5115](markdown/NCIT_C5115.md) (Malignant Adult Brain Neoplasm) [7][62.50%]
1. [NCIT:C5116](markdown/NCIT_C5116.md) (Benign Adult Brain Neoplasm) [4][60.00%]
1. [NCIT:C5117](markdown/NCIT_C5117.md) (Spiradenocarcinoma) [2][53.67%]
1. [NCIT:C5120](markdown/NCIT_C5120.md) (Vestibulocochlear Nerve Neoplasm) [2][75.00%]
1. [NCIT:C5121](markdown/NCIT_C5121.md) (Olfactory Nerve Neoplasm) [7][75.00%]
1. [NCIT:C5125](markdown/NCIT_C5125.md) (Diencephalic Neoplasm) [8][62.50%]
1. [NCIT:C5126](markdown/NCIT_C5126.md) (Malignant Diencephalic Neoplasm) [3][58.33%]
1. [NCIT:C5136](markdown/NCIT_C5136.md) (Childhood Glioblastoma) [6][54.60%]
1. [NCIT:C5141](markdown/NCIT_C5141.md) (Apocrine Breast Carcinoma) [2][55.00%]
1. [NCIT:C5148](markdown/NCIT_C5148.md) (Infratentorial Glioblastoma) [4][54.74%]
1. [NCIT:C5149](markdown/NCIT_C5149.md) (Supratentorial Glioblastoma) [2][54.74%]
1. [NCIT:C5153](markdown/NCIT_C5153.md) (Central Nervous System Sarcoma) [12][54.55%]
1. [NCIT:C5160](markdown/NCIT_C5160.md) (Mixed Lobular and Ductal Breast Carcinoma) [6][54.16%]
1. [NCIT:C5165](markdown/NCIT_C5165.md) (Childhood Lymphoma) [48][52.53%]
1. [NCIT:C5166](markdown/NCIT_C5166.md) (Mucoepidermoid Breast Carcinoma) [2][57.14%]
1. [NCIT:C5169](markdown/NCIT_C5169.md) (Breast Neuroendocrine Neoplasm) [5][55.56%]
1. [NCIT:C5175](markdown/NCIT_C5175.md) (Signet Ring Cell Breast Carcinoma) [2][53.67%]
1. [NCIT:C5177](markdown/NCIT_C5177.md) (Squamous Cell Breast Carcinoma) [2][53.49%]
1. [NCIT:C5181](markdown/NCIT_C5181.md) (Non-Hodgkin Breast Lymphoma) [5][52.89%]
1. [NCIT:C5184](markdown/NCIT_C5184.md) (Breast Angiosarcoma) [2][53.92%]
1. [NCIT:C5197](markdown/NCIT_C5197.md) (Benign Nipple Neoplasm) [2][51.96%]
1. [NCIT:C5206](markdown/NCIT_C5206.md) (Papillary Breast Neoplasm) [13][52.40%]
1. [NCIT:C5209](markdown/NCIT_C5209.md) (Vascular Breast Neoplasm) [6][56.25%]
1. [NCIT:C5213](markdown/NCIT_C5213.md) (Malignant Nipple Neoplasm) [4][75.00%]
1. [NCIT:C5214](markdown/NCIT_C5214.md) (Breast Adenocarcinoma) [54][53.20%]
1. [NCIT:C5226](markdown/NCIT_C5226.md) (Borderline Ovarian Serous Tumor) [2][53.67%]
1. [NCIT:C5228](markdown/NCIT_C5228.md) (Ovarian Cystadenocarcinoma) [3][53.75%]
1. [NCIT:C5229](markdown/NCIT_C5229.md) (Ovarian Carcinoid Tumor) [2][53.57%]
1. [NCIT:C5237](markdown/NCIT_C5237.md) (Ovarian Neuroendocrine Neoplasm) [5][55.00%]
1. [NCIT:C5241](markdown/NCIT_C5241.md) (Mixed Germ Cell-Sex Cord-Stromal Tumor) [3][52.89%]
1. [NCIT:C5242](markdown/NCIT_C5242.md) (Ovarian Mucinous Tumor) [9][53.20%]
1. [NCIT:C5244](markdown/NCIT_C5244.md) (Ovarian Soft Tissue Neoplasm) [13][62.50%]
1. [NCIT:C5259](markdown/NCIT_C5259.md) (Gastric Teratoma) [2][54.17%]
1. [NCIT:C5265](markdown/NCIT_C5265.md) (Thyroid Gland Lymphoma) [3][52.77%]
1. [NCIT:C5308](markdown/NCIT_C5308.md) (Ectopic Meningioma) [4][62.50%]
1. [NCIT:C5322](markdown/NCIT_C5322.md) (Central Nervous System Anaplastic Large Cell Lymphoma) [2][54.24%]
1. [NCIT:C5327](markdown/NCIT_C5327.md) (Head and Neck Paraganglioma) [7][53.57%]
1. [NCIT:C5335](markdown/NCIT_C5335.md) (Small Intestinal Sarcoma) [5][52.77%]
1. [NCIT:C5340](markdown/NCIT_C5340.md) (Small Intestinal Adenoma) [5][53.20%]
1. [NCIT:C5341](markdown/NCIT_C5341.md) (Esophageal Sarcoma) [4][52.77%]
1. [NCIT:C5346](markdown/NCIT_C5346.md) (Endocardial Neoplasm) [7][75.00%]
1. [NCIT:C5347](markdown/NCIT_C5347.md) (Epicardial Neoplasm) [4][75.00%]
1. [NCIT:C5348](markdown/NCIT_C5348.md) (Great Vessel Neoplasm) [9][60.00%]
1. [NCIT:C5349](markdown/NCIT_C5349.md) (Myocardial Neoplasm) [4][75.00%]
1. [NCIT:C5353](markdown/NCIT_C5353.md) (Breast Hemangioma) [2][53.33%]
1. [NCIT:C5354](markdown/NCIT_C5354.md) (Cutaneous Vascular Neoplasm) [15][57.14%]
1. [NCIT:C5387](markdown/NCIT_C5387.md) (Leiomyosarcoma of Vessels) [5][54.67%]
1. [NCIT:C5389](markdown/NCIT_C5389.md) (Benign Atrial Neoplasm) [3][52.53%]
1. [NCIT:C5398](markdown/NCIT_C5398.md) (Central Nervous System Embryonal Tumor, Not Otherwise Specified) [10][55.56%]
1. [NCIT:C5409](markdown/NCIT_C5409.md) (Central Nervous System T-Cell Non-Hodgkin Lymphoma) [4][53.40%]
1. [NCIT:C5437](markdown/NCIT_C5437.md) (Extracranial Neuroblastoma) [8][53.58%]
1. [NCIT:C5441](markdown/NCIT_C5441.md) (Central Nervous System Teratoma) [11][57.69%]
1. [NCIT:C5444](markdown/NCIT_C5444.md) (Intracranial Lipoma) [2][53.33%]
1. [NCIT:C5449](markdown/NCIT_C5449.md) (Central Nervous System Mesenchymal, Non-Meningothelial Neoplasm) [36][66.67%]
1. [NCIT:C5451](markdown/NCIT_C5451.md) (Central Nervous System Lipoma) [4][54.17%]
1. [NCIT:C5461](markdown/NCIT_C5461.md) (Central Nervous System Germ Cell Tumor) [27][58.33%]
1. [NCIT:C5478](markdown/NCIT_C5478.md) (Adult Intracranial Neoplasm) [26][75.00%]
1. [NCIT:C5486](markdown/NCIT_C5486.md) (Malignant Gastric Germ Cell Tumor) [2][52.40%]
1. [NCIT:C5487](markdown/NCIT_C5487.md) (Gastric Soft Tissue Neoplasm) [17][66.67%]
1. [NCIT:C5495](markdown/NCIT_C5495.md) (Colon Sarcoma) [2][53.00%]
1. [NCIT:C5497](markdown/NCIT_C5497.md) (Colon Neuroendocrine Tumor G1) [4][54.16%]
1. [NCIT:C5503](markdown/NCIT_C5503.md) (Central Nervous System Hematopoietic Neoplasm) [29][66.67%]
1. [NCIT:C5504](markdown/NCIT_C5504.md) (Central Nervous System Melanocytic Neoplasm) [2][58.33%]
1. [NCIT:C5545](markdown/NCIT_C5545.md) (Prostate Neuroendocrine Neoplasm) [2][55.00%]
1. [NCIT:C5546](markdown/NCIT_C5546.md) (Rectal Adenoma) [7][53.20%]
1. [NCIT:C5548](markdown/NCIT_C5548.md) (Rectal Sarcoma) [3][52.89%]
1. [NCIT:C5559](markdown/NCIT_C5559.md) (Malignant Eccrine Neoplasm) [8][52.66%]
1. [NCIT:C5566](markdown/NCIT_C5566.md) (Cutaneous Lipomatous Neoplasm) [2][55.56%]
1. [NCIT:C5585](markdown/NCIT_C5585.md) (Skin Sarcoma) [9][53.85%]
1. [NCIT:C5591](markdown/NCIT_C5591.md) (Benign Childhood Central Nervous System Neoplasm) [5][55.00%]
1. [NCIT:C5596](markdown/NCIT_C5596.md) (Prostate Acinar Adenocarcinoma) [2][55.43%]
1. [NCIT:C5598](markdown/NCIT_C5598.md) (Paget Disease of the Anus) [2][53.58%]
1. [NCIT:C5600](markdown/NCIT_C5600.md) (Anal Adenocarcinoma) [7][53.30%]
1. [NCIT:C5603](markdown/NCIT_C5603.md) (Anal Canal Neuroendocrine Neoplasm) [6][54.55%]
1. [NCIT:C5611](markdown/NCIT_C5611.md) (Anal Sarcoma) [3][52.77%]
1. [NCIT:C5629](markdown/NCIT_C5629.md) (Metastatic Malignant Neoplasm in the Skin) [2][60.00%]
1. [NCIT:C5636](markdown/NCIT_C5636.md) (Childhood Anaplastic Large Cell Lymphoma) [7][53.84%]
1. [NCIT:C5637](markdown/NCIT_C5637.md) (Childhood Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma) [9][53.30%]
1. [NCIT:C5640](markdown/NCIT_C5640.md) (Childhood T Lymphoblastic Leukemia/Lymphoma) [4][54.93%]
1. [NCIT:C5669](markdown/NCIT_C5669.md) (Pleuropulmonary Blastoma) [3][53.49%]
1. [NCIT:C5670](markdown/NCIT_C5670.md) (Lung Neuroendocrine Neoplasm) [11][55.00%]
1. [NCIT:C5673](markdown/NCIT_C5673.md) (Colorectal Adenoma) [28][53.57%]
1. [NCIT:C5674](markdown/NCIT_C5674.md) (Colorectal Traditional Serrated Adenoma) [2][53.84%]
1. [NCIT:C5675](markdown/NCIT_C5675.md) (Colorectal Tubulovillous Adenoma) [2][53.30%]
1. [NCIT:C5676](markdown/NCIT_C5676.md) (Colorectal Villous Adenoma) [3][53.49%]
1. [NCIT:C5677](markdown/NCIT_C5677.md) (Colorectal Leiomyoma) [2][53.67%]
1. [NCIT:C5678](markdown/NCIT_C5678.md) (Colorectal Lipoma) [2][53.33%]
1. [NCIT:C5684](markdown/NCIT_C5684.md) (Lung Non-Hodgkin Lymphoma) [2][53.00%]
1. [NCIT:C5685](markdown/NCIT_C5685.md) (Colorectal Adenoma with Severe Dysplasia) [2][53.20%]
1. [NCIT:C5687](markdown/NCIT_C5687.md) (Esophageal Lymphoma) [4][52.89%]
1. [NCIT:C5688](markdown/NCIT_C5688.md) (Esophageal Non-Hodgkin Lymphoma) [2][53.00%]
1. [NCIT:C5695](markdown/NCIT_C5695.md) (Intestinal Neuroendocrine Neoplasm) [52][54.55%]
1. [NCIT:C5696](markdown/NCIT_C5696.md) (Gastric Neuroendocrine Neoplasm) [10][54.55%]
1. [NCIT:C5697](markdown/NCIT_C5697.md) (Colon Neuroendocrine Neoplasm) [10][53.57%]
1. [NCIT:C5698](markdown/NCIT_C5698.md) (Rectal Neuroendocrine Neoplasm) [6][53.57%]
1. [NCIT:C5716](markdown/NCIT_C5716.md) (Borderline Exocrine Pancreatic Neoplasm) [13][60.00%]
1. [NCIT:C5736](markdown/NCIT_C5736.md) (Gallbladder Sarcoma) [4][53.85%]
1. [NCIT:C5749](markdown/NCIT_C5749.md) (Liver and Intrahepatic Bile Duct Benign Non-Epithelial Neoplasm) [6][55.56%]
1. [NCIT:C5766](markdown/NCIT_C5766.md) (Liver Non-Hodgkin Lymphoma) [3][53.67%]
1. [NCIT:C5794](markdown/NCIT_C5794.md) (Adult Central Nervous System Teratoma) [2][57.14%]
1. [NCIT:C5798](markdown/NCIT_C5798.md) (Benign Childhood Brain Neoplasm) [4][53.57%]
1. [NCIT:C5799](markdown/NCIT_C5799.md) (Benign Childhood Supratentorial Neoplasm) [3][53.33%]
1. [NCIT:C5802](markdown/NCIT_C5802.md) (Childhood Infratentorial Neoplasm) [15][62.50%]
1. [NCIT:C5803](markdown/NCIT_C5803.md) (Small Intestinal Neuroendocrine Neoplasm) [18][53.85%]
1. [NCIT:C5806](markdown/NCIT_C5806.md) (Gastric Gastrointestinal Stromal Tumor) [5][53.40%]
1. [NCIT:C5811](markdown/NCIT_C5811.md) (Small Intestinal Gastrointestinal Stromal Tumor) [3][53.40%]
1. [NCIT:C5817](markdown/NCIT_C5817.md) (Intracranial Embryonal Tumor, Not Otherwise Specified) [6][54.55%]
1. [NCIT:C5821](markdown/NCIT_C5821.md) (Esophageal Neuroendocrine Neoplasm) [6][54.17%]
1. [NCIT:C5856](markdown/NCIT_C5856.md) (Benign Extrahepatic Bile Duct Soft Tissue Neoplasm) [3][54.17%]
1. [NCIT:C5857](markdown/NCIT_C5857.md) (Extrahepatic Bile Duct Adenoma) [3][53.40%]
1. [NCIT:C5883](markdown/NCIT_C5883.md) (Stage I Oral Cavity Cancer AJCC v6 and v7) [3][53.20%]
1. [NCIT:C5884](markdown/NCIT_C5884.md) (Stage II Oral Cavity Cancer AJCC v6 and v7) [3][53.20%]
1. [NCIT:C5885](markdown/NCIT_C5885.md) (Stage III Oral Cavity Cancer AJCC v6 and v7) [3][53.20%]
1. [NCIT:C5886](markdown/NCIT_C5886.md) (Stage IV Oral Cavity Cancer AJCC v6 and v7) [3][53.20%]
1. [NCIT:C5898](markdown/NCIT_C5898.md) (Stage IV Major Salivary Gland Cancer AJCC v7) [2][53.57%]
1. [NCIT:C5902](markdown/NCIT_C5902.md) (Malignant Mixed Tumor of the Major Salivary Gland) [6][52.26%]
1. [NCIT:C5903](markdown/NCIT_C5903.md) (Major Salivary Gland Adenocarcinoma) [3][53.30%]
1. [NCIT:C5905](markdown/NCIT_C5905.md) (Major Salivary Gland Adenoid Cystic Carcinoma) [2][53.49%]
1. [NCIT:C5906](markdown/NCIT_C5906.md) (Major Salivary Gland Mucoepidermoid Carcinoma) [2][57.50%]
1. [NCIT:C5907](markdown/NCIT_C5907.md) (Major Salivary Gland Carcinoma) [33][52.77%]
1. [NCIT:C5908](markdown/NCIT_C5908.md) (Salivary Gland Mucoepidermoid Carcinoma) [6][57.89%]
1. [NCIT:C5913](markdown/NCIT_C5913.md) (Oral Cavity Adenoma) [2][53.40%]
1. [NCIT:C5945](markdown/NCIT_C5945.md) (Malignant Parotid Gland Mixed Tumor) [2][55.56%]
1. [NCIT:C5957](markdown/NCIT_C5957.md) (Minor Salivary Gland Carcinoma) [7][52.77%]
1. [NCIT:C5960](markdown/NCIT_C5960.md) (Childhood Supratentorial Neoplasm) [23][62.50%]
1. [NCIT:C5961](markdown/NCIT_C5961.md) (Childhood Central Nervous System Embryonal Tumor, Not Otherwise Specified) [2][55.00%]
1. [NCIT:C5967](markdown/NCIT_C5967.md) (Adult Brain Stem Neoplasm) [5][60.00%]
1. [NCIT:C5968](markdown/NCIT_C5968.md) (Adult Cerebellar Neoplasm) [3][60.00%]
1. [NCIT:C5969](markdown/NCIT_C5969.md) (Childhood Brain Stem Neoplasm) [6][60.00%]
1. [NCIT:C5970](markdown/NCIT_C5970.md) (Childhood Cerebellar Neoplasm) [5][60.00%]
1. [NCIT:C5971](markdown/NCIT_C5971.md) (Ear Polyp) [2][52.40%]
1. [NCIT:C5975](markdown/NCIT_C5975.md) (Major Salivary Gland Carcinoma ex Pleomorphic Adenoma) [2][53.92%]
1. [NCIT:C6014](markdown/NCIT_C6014.md) (Paranasal Sinus Carcinoma) [12][53.20%]
1. [NCIT:C6020](markdown/NCIT_C6020.md) (Laryngeal Sarcoma) [2][54.55%]
1. [NCIT:C6023](markdown/NCIT_C6023.md) (Laryngeal Neuroendocrine Neoplasm) [3][55.56%]
1. [NCIT:C6044](markdown/NCIT_C6044.md) (Thyroid Gland Non-Hodgkin Lymphoma) [2][52.89%]
1. [NCIT:C6061](markdown/NCIT_C6061.md) (Malignant Anterior Tongue Neoplasm) [4][66.67%]
1. [NCIT:C6062](markdown/NCIT_C6062.md) (Anterior Tongue Neoplasm) [6][75.00%]
1. [NCIT:C6068](markdown/NCIT_C6068.md) (Paranasal Sinus Lymphoma) [2][52.66%]
1. [NCIT:C6076](markdown/NCIT_C6076.md) (Recurrent Oral Cavity Carcinoma) [4][53.00%]
1. [NCIT:C6077](markdown/NCIT_C6077.md) (Neck Carcinoma) [186][52.66%]
1. [NCIT:C6078](markdown/NCIT_C6078.md) (Eyelid Carcinoma) [4][52.66%]
1. [NCIT:C6079](markdown/NCIT_C6079.md) (Eye Carcinoma) [14][52.53%]
1. [NCIT:C6081](markdown/NCIT_C6081.md) (External Ear Carcinoma) [2][52.77%]
1. [NCIT:C6089](markdown/NCIT_C6089.md) (Middle Ear Carcinoma) [3][52.77%]
1. [NCIT:C6093](markdown/NCIT_C6093.md) (Corneal Intraepithelial Neoplasia) [2][53.57%]
1. [NCIT:C6104](markdown/NCIT_C6104.md) (Benign Uveal Neoplasm) [4][60.00%]
1. [NCIT:C6120](markdown/NCIT_C6120.md) (Conjunctival Intraepithelial Neoplasia) [2][53.33%]
1. [NCIT:C6129](markdown/NCIT_C6129.md) (Lacrimal Gland Carcinoma) [5][52.77%]
1. [NCIT:C6142](markdown/NCIT_C6142.md) (Renal Pelvis Carcinoma) [12][52.89%]
1. [NCIT:C6149](markdown/NCIT_C6149.md) (Stage 0 Ureter Urothelial Carcinoma) [2][54.00%]
1. [NCIT:C6165](markdown/NCIT_C6165.md) (Urethral Squamous Cell Carcinoma) [2][53.00%]
1. [NCIT:C6188](markdown/NCIT_C6188.md) (Stage 0 Bladder Urothelial Carcinoma) [3][54.00%]
1. [NCIT:C6192](markdown/NCIT_C6192.md) (Inverted Urothelial Papilloma) [4][54.24%]
1. [NCIT:C6193](markdown/NCIT_C6193.md) (Stage 0 Renal Pelvis Urothelial Carcinoma) [2][54.24%]
1. [NCIT:C6195](markdown/NCIT_C6195.md) (Stage 0 Urethral Cancer) [2][52.66%]
1. [NCIT:C6204](markdown/NCIT_C6204.md) (Childhood Central Nervous System Teratoma) [2][57.14%]
1. [NCIT:C6205](markdown/NCIT_C6205.md) (Childhood Central Nervous System Germ Cell Tumor) [4][57.14%]
1. [NCIT:C6215](markdown/NCIT_C6215.md) (Childhood Anaplastic Astrocytoma) [4][55.06%]
1. [NCIT:C6219](markdown/NCIT_C6219.md) (Benign Childhood Cerebral Neoplasm) [2][53.20%]
1. [NCIT:C6221](markdown/NCIT_C6221.md) (Thalamic Neoplasm) [2][60.00%]
1. [NCIT:C6249](markdown/NCIT_C6249.md) (Anterior Tongue Carcinoma) [3][53.20%]
1. [NCIT:C6252](markdown/NCIT_C6252.md) (Childhood Brain Anaplastic Astrocytoma) [2][55.25%]
1. [NCIT:C6257](markdown/NCIT_C6257.md) (Ovarian Endometrioid Tumor) [11][54.55%]
1. [NCIT:C6262](markdown/NCIT_C6262.md) (Visual Pathway Neoplasm) [11][75.00%]
1. [NCIT:C6265](markdown/NCIT_C6265.md) (Fallopian Tube Adenocarcinoma) [9][53.20%]
1. [NCIT:C6285](markdown/NCIT_C6285.md) (Adult Central Nervous System Germ Cell Tumor) [8][57.14%]
1. [NCIT:C6286](markdown/NCIT_C6286.md) (Childhood Cerebellar Astrocytoma) [2][53.67%]
1. [NCIT:C6287](markdown/NCIT_C6287.md) (Endometrial Endometrioid Adenocarcinoma) [11][54.67%]
1. [NCIT:C6311](markdown/NCIT_C6311.md) (Malignant Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm) [3][53.20%]
1. [NCIT:C6335](markdown/NCIT_C6335.md) (Benign Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm) [2][53.49%]
1. [NCIT:C6339](markdown/NCIT_C6339.md) (Uterine Corpus Sarcoma) [14][54.17%]
1. [NCIT:C6340](markdown/NCIT_C6340.md) (Uterine Corpus Leiomyosarcoma) [2][54.93%]
1. [NCIT:C6380](markdown/NCIT_C6380.md) (Vulvar Adenocarcinoma) [9][53.20%]
1. [NCIT:C6410](markdown/NCIT_C6410.md) (Cardiac Paraganglioma) [2][53.33%]
1. [NCIT:C6421](markdown/NCIT_C6421.md) (Foregut Carcinoid Tumor) [8][53.33%]
1. [NCIT:C6422](markdown/NCIT_C6422.md) (Midgut Carcinoid Tumor) [6][54.17%]
1. [NCIT:C6423](markdown/NCIT_C6423.md) (Hindgut Carcinoid Tumor) [3][53.33%]
1. [NCIT:C6431](markdown/NCIT_C6431.md) (Metastatic Carcinoid Tumor) [2][53.33%]
1. [NCIT:C6432](markdown/NCIT_C6432.md) (Multiple Endocrine Neoplasia) [4][56.25%]
1. [NCIT:C6437](markdown/NCIT_C6437.md) (Mediastinal Germ Cell Tumor) [3][54.17%]
1. [NCIT:C6448](markdown/NCIT_C6448.md) (Gastric Germ Cell Tumor) [5][58.33%]
1. [NCIT:C6449](markdown/NCIT_C6449.md) (Benign Germ Cell Tumor) [5][52.26%]
1. [NCIT:C6450](markdown/NCIT_C6450.md) (Thymus Epithelial Neoplasm) [48][51.96%]
1. [NCIT:C6451](markdown/NCIT_C6451.md) (Thymic Lymphoma) [7][53.20%]
1. [NCIT:C6478](markdown/NCIT_C6478.md) (Vascular Bone Neoplasm) [4][58.33%]
1. [NCIT:C6481](markdown/NCIT_C6481.md) (Inflammatory Myofibroblastic Tumor) [9][54.16%]
1. [NCIT:C6484](markdown/NCIT_C6484.md) (Dermal Fibroma) [2][53.30%]
1. [NCIT:C6490](markdown/NCIT_C6490.md) (Benign Fibrohistiocytic Neoplasm) [11][52.26%]
1. [NCIT:C6491](markdown/NCIT_C6491.md) (Intermediate Fibrohistiocytic Neoplasm) [2][52.53%]
1. [NCIT:C6498](markdown/NCIT_C6498.md) (Deep Lipoma) [4][54.17%]
1. [NCIT:C6510](markdown/NCIT_C6510.md) (Benign Smooth Muscle Neoplasm) [51][53.85%]
1. [NCIT:C6511](markdown/NCIT_C6511.md) (Malignant Smooth Muscle Neoplasm) [52][54.17%]
1. [NCIT:C6514](markdown/NCIT_C6514.md) (Skeletal Muscle Neoplasm) [44][52.53%]
1. [NCIT:C6515](markdown/NCIT_C6515.md) (Benign Skeletal Muscle Neoplasm) [7][52.89%]
1. [NCIT:C6516](markdown/NCIT_C6516.md) (Malignant Skeletal Muscle Neoplasm) [35][52.77%]
1. [NCIT:C6524](markdown/NCIT_C6524.md) (Benign Lymphatic Vessel Neoplasm) [12][55.56%]
1. [NCIT:C6528](markdown/NCIT_C6528.md) (Pericytic Neoplasm) [20][58.33%]
1. [NCIT:C6529](markdown/NCIT_C6529.md) (Benign Pericytic Neoplasm) [8][57.14%]
1. [NCIT:C6555](markdown/NCIT_C6555.md) (Deep Hemangioma) [3][54.17%]
1. [NCIT:C6563](markdown/NCIT_C6563.md) (Childhood Kidney Neoplasm) [12][66.67%]
1. [NCIT:C6569](markdown/NCIT_C6569.md) (Congenital Mesoblastic Nephroma) [3][52.26%]
1. [NCIT:C6570](markdown/NCIT_C6570.md) (Extraskeletal Cartilaginous and Osseous Neoplasm) [17][51.79%]
1. [NCIT:C6571](markdown/NCIT_C6571.md) (Benign Extraskeletal Cartilaginous and Osseous Neoplasm) [4][52.12%]
1. [NCIT:C6572](markdown/NCIT_C6572.md) (Malignant Extraskeletal Cartilaginous and Osseous Neoplasm) [11][51.96%]
1. [NCIT:C6577](markdown/NCIT_C6577.md) (Myxoma) [11][55.00%]
1. [NCIT:C6585](markdown/NCIT_C6585.md) (Childhood Osteosarcoma) [4][53.33%]
1. [NCIT:C6587](markdown/NCIT_C6587.md) (Benign Soft Tissue Tumor of Uncertain Differentiation) [14][60.00%]
1. [NCIT:C6588](markdown/NCIT_C6588.md) (Malignant Soft Tissue Tumor of Uncertain Differentiation) [30][58.33%]
1. [NCIT:C6591](markdown/NCIT_C6591.md) (Peripheral Neuroblastoma) [2][54.24%]
1. [NCIT:C6593](markdown/NCIT_C6593.md) (Benign Mediastinal Soft Tissue Neoplasm) [6][52.77%]
1. [NCIT:C6594](markdown/NCIT_C6594.md) (Peripheral Ganglioneuroblastoma) [2][53.30%]
1. [NCIT:C6602](markdown/NCIT_C6602.md) (Benign Osteogenic Neoplasm) [6][56.25%]
1. [NCIT:C6603](markdown/NCIT_C6603.md) (Osteogenic Neoplasm) [48][57.14%]
1. [NCIT:C6605](markdown/NCIT_C6605.md) (Soft Tissue Fibrosarcoma) [9][53.20%]
1. [NCIT:C6606](markdown/NCIT_C6606.md) (Mediastinal Sarcoma) [6][53.85%]
1. [NCIT:C6624](markdown/NCIT_C6624.md) (Mediastinal Neural Neoplasm) [5][66.67%]
1. [NCIT:C6633](markdown/NCIT_C6633.md) (Mediastinal Lymphoma) [9][52.89%]
1. [NCIT:C6637](markdown/NCIT_C6637.md) (Mediastinal Soft Tissue Neoplasm) [17][62.50%]
1. [NCIT:C6642](markdown/NCIT_C6642.md) (Malignant Mediastinal Soft Tissue Neoplasm) [7][57.14%]
1. [NCIT:C6650](markdown/NCIT_C6650.md) (Ampulla of Vater Adenocarcinoma) [5][54.24%]
1. [NCIT:C6657](markdown/NCIT_C6657.md) (Ampulla of Vater Intestinal-Type Adenoma) [3][53.92%]
1. [NCIT:C6671](markdown/NCIT_C6671.md) (Stage I Non-Small Cell Lung Cancer AJCC v7) [3][53.58%]
1. [NCIT:C6751](markdown/NCIT_C6751.md) (Benign Extragonadal Germ Cell Tumor) [2][52.40%]
1. [NCIT:C6757](markdown/NCIT_C6757.md) (Benign Central Nervous System Mesenchymal, Non-Meningothelial Neoplasm) [12][60.00%]
1. [NCIT:C6758](markdown/NCIT_C6758.md) (Malignant Central Nervous System Mesenchymal, Non-Meningothelial Neoplasm) [16][60.00%]
1. [NCIT:C6770](markdown/NCIT_C6770.md) (Ependymal Tumor) [39][53.00%]
1. [NCIT:C6781](markdown/NCIT_C6781.md) (Stromal Neoplasm) [53][52.26%]
1. [NCIT:C6783](markdown/NCIT_C6783.md) (Transitional Cell Neoplasm) [94][58.33%]
1. [NCIT:C6791](markdown/NCIT_C6791.md) (Parotid Gland Carcinoma) [6][52.89%]
1. [NCIT:C6795](markdown/NCIT_C6795.md) (Gastric Pylorus Carcinoma) [2][53.00%]
1. [NCIT:C6796](markdown/NCIT_C6796.md) (Eccrine Neoplasm) [13][56.25%]
1. [NCIT:C6797](markdown/NCIT_C6797.md) (Benign Eccrine Neoplasm) [3][53.58%]
1. [NCIT:C6798](markdown/NCIT_C6798.md) (Apocrine Neoplasm) [10][56.25%]
1. [NCIT:C6799](markdown/NCIT_C6799.md) (Benign Apocrine Neoplasm) [3][53.58%]
1. [NCIT:C6800](markdown/NCIT_C6800.md) (Malignant Apocrine Neoplasm) [5][54.55%]
1. [NCIT:C6801](markdown/NCIT_C6801.md) (Cutaneous Fibrous Histiocytoma) [2][53.20%]
1. [NCIT:C6803](markdown/NCIT_C6803.md) (Benign Ovarian Sex Cord-Stromal Tumor) [3][53.67%]
1. [NCIT:C6806](markdown/NCIT_C6806.md) (Benign Cutaneous Fibroblastic Neoplasm) [3][53.33%]
1. [NCIT:C6807](markdown/NCIT_C6807.md) (Benign External Ear Neoplasm) [2][52.12%]
1. [NCIT:C6810](markdown/NCIT_C6810.md) (Testicular Lymphoma) [2][52.66%]
1. [NCIT:C6813](markdown/NCIT_C6813.md) (Prostate Ductal Adenocarcinoma) [3][54.08%]
1. [NCIT:C6814](markdown/NCIT_C6814.md) (Superficial Fibromatosis) [2][53.10%]
1. [NCIT:C6820](markdown/NCIT_C6820.md) (Pancreatic Intraepithelial Neoplasia-1) [2][54.00%]
1. [NCIT:C6849](markdown/NCIT_C6849.md) (Paranasal Sinus Sarcoma) [2][52.66%]
1. [NCIT:C6858](markdown/NCIT_C6858.md) (Primary Cutaneous B-Cell Non-Hodgkin Lymphoma) [11][53.58%]
1. [NCIT:C6860](markdown/NCIT_C6860.md) (Primary Cutaneous Anaplastic Large Cell Lymphoma) [2][55.19%]
1. [NCIT:C6875](markdown/NCIT_C6875.md) (Large Cell Neuroendocrine Carcinoma) [20][53.67%]
1. [NCIT:C6877](markdown/NCIT_C6877.md) (Grade III Glandular Intraepithelial Neoplasia) [12][54.00%]
1. [NCIT:C6881](markdown/NCIT_C6881.md) (Bile Duct Papillary Neoplasm) [7][54.17%]
1. [NCIT:C6894](markdown/NCIT_C6894.md) (Malignant Solitary Fibrous Tumor) [3][55.56%]
1. [NCIT:C6899](markdown/NCIT_C6899.md) (Breast Adenomyoepithelioma) [2][52.53%]
1. [NCIT:C6906](markdown/NCIT_C6906.md) (Atypical Teratoid/Rhabdoid Tumor) [2][53.20%]
1. [NCIT:C6913](markdown/NCIT_C6913.md) (Lymphocyte-Rich Classical Hodgkin Lymphoma) [3][54.87%]
1. [NCIT:C6917](markdown/NCIT_C6917.md) (Atypical Burkitt/Burkitt-Like Lymphoma) [2][54.46%]
1. [NCIT:C6919](markdown/NCIT_C6919.md) (T Lymphoblastic Lymphoma) [4][55.25%]
1. [NCIT:C6926](markdown/NCIT_C6926.md) (Stromal Sarcoma) [22][53.20%]
1. [NCIT:C6930](markdown/NCIT_C6930.md) (Mixed Neoplasm) [185][51.39%]
1. [NCIT:C6938](markdown/NCIT_C6938.md) (Sweat Gland Carcinoma) [25][53.49%]
1. [NCIT:C6958](markdown/NCIT_C6958.md) (Astrocytic Tumor) [116][52.89%]
1. [NCIT:C6959](markdown/NCIT_C6959.md) (Anaplastic Oligoastrocytoma) [3][54.60%]
1. [NCIT:C6960](markdown/NCIT_C6960.md) (Oligodendroglial Tumor) [17][53.10%]
1. [NCIT:C6963](markdown/NCIT_C6963.md) (Neuroblastic Tumor) [43][55.80%]
1. [NCIT:C6965](markdown/NCIT_C6965.md) (Pineal Parenchymal Cell Neoplasm) [10][52.89%]
1. [NCIT:C6968](markdown/NCIT_C6968.md) (Supratentorial Embryonal Tumor, Not Otherwise Specified) [4][54.17%]
1. [NCIT:C6971](markdown/NCIT_C6971.md) (Meningothelial Cell Neoplasm) [43][66.67%]
1. [NCIT:C6974](markdown/NCIT_C6974.md) (Neoplasm of Uncertain Histogenesis) [5][66.67%]
1. [NCIT:C6975](markdown/NCIT_C6975.md) (Papillary Renal Cell Carcinoma) [4][54.38%]
1. [NCIT:C6977](markdown/NCIT_C6977.md) (Breast Papillomatosis) [2][53.30%]
1. [NCIT:C6983](markdown/NCIT_C6983.md) (Papillary Carcinoma of the Penis) [3][53.75%]
1. [NCIT:C6990](markdown/NCIT_C6990.md) (Central Nervous System Embryonal Neoplasm) [56][57.14%]
1. [NCIT:C7004](markdown/NCIT_C7004.md) (Central Nervous System Hemangioma) [2][53.85%]
1. [NCIT:C7007](markdown/NCIT_C7007.md) (Central Nervous System Hemangioblastoma) [2][53.85%]
1. [NCIT:C7013](markdown/NCIT_C7013.md) (Central Nervous System Mature Teratoma) [2][56.67%]
1. [NCIT:C7014](markdown/NCIT_C7014.md) (Central Nervous System Immature Teratoma) [2][61.76%]
1. [NCIT:C7046](markdown/NCIT_C7046.md) (Urinary System Paraganglioma) [2][53.57%]
1. [NCIT:C7047](markdown/NCIT_C7047.md) (Functioning Pituitary Gland Neoplasm) [3][53.20%]
1. [NCIT:C7049](markdown/NCIT_C7049.md) (Adult Astrocytic Tumor) [13][53.00%]
1. [NCIT:C7055](markdown/NCIT_C7055.md) (Precursor Lymphoid Neoplasm) [87][53.00%]
1. [NCIT:C7056](markdown/NCIT_C7056.md) (Mature B-Cell Non-Hodgkin Lymphoma) [251][53.20%]
1. [NCIT:C7058](markdown/NCIT_C7058.md) (Melanocytic Neoplasm) [111][60.00%]
1. [NCIT:C7059](markdown/NCIT_C7059.md) (Mesenchymal Cell Neoplasm) [509][51.60%]
1. [NCIT:C7061](markdown/NCIT_C7061.md) (Retinal Cell Neoplasm) [16][62.50%]
1. [NCIT:C7063](markdown/NCIT_C7063.md) (Notochordal Tumor) [6][60.00%]
1. [NCIT:C7064](markdown/NCIT_C7064.md) (Erythroid Neoplasm) [6][52.26%]
1. [NCIT:C7065](markdown/NCIT_C7065.md) (Lymphocytic Neoplasm) [764][52.26%]
1. [NCIT:C7066](markdown/NCIT_C7066.md) (Megakaryocytic Neoplasm) [4][52.40%]
1. [NCIT:C7068](markdown/NCIT_C7068.md) (Neoplastic Polyp) [18][51.39%]
1. [NCIT:C7069](markdown/NCIT_C7069.md) (Giant Cell Neoplasm) [23][62.50%]
1. [NCIT:C7070](markdown/NCIT_C7070.md) (Mucinous Neoplasm) [60][55.00%]
1. [NCIT:C7072](markdown/NCIT_C7072.md) (Oncocytic Neoplasm) [12][55.56%]
1. [NCIT:C7073](markdown/NCIT_C7073.md) (Paget Disease) [11][53.57%]
1. [NCIT:C7074](markdown/NCIT_C7074.md) (Serous Neoplasm) [57][55.00%]
1. [NCIT:C7075](markdown/NCIT_C7075.md) (Fibroblastic Neoplasm) [90][58.33%]
1. [NCIT:C7087](markdown/NCIT_C7087.md) (Recurrent Melanoma) [3][56.25%]
1. [NCIT:C7091](markdown/NCIT_C7091.md) (Digestive System Melanoma) [4][55.00%]
1. [NCIT:C7103](markdown/NCIT_C7103.md) (Liver and Intrahepatic Bile Duct Neoplasm) [132][66.67%]
1. [NCIT:C7106](markdown/NCIT_C7106.md) (Liver and Intrahepatic Bile Duct Epithelial Neoplasm) [98][57.14%]
1. [NCIT:C7107](markdown/NCIT_C7107.md) (Liver and Intrahepatic Bile Duct Non-Epithelial Neoplasm) [24][58.33%]
1. [NCIT:C7109](markdown/NCIT_C7109.md) (Distal Bile Duct Carcinoma) [10][54.00%]
1. [NCIT:C7110](markdown/NCIT_C7110.md) (Recurrent Liver Carcinoma) [5][53.40%]
1. [NCIT:C7113](markdown/NCIT_C7113.md) (Endometrioid Tumor) [39][56.25%]
1. [NCIT:C7114](markdown/NCIT_C7114.md) (Thymoma Type B) [5][54.55%]
1. [NCIT:C7115](markdown/NCIT_C7115.md) (Liver and Intrahepatic Bile Duct Malignant Non-Epithelial Neoplasm) [14][55.56%]
1. [NCIT:C7116](markdown/NCIT_C7116.md) (Stage I Liver Cancer) [7][53.40%]
1. [NCIT:C7117](markdown/NCIT_C7117.md) (Stage II Liver Cancer) [7][53.40%]
1. [NCIT:C7118](markdown/NCIT_C7118.md) (Stage III Liver Cancer) [8][53.40%]
1. [NCIT:C7121](markdown/NCIT_C7121.md) (Stage IV Liver Cancer) [7][53.40%]
1. [NCIT:C7128](markdown/NCIT_C7128.md) (Benign Extrahepatic Bile Duct Non-Epithelial Neoplasm) [5][56.25%]
1. [NCIT:C7129](markdown/NCIT_C7129.md) (Benign Non-Epithelial Gallbladder Neoplasm) [4][57.14%]
1. [NCIT:C7130](markdown/NCIT_C7130.md) (Gallbladder Papillary Neoplasm) [3][54.55%]
1. [NCIT:C7132](markdown/NCIT_C7132.md) (Glandular Cell Neoplasm) [724][56.25%]
1. [NCIT:C7134](markdown/NCIT_C7134.md) (Bone Surface (Peripheral) Osteosarcoma) [5][53.75%]
1. [NCIT:C7135](markdown/NCIT_C7135.md) (Extraskeletal Ewing Sarcoma) [3][54.53%]
1. [NCIT:C7147](markdown/NCIT_C7147.md) (Benign Fibroblastic Neoplasm) [25][55.00%]
1. [NCIT:C7148](markdown/NCIT_C7148.md) (Soft Tissue Tumor of Uncertain Differentiation) [63][66.67%]
1. [NCIT:C7153](markdown/NCIT_C7153.md) (Differentiated Thyroid Gland Carcinoma) [22][54.08%]
1. [NCIT:C7158](markdown/NCIT_C7158.md) (Benign Dermal Neoplasm) [22][60.00%]
1. [NCIT:C7161](markdown/NCIT_C7161.md) (Melanocytic Skin Neoplasm) [66][57.14%]
1. [NCIT:C7162](markdown/NCIT_C7162.md) (Primary Cutaneous Lymphoma) [32][52.77%]
1. [NCIT:C7164](markdown/NCIT_C7164.md) (Classical Hodgkin Lymphoma) [31][54.67%]
1. [NCIT:C7171](markdown/NCIT_C7171.md) (Acute Monoblastic Leukemia) [2][53.67%]
1. [NCIT:C7173](markdown/NCIT_C7173.md) (Diffuse Astrocytoma) [17][54.16%]
1. [NCIT:C7175](markdown/NCIT_C7175.md) (Acute Myeloid Leukemia with Recurrent Genetic Abnormalities) [29][53.20%]
1. [NCIT:C7182](markdown/NCIT_C7182.md) (B-Cell Proliferation of Uncertain Malignant Potential) [18][53.00%]
1. [NCIT:C7185](markdown/NCIT_C7185.md) (Lymphoma by Site) [190][52.40%]
1. [NCIT:C7190](markdown/NCIT_C7190.md) (Malignant Hypopharyngeal Neoplasm) [26][75.00%]
1. [NCIT:C7195](markdown/NCIT_C7195.md) (Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder) [6][53.92%]
1. [NCIT:C7215](markdown/NCIT_C7215.md) (Non-Hodgkin Lymphoma by Clinical Course) [240][52.53%]
1. [NCIT:C7216](markdown/NCIT_C7216.md) (Non-Hodgkin Lymphoma with Variable Clinical Course) [7][52.53%]
1. [NCIT:C7218](markdown/NCIT_C7218.md) (Cutaneous Follicular Lymphoma) [4][53.92%]
1. [NCIT:C7224](markdown/NCIT_C7224.md) (Plasmablastic Lymphoma) [3][53.67%]
1. [NCIT:C7228](markdown/NCIT_C7228.md) (Refractory Mature B-Cell Non-Hodgkin Lymphoma) [13][53.30%]
1. [NCIT:C7231](markdown/NCIT_C7231.md) (Small Intestinal Non-Hodgkin Lymphoma) [12][53.00%]
1. [NCIT:C7232](markdown/NCIT_C7232.md) (Neoplastic Post-Transplant Lymphoproliferative Disorder) [16][52.66%]
1. [NCIT:C7233](markdown/NCIT_C7233.md) (Monomorphic Post-Transplant Lymphoproliferative Disorder) [11][53.67%]
1. [NCIT:C7237](markdown/NCIT_C7237.md) (Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder) [9][53.84%]
1. [NCIT:C7240](markdown/NCIT_C7240.md) (Plasma Cell Post-Transplant Lymphoproliferative Disorder) [2][54.24%]
1. [NCIT:C7246](markdown/NCIT_C7246.md) (Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder) [3][54.53%]
1. [NCIT:C7258](markdown/NCIT_C7258.md) (Nodular Lymphocyte Predominant Hodgkin Lymphoma) [8][53.84%]
1. [NCIT:C7264](markdown/NCIT_C7264.md) (Diffuse Follicular Lymphoma) [2][54.00%]
1. [NCIT:C7280](markdown/NCIT_C7280.md) (Ovarian Transitional Cell Tumor) [8][55.00%]
1. [NCIT:C7282](markdown/NCIT_C7282.md) (Benign Ovarian Seromucinous Tumor) [2][54.17%]
1. [NCIT:C7287](markdown/NCIT_C7287.md) (Ovarian Granulosa-Stromal Cell Tumor) [3][53.40%]
1. [NCIT:C7290](markdown/NCIT_C7290.md) (Ovarian Tumor of the Thecoma/Fibroma Group) [2][54.25%]
1. [NCIT:C7294](markdown/NCIT_C7294.md) (Splenic Non-Hodgkin Lymphoma) [8][52.77%]
1. [NCIT:C7296](markdown/NCIT_C7296.md) (Splenic Manifestation of Leukemia) [7][52.12%]
1. [NCIT:C7297](markdown/NCIT_C7297.md) (Splenic Manifestation of Prolymphocytic Leukemia) [2][53.58%]
1. [NCIT:C7312](markdown/NCIT_C7312.md) (Splenic Lymphoblastic Lymphoma) [2][53.67%]
1. [NCIT:C7313](markdown/NCIT_C7313.md) (Benign Ovarian Serous Tumor) [5][54.00%]
1. [NCIT:C7318](markdown/NCIT_C7318.md) (Acute Monoblastic and Monocytic Leukemia) [9][53.58%]
1. [NCIT:C7319](markdown/NCIT_C7319.md) (Adult Acute Monoblastic and Monocytic Leukemia) [2][53.67%]
1. [NCIT:C7333](markdown/NCIT_C7333.md) (Intermediate Fibroblastic Neoplasm) [23][52.53%]
1. [NCIT:C7334](markdown/NCIT_C7334.md) (Intermediate Vascular Neoplasm) [9][56.25%]
1. [NCIT:C7335](markdown/NCIT_C7335.md) (Reproductive Endocrine Neoplasm) [15][52.53%]
1. [NCIT:C7341](markdown/NCIT_C7341.md) (Benign Epithelial Skin Neoplasm) [49][53.85%]
1. [NCIT:C7342](markdown/NCIT_C7342.md) (Epithelial Skin Neoplasm) [160][58.33%]
1. [NCIT:C7343](markdown/NCIT_C7343.md) (Benign Cutaneous Fibrohistiocytic Neoplasm) [3][52.89%]
1. [NCIT:C7346](markdown/NCIT_C7346.md) (Cervical Squamous Intraepithelial Neoplasia) [5][53.40%]
1. [NCIT:C7348](markdown/NCIT_C7348.md) (High Grade Intraepithelial Neoplasia) [53][56.25%]
1. [NCIT:C7351](markdown/NCIT_C7351.md) (Grade II Squamous Intraepithelial Neoplasia) [2][53.20%]
1. [NCIT:C7355](markdown/NCIT_C7355.md) (Renal Pelvis Urothelial Carcinoma) [5][54.35%]
1. [NCIT:C7359](markdown/NCIT_C7359.md) (Endometrial Adenocarcinoma) [24][53.75%]
1. [NCIT:C7367](markdown/NCIT_C7367.md) (Hair Follicle Neoplasm) [29][62.50%]
1. [NCIT:C7371](markdown/NCIT_C7371.md) (Accessory Urethral Gland Carcinoma) [2][52.66%]
1. [NCIT:C7372](markdown/NCIT_C7372.md) (Cerebellar Neuronal and Mixed Neuronal-Glial Tumor) [2][53.00%]
1. [NCIT:C7373](markdown/NCIT_C7373.md) (Nasopharyngeal Nonkeratinizing Carcinoma) [7][54.87%]
1. [NCIT:C7376](markdown/NCIT_C7376.md) (Pleural Malignant Mesothelioma) [16][54.67%]
1. [NCIT:C7377](markdown/NCIT_C7377.md) (Malignant Lung Neoplasm) [121][66.67%]
1. [NCIT:C7379](markdown/NCIT_C7379.md) (Malignant Anal Neoplasm) [45][75.00%]
1. [NCIT:C7383](markdown/NCIT_C7383.md) (Bladder Papillary Urothelial Carcinoma) [2][53.92%]
1. [NCIT:C7387](markdown/NCIT_C7387.md) (Blood Vessel Neoplasm) [143][57.14%]
1. [NCIT:C7388](markdown/NCIT_C7388.md) (Vascular Neoplasm) [171][60.00%]
1. [NCIT:C7389](markdown/NCIT_C7389.md) (Benign Vascular Neoplasm) [69][57.14%]
1. [NCIT:C7390](markdown/NCIT_C7390.md) (Malignant Vascular Neoplasm) [80][56.25%]
1. [NCIT:C7391](markdown/NCIT_C7391.md) (Intermediate Blood Vessel Neoplasm) [8][55.00%]
1. [NCIT:C7398](markdown/NCIT_C7398.md) (Malignant Oropharyngeal Neoplasm) [29][75.00%]
1. [NCIT:C7399](markdown/NCIT_C7399.md) (Villous Adenoma) [11][54.55%]
1. [NCIT:C7400](markdown/NCIT_C7400.md) (Burkitt Leukemia) [2][54.08%]
1. [NCIT:C7402](markdown/NCIT_C7402.md) (Hairy Cell Leukemia) [3][54.53%]
1. [NCIT:C7418](markdown/NCIT_C7418.md) (Malignant Rectal Neoplasm) [41][62.50%]
1. [NCIT:C7420](markdown/NCIT_C7420.md) (Malignant Rectosigmoid Neoplasm) [15][62.50%]
1. [NCIT:C7421](markdown/NCIT_C7421.md) (Rectosigmoid Carcinoma) [14][53.92%]
1. [NCIT:C7430](markdown/NCIT_C7430.md) (Malignant Exocrine Pancreas Neoplasm) [40][66.67%]
1. [NCIT:C7438](markdown/NCIT_C7438.md) (Infiltrating Papillary Adenocarcinoma) [3][53.40%]
1. [NCIT:C7440](markdown/NCIT_C7440.md) (Papilloma) [48][54.17%]
1. [NCIT:C7442](markdown/NCIT_C7442.md) (Benign Myoepithelioma) [2][52.12%]
1. [NCIT:C7445](markdown/NCIT_C7445.md) (Brain Stem Astrocytoma) [4][53.58%]
1. [NCIT:C7446](markdown/NCIT_C7446.md) (Anaplastic Brain Stem Glioma) [4][53.40%]
1. [NCIT:C7457](markdown/NCIT_C7457.md) (Capillary Hemangioma) [10][54.17%]
1. [NCIT:C7463](markdown/NCIT_C7463.md) (Acute Myelomonocytic Leukemia) [4][54.16%]
1. [NCIT:C7464](markdown/NCIT_C7464.md) (Acute Leukemia of Ambiguous Lineage) [11][52.89%]
1. [NCIT:C7471](markdown/NCIT_C7471.md) (Anal Canal Adenocarcinoma) [2][53.49%]
1. [NCIT:C7472](markdown/NCIT_C7472.md) (Anal Margin Carcinoma) [3][53.10%]
1. [NCIT:C7478](markdown/NCIT_C7478.md) (Malignant Esophageal Neoplasm) [61][75.00%]
1. [NCIT:C7481](markdown/NCIT_C7481.md) (Malignant Gallbladder Neoplasm) [49][62.50%]
1. [NCIT:C7483](markdown/NCIT_C7483.md) (Malignant Extrahepatic Bile Duct Neoplasm) [38][60.00%]
1. [NCIT:C7489](markdown/NCIT_C7489.md) (Anal Canal Carcinoma) [17][53.00%]
1. [NCIT:C7506](markdown/NCIT_C7506.md) (Myelodysplastic Syndrome with Excess Blasts) [3][54.53%]
1. [NCIT:C7515](markdown/NCIT_C7515.md) (Renal Pelvis and Ureter Carcinoma) [33][65.82%]
1. [NCIT:C7517](markdown/NCIT_C7517.md) (Stage 0a Renal Pelvis and Ureter Urothelial Carcinoma) [2][54.31%]
1. [NCIT:C7518](markdown/NCIT_C7518.md) (Stage 0is Renal Pelvis and Ureter Urothelial Carcinoma) [2][54.31%]
1. [NCIT:C7519](markdown/NCIT_C7519.md) (Stage I Renal Pelvis and Ureter Carcinoma) [2][58.33%]
1. [NCIT:C7520](markdown/NCIT_C7520.md) (Stage II Renal Pelvis and Ureter Carcinoma) [2][58.33%]
1. [NCIT:C7521](markdown/NCIT_C7521.md) (Stage III Renal Pelvis and Ureter Carcinoma) [2][58.33%]
1. [NCIT:C7522](markdown/NCIT_C7522.md) (Stage IV Renal Pelvis and Ureter Carcinoma) [2][58.33%]
1. [NCIT:C7523](markdown/NCIT_C7523.md) (Malignant Small Intestinal Neoplasm) [58][66.67%]
1. [NCIT:C7525](markdown/NCIT_C7525.md) (Malignant Renal Pelvis Neoplasm) [13][66.67%]
1. [NCIT:C7528](markdown/NCIT_C7528.md) (Angioimmunoblastic T-Cell Lymphoma) [7][54.93%]
1. [NCIT:C7529](markdown/NCIT_C7529.md) (Recurrent Childhood Visual Pathway Glioma) [3][53.10%]
1. [NCIT:C7533](markdown/NCIT_C7533.md) (Visual Pathway Astrocytoma) [4][53.20%]
1. [NCIT:C7534](markdown/NCIT_C7534.md) (Childhood Visual Pathway Astrocytoma) [2][53.40%]
1. [NCIT:C7535](markdown/NCIT_C7535.md) (Childhood Visual Pathway Glioma) [5][53.00%]
1. [NCIT:C7539](markdown/NCIT_C7539.md) (Lymphoid Leukemia) [77][52.77%]
1. [NCIT:C7540](markdown/NCIT_C7540.md) (Small Lymphocytic Lymphoma) [10][53.84%]
1. [NCIT:C7541](markdown/NCIT_C7541.md) (Retinoblastoma) [13][53.20%]
1. [NCIT:C7542](markdown/NCIT_C7542.md) (Askin Tumor) [2][54.46%]
1. [NCIT:C7543](markdown/NCIT_C7543.md) (Malignant Ureter Neoplasm) [21][75.00%]
1. [NCIT:C7546](markdown/NCIT_C7546.md) (Metastatic Malignant Neoplasm in the Pharynx) [3][60.00%]
1. [NCIT:C7548](markdown/NCIT_C7548.md) (Malignant Kidney Neoplasm) [83][75.00%]
1. [NCIT:C7550](markdown/NCIT_C7550.md) (Ovarian Serous Adenocarcinoma) [4][54.31%]
1. [NCIT:C7558](markdown/NCIT_C7558.md) (Endometrial Carcinoma) [31][53.30%]
1. [NCIT:C7560](markdown/NCIT_C7560.md) (Sweat Gland Adenoma) [7][53.40%]
1. [NCIT:C7563](markdown/NCIT_C7563.md) (Hidradenoma) [3][53.58%]
1. [NCIT:C7569](markdown/NCIT_C7569.md) (Thymic Carcinoma) [13][53.33%]
1. [NCIT:C7570](markdown/NCIT_C7570.md) (Melanocytic Nevus) [30][57.14%]
1. [NCIT:C7571](markdown/NCIT_C7571.md) (Benign Melanocytic Skin Nevus) [17][55.00%]
1. [NCIT:C7574](markdown/NCIT_C7574.md) (Prostate Phyllodes Tumor) [2][53.85%]
1. [NCIT:C7575](markdown/NCIT_C7575.md) (Breast Phyllodes Tumor) [3][53.00%]
1. [NCIT:C7580](markdown/NCIT_C7580.md) (Skin Appendage Adenoma) [9][53.20%]
1. [NCIT:C7586](markdown/NCIT_C7586.md) (Malignant Basal Cell Neoplasm) [29][52.12%]
1. [NCIT:C7587](markdown/NCIT_C7587.md) (Adult Lymphoma) [58][52.53%]
1. [NCIT:C7596](markdown/NCIT_C7596.md) (Malignant Myoepithelioma) [3][55.26%]
1. [NCIT:C7600](markdown/NCIT_C7600.md) (Acute Myeloid Leukemia with Myelodysplasia-Related Changes) [3][55.13%]
1. [NCIT:C7607](markdown/NCIT_C7607.md) (Benign Oral Cavity Neoplasm) [16][52.40%]
1. [NCIT:C7608](markdown/NCIT_C7608.md) (Benign Oral Neoplasm) [18][52.26%]
1. [NCIT:C7611](markdown/NCIT_C7611.md) (Cerebral Lymphoma) [3][53.40%]
1. [NCIT:C7612](markdown/NCIT_C7612.md) (Malignant Thymoma) [8][53.33%]
1. [NCIT:C7614](markdown/NCIT_C7614.md) (Cutaneous Lymphoproliferative Disorder) [57][58.33%]
1. [NCIT:C7615](markdown/NCIT_C7615.md) (Adult Diffuse Large B-Cell Lymphoma) [8][53.75%]
1. [NCIT:C7616](markdown/NCIT_C7616.md) (Childhood Diffuse Large B-Cell Lymphoma) [3][53.75%]
1. [NCIT:C7617](markdown/NCIT_C7617.md) (Benign Reproductive System Neoplasm) [123][60.00%]
1. [NCIT:C7619](markdown/NCIT_C7619.md) (Recurrent Carcinoma) [85][52.40%]
1. [NCIT:C7620](markdown/NCIT_C7620.md) (Recurrent Female Reproductive System Carcinoma) [10][52.66%]
1. [NCIT:C7621](markdown/NCIT_C7621.md) (Recurrent Male Reproductive System Carcinoma) [2][52.66%]
1. [NCIT:C7622](markdown/NCIT_C7622.md) (Recurrent Digestive System Carcinoma) [22][52.77%]
1. [NCIT:C7623](markdown/NCIT_C7623.md) (Recurrent Urinary Tract Carcinoma) [9][52.66%]
1. [NCIT:C7624](markdown/NCIT_C7624.md) (Recurrent Head and Neck Carcinoma) [25][52.66%]
1. [NCIT:C7625](markdown/NCIT_C7625.md) (Localized Carcinoma) [4][52.40%]
1. [NCIT:C7632](markdown/NCIT_C7632.md) (Pericardial Mesothelioma) [3][56.25%]
1. [NCIT:C7633](markdown/NCIT_C7633.md) (Peritoneal Mesothelioma) [5][58.33%]
1. [NCIT:C7634](markdown/NCIT_C7634.md) (Solitary Fibrous Tumor) [14][54.17%]
1. [NCIT:C7635](markdown/NCIT_C7635.md) (Well Differentiated Papillary Mesothelioma) [2][54.17%]
1. [NCIT:C7653](markdown/NCIT_C7653.md) (Intermediate Soft Tissue Tumor) [51][66.67%]
1. [NCIT:C7656](markdown/NCIT_C7656.md) (Liver Dysplastic Nodule) [2][54.17%]
1. [NCIT:C7658](markdown/NCIT_C7658.md) (Intestinal Intraepithelial Neoplasia) [5][53.20%]
1. [NCIT:C7660](markdown/NCIT_C7660.md) (Grade II Glandular Intraepithelial Neoplasia) [2][53.30%]
1. [NCIT:C7661](markdown/NCIT_C7661.md) (Low Grade Glandular Intraepithelial Neoplasia) [8][53.30%]
1. [NCIT:C7662](markdown/NCIT_C7662.md) (High Grade Glandular Intraepithelial Neoplasia) [22][53.33%]
1. [NCIT:C7667](markdown/NCIT_C7667.md) (High Grade Penile Intraepithelial Neoplasia) [2][53.20%]
1. [NCIT:C7670](markdown/NCIT_C7670.md) (High Grade Cervical Intraepithelial Neoplasia) [6][54.55%]
1. [NCIT:C7673](markdown/NCIT_C7673.md) (Cervical Glandular Intraepithelial Neoplasia) [3][53.49%]
1. [NCIT:C7676](markdown/NCIT_C7676.md) (Adenocarcinoma in Adenomatous Polyp) [9][53.30%]
1. [NCIT:C7678](markdown/NCIT_C7678.md) (Adenocarcinoma In Situ in Adenomatous Polyp) [3][53.75%]
1. [NCIT:C7680](markdown/NCIT_C7680.md) (Adenocarcinoma In Situ in a Polyp) [4][53.49%]
1. [NCIT:C7681](markdown/NCIT_C7681.md) (Carcinoma In Situ in a Polyp) [5][53.57%]
1. [NCIT:C7682](markdown/NCIT_C7682.md) (Carcinoma in a Polyp) [12][52.40%]
1. [NCIT:C7683](markdown/NCIT_C7683.md) (Adenocarcinoma with Cartilaginous and Osseous Metaplasia) [2][53.67%]
1. [NCIT:C7688](markdown/NCIT_C7688.md) (Invasive Ductal and Lobular Carcinoma) [2][54.46%]
1. [NCIT:C7690](markdown/NCIT_C7690.md) (Intraductal and Lobular Carcinoma) [2][54.24%]
1. [NCIT:C7700](markdown/NCIT_C7700.md) (Ovarian Adenocarcinoma) [12][53.75%]
1. [NCIT:C7702](markdown/NCIT_C7702.md) (Adult Hodgkin Lymphoma) [11][52.77%]
1. [NCIT:C7703](markdown/NCIT_C7703.md) (Childhood Brain Neoplasm) [52][66.67%]
1. [NCIT:C7704](markdown/NCIT_C7704.md) (Adult Non-Hodgkin Lymphoma) [45][52.66%]
1. [NCIT:C7706](markdown/NCIT_C7706.md) (Childhood Non-Hodgkin Lymphoma) [35][52.66%]
1. [NCIT:C7707](markdown/NCIT_C7707.md) (Adult Soft Tissue Sarcoma) [11][52.66%]
1. [NCIT:C7708](markdown/NCIT_C7708.md) (Childhood Malignant Liver Neoplasm) [11][56.25%]
1. [NCIT:C7709](markdown/NCIT_C7709.md) (Digestive System Neuroendocrine Tumor G1) [20][53.84%]
1. [NCIT:C7710](markdown/NCIT_C7710.md) (Adult Brain Neoplasm) [24][66.67%]
1. [NCIT:C7711](markdown/NCIT_C7711.md) (Adult Liver Carcinoma) [9][53.40%]
1. [NCIT:C7714](markdown/NCIT_C7714.md) (Childhood Hodgkin Lymphoma) [11][52.77%]
1. [NCIT:C7715](markdown/NCIT_C7715.md) (Childhood Soft Tissue Sarcoma) [14][52.66%]
1. [NCIT:C7716](markdown/NCIT_C7716.md) (Renal Pelvis and Ureter Urothelial Carcinoma) [20][53.49%]
1. [NCIT:C7718](markdown/NCIT_C7718.md) (Appendix Adenocarcinoma) [6][53.49%]
1. [NCIT:C7720](markdown/NCIT_C7720.md) (Gallbladder Adenoma) [3][53.49%]
1. [NCIT:C7721](markdown/NCIT_C7721.md) (Gingival Carcinoma) [9][53.10%]
1. [NCIT:C7723](markdown/NCIT_C7723.md) (Cardiac Sarcoma) [5][53.57%]
1. [NCIT:C7724](markdown/NCIT_C7724.md) (Small Intestinal Carcinoma) [31][53.10%]
1. [NCIT:C7729](markdown/NCIT_C7729.md) (Squamous Cell Carcinoma of the Penis) [9][53.10%]
1. [NCIT:C7731](markdown/NCIT_C7731.md) (Prostate Sarcoma) [6][54.17%]
1. [NCIT:C7736](markdown/NCIT_C7736.md) (Vaginal Squamous Cell Carcinoma, Not Otherwise Specified) [5][53.40%]
1. [NCIT:C7737](markdown/NCIT_C7737.md) (Vaginal Sarcoma) [4][54.17%]
1. [NCIT:C7741](markdown/NCIT_C7741.md) (Digestive System Hemangioma) [3][53.57%]
1. [NCIT:C7748](markdown/NCIT_C7748.md) (Cardiac Myxoma) [4][54.17%]
1. [NCIT:C7749](markdown/NCIT_C7749.md) (Cutaneous Fibrohistiocytic Neoplasm) [5][52.40%]
1. [NCIT:C7764](markdown/NCIT_C7764.md) (Atypical Lymphoproliferative Disorder) [5][56.25%]
1. [NCIT:C7777](markdown/NCIT_C7777.md) (Stage II Non-Small Cell Lung Cancer AJCC v7) [3][53.58%]
1. [NCIT:C7778](markdown/NCIT_C7778.md) (Stage III Non-Small Cell Lung Cancer AJCC v7) [3][53.58%]
1. [NCIT:C7781](markdown/NCIT_C7781.md) (Metastatic Osteosarcoma) [2][53.20%]
1. [NCIT:C7783](markdown/NCIT_C7783.md) (Recurrent Non-Small Cell Lung Carcinoma) [3][53.49%]
1. [NCIT:C7788](markdown/NCIT_C7788.md) (Stage 0 Gastric Cancer AJCC v6 and v7) [3][53.58%]
1. [NCIT:C7804](markdown/NCIT_C7804.md) (Recurrent Cervical Carcinoma) [3][53.67%]
1. [NCIT:C7807](markdown/NCIT_C7807.md) (Metastatic Ewing Sarcoma) [2][54.24%]
1. [NCIT:C7808](markdown/NCIT_C7808.md) (Recurrent Ewing Sarcoma) [2][54.24%]
1. [NCIT:C7834](markdown/NCIT_C7834.md) (Recurrent Childhood Brain Neoplasm) [12][62.50%]
1. [NCIT:C7839](markdown/NCIT_C7839.md) (Recurrent Childhood Liver Cancer) [2][55.00%]
1. [NCIT:C7866](markdown/NCIT_C7866.md) (Recurrent Malignant Mesothelioma) [3][52.26%]
1. [NCIT:C7873](markdown/NCIT_C7873.md) (Adult Immunoblastic Lymphoma) [5][54.74%]
1. [NCIT:C7888](markdown/NCIT_C7888.md) (Small Intestinal Adenocarcinoma) [11][54.53%]
1. [NCIT:C7895](markdown/NCIT_C7895.md) (Stage 0 Bladder Cancer) [6][52.77%]
1. [NCIT:C7896](markdown/NCIT_C7896.md) (Stage I Bladder Cancer) [5][54.17%]
1. [NCIT:C7897](markdown/NCIT_C7897.md) (Stage II Bladder Cancer) [3][54.17%]
1. [NCIT:C7898](markdown/NCIT_C7898.md) (Stage III Bladder Cancer) [3][54.17%]
1. [NCIT:C7899](markdown/NCIT_C7899.md) (Recurrent Bladder Carcinoma) [3][52.89%]
1. [NCIT:C7903](markdown/NCIT_C7903.md) (Recurrent Skin Carcinoma) [2][52.77%]
1. [NCIT:C7909](markdown/NCIT_C7909.md) (ACTH-Producing Pituitary Gland Neoplasm) [2][53.20%]
1. [NCIT:C7910](markdown/NCIT_C7910.md) (Prolactin-Producing Pituitary Gland Neoplasm) [2][53.40%]
1. [NCIT:C7911](markdown/NCIT_C7911.md) (Growth Hormone-Producing Pituitary Gland Neoplasm) [2][53.30%]
1. [NCIT:C7915](markdown/NCIT_C7915.md) (TSH-Producing Pituitary Gland Neoplasm) [2][53.30%]
1. [NCIT:C7917](markdown/NCIT_C7917.md) (Stage II Cutaneous Melanoma AJCC v6 and v7) [2][53.57%]
1. [NCIT:C7927](markdown/NCIT_C7927.md) (Liver and Intrahepatic Bile Duct Carcinoma) [79][53.30%]
1. [NCIT:C7928](markdown/NCIT_C7928.md) (Childhood Germ Cell Tumor) [16][60.00%]
1. [NCIT:C7930](markdown/NCIT_C7930.md) (Lymphomatoid Granulomatosis) [14][53.92%]
1. [NCIT:C7933](markdown/NCIT_C7933.md) (Grade III Lymphomatoid Granulomatosis) [5][55.13%]
1. [NCIT:C7934](markdown/NCIT_C7934.md) (Recurrent Lymphomatoid Granulomatosis) [6][54.00%]
1. [NCIT:C7939](markdown/NCIT_C7939.md) (Stage 0 Lip and Oral Cavity Cancer AJCC v6 and v7) [4][53.40%]
1. [NCIT:C7940](markdown/NCIT_C7940.md) (Childhood Acute Monoblastic and Monocytic Leukemia) [2][53.67%]
1. [NCIT:C7950](markdown/NCIT_C7950.md) (Invasive Lobular Breast Carcinoma) [5][54.31%]
1. [NCIT:C7953](markdown/NCIT_C7953.md) (Childhood T Acute Lymphoblastic Leukemia) [2][55.43%]
1. [NCIT:C7955](markdown/NCIT_C7955.md) (Childhood Hepatocellular Carcinoma) [5][56.40%]
1. [NCIT:C7956](markdown/NCIT_C7956.md) (Adult Hepatocellular Carcinoma) [2][56.40%]
1. [NCIT:C7975](markdown/NCIT_C7975.md) (Extrahepatic Bile Duct Adenocarcinoma) [7][54.38%]
1. [NCIT:C7981](markdown/NCIT_C7981.md) (Vaginal Adenocarcinoma) [4][53.75%]
1. [NCIT:C7983](markdown/NCIT_C7983.md) (Borderline Ovarian Endometrioid Tumor/Atypical Proliferative Ovarian Endometrioid Tumor) [2][53.33%]
1. [NCIT:C7991](markdown/NCIT_C7991.md) (Salivary Gland Squamous Cell Carcinoma) [4][53.40%]
1. [NCIT:C7992](markdown/NCIT_C7992.md) (Nasopharyngeal Keratinizing Squamous Cell Carcinoma) [7][54.93%]
1. [NCIT:C8006](markdown/NCIT_C8006.md) (Pancreatic Somatostatin-Producing Neuroendocrine Tumor) [2][54.16%]
1. [NCIT:C8012](markdown/NCIT_C8012.md) (Low Grade Salivary Gland Carcinoma) [3][54.17%]
1. [NCIT:C8014](markdown/NCIT_C8014.md) (Lip Basal Cell Carcinoma) [6][55.00%]
1. [NCIT:C8018](markdown/NCIT_C8018.md) (High Grade Salivary Gland Carcinoma) [3][54.17%]
1. [NCIT:C8021](markdown/NCIT_C8021.md) (Salivary Gland Adenocarcinoma) [12][53.20%]
1. [NCIT:C8023](markdown/NCIT_C8023.md) (Nasopharyngeal Undifferentiated Carcinoma) [6][55.19%]
1. [NCIT:C8024](markdown/NCIT_C8024.md) (Salivary Gland Undifferentiated Carcinoma) [4][53.57%]
1. [NCIT:C8025](markdown/NCIT_C8025.md) (Malignant Mixed Tumor of the Salivary Gland) [11][52.12%]
1. [NCIT:C8026](markdown/NCIT_C8026.md) (Salivary Gland Adenoid Cystic Carcinoma) [4][53.40%]
1. [NCIT:C8033](markdown/NCIT_C8033.md) (Stage I Lip and Oral Cavity Cancer AJCC v6 and v7) [7][53.57%]
1. [NCIT:C8034](markdown/NCIT_C8034.md) (Stage II Lip and Oral Cavity Cancer AJCC v6 and v7) [7][53.57%]
1. [NCIT:C8035](markdown/NCIT_C8035.md) (Stage III Lip and Oral Cavity Cancer AJCC v6 and v7) [7][53.57%]
1. [NCIT:C8036](markdown/NCIT_C8036.md) (Stage IV Lip and Oral Cavity Cancer AJCC v6 and v7) [7][53.57%]
1. [NCIT:C8037](markdown/NCIT_C8037.md) (Recurrent Lip and Oral Cavity Carcinoma) [7][52.77%]
1. [NCIT:C8048](markdown/NCIT_C8048.md) (Stage I Oropharyngeal Carcinoma AJCC v6 and v7) [2][53.40%]
1. [NCIT:C8049](markdown/NCIT_C8049.md) (Stage II Oropharyngeal Carcinoma AJCC v6 and v7) [2][53.40%]
1. [NCIT:C8051](markdown/NCIT_C8051.md) (Recurrent Oropharyngeal Carcinoma) [2][53.20%]
1. [NCIT:C8054](markdown/NCIT_C8054.md) (Thyroid Gland Follicular Carcinoma) [6][55.06%]
1. [NCIT:C8083](markdown/NCIT_C8083.md) (Stage I Ovarian Germ Cell Tumor) [5][55.56%]
1. [NCIT:C8084](markdown/NCIT_C8084.md) (Stage II Ovarian Germ Cell Tumor) [5][55.56%]
1. [NCIT:C8085](markdown/NCIT_C8085.md) (Stage III Ovarian Germ Cell Tumor) [5][55.56%]
1. [NCIT:C8086](markdown/NCIT_C8086.md) (Stage IV Ovarian Germ Cell Tumor) [5][55.56%]
1. [NCIT:C8098](markdown/NCIT_C8098.md) (Recurrent Adult Non-Hodgkin Lymphoma) [6][52.77%]
1. [NCIT:C8102](markdown/NCIT_C8102.md) (Stage I Adult Non-Hodgkin Lymphoma) [5][54.17%]
1. [NCIT:C8103](markdown/NCIT_C8103.md) (Stage II Adult Non-Hodgkin Lymphoma) [5][54.17%]
1. [NCIT:C8104](markdown/NCIT_C8104.md) (Stage III Adult Non-Hodgkin Lymphoma) [5][54.17%]
1. [NCIT:C8105](markdown/NCIT_C8105.md) (Stage IV Adult Non-Hodgkin Lymphoma) [5][54.17%]
1. [NCIT:C8106](markdown/NCIT_C8106.md) (Ovarian Dysgerminoma) [4][53.10%]
1. [NCIT:C8107](markdown/NCIT_C8107.md) (Ovarian Yolk Sac Tumor) [6][53.20%]
1. [NCIT:C8108](markdown/NCIT_C8108.md) (Ovarian Embryonal Carcinoma) [4][53.30%]
1. [NCIT:C8110](markdown/NCIT_C8110.md) (Ovarian Teratoma) [5][53.57%]
1. [NCIT:C8174](markdown/NCIT_C8174.md) (Oral Cavity Verrucous Carcinoma) [4][54.38%]
1. [NCIT:C8177](markdown/NCIT_C8177.md) (Oral Cavity Mucoepidermoid Carcinoma) [7][57.50%]
1. [NCIT:C8179](markdown/NCIT_C8179.md) (Oral Cavity Adenoid Cystic Carcinoma) [7][53.49%]
1. [NCIT:C8181](markdown/NCIT_C8181.md) (Oropharyngeal Squamous Cell Carcinoma) [8][53.67%]
1. [NCIT:C8193](markdown/NCIT_C8193.md) (Paranasal Sinus Squamous Cell Carcinoma) [2][53.84%]
1. [NCIT:C8252](markdown/NCIT_C8252.md) (Therapy-Related Acute Myeloid Leukemia) [2][53.40%]
1. [NCIT:C8264](markdown/NCIT_C8264.md) (Childhood Meningioma) [3][53.20%]
1. [NCIT:C8267](markdown/NCIT_C8267.md) (Ovarian Sarcoma) [8][54.17%]
1. [NCIT:C8273](markdown/NCIT_C8273.md) (Adult Pineal Parenchymal Cell Neoplasm) [2][53.00%]
1. [NCIT:C8289](markdown/NCIT_C8289.md) (Adult Infiltrating Astrocytic Tumor) [8][53.10%]
1. [NCIT:C8294](markdown/NCIT_C8294.md) (Pancreatic Adenocarcinoma) [18][53.92%]
1. [NCIT:C8300](markdown/NCIT_C8300.md) (Desmoplastic Small Round Cell Tumor) [3][53.75%]
1. [NCIT:C8318](markdown/NCIT_C8318.md) (Stage I Lymphoma) [42][55.00%]
1. [NCIT:C8319](markdown/NCIT_C8319.md) (Stage II Lymphoma) [42][55.00%]
1. [NCIT:C8320](markdown/NCIT_C8320.md) (Stage III Lymphoma) [41][55.00%]
1. [NCIT:C8321](markdown/NCIT_C8321.md) (Stage IV Lymphoma) [41][55.00%]
1. [NCIT:C8334](markdown/NCIT_C8334.md) (Squamous Cell Intraepithelial Neoplasia) [33][53.85%]
1. [NCIT:C8335](markdown/NCIT_C8335.md) (Low Grade Squamous Intraepithelial Neoplasia) [6][53.20%]
1. [NCIT:C8336](markdown/NCIT_C8336.md) (High Grade Squamous Intraepithelial Neoplasia) [20][53.57%]
1. [NCIT:C8366](markdown/NCIT_C8366.md) (Intraepithelial Neoplasia) [118][57.14%]
1. [NCIT:C8367](markdown/NCIT_C8367.md) (Low Grade Intraepithelial Neoplasia) [20][55.00%]
1. [NCIT:C8368](markdown/NCIT_C8368.md) (Grade II Intraepithelial Neoplasia) [7][55.00%]
1. [NCIT:C8373](markdown/NCIT_C8373.md) (Lymphangiomatosis) [2][56.25%]
1. [NCIT:C8383](markdown/NCIT_C8383.md) (Kidney Adenoma) [4][54.55%]
1. [NCIT:C8384](markdown/NCIT_C8384.md) (Endometrioid Stromal and Related Neoplasms) [19][52.26%]
1. [NCIT:C8388](markdown/NCIT_C8388.md) (Functioning Pituitary Gland Adenoma) [2][53.58%]
1. [NCIT:C8392](markdown/NCIT_C8392.md) (Upper Gingival Carcinoma) [2][53.20%]
1. [NCIT:C8393](markdown/NCIT_C8393.md) (Lower Gingival Carcinoma) [2][53.20%]
1. [NCIT:C8396](markdown/NCIT_C8396.md) (Submandibular Gland Carcinoma) [6][52.89%]
1. [NCIT:C8402](markdown/NCIT_C8402.md) (Fibrohistiocytic Neoplasm) [18][52.12%]
1. [NCIT:C8404](markdown/NCIT_C8404.md) (Renal Pelvis Neoplasm) [18][75.00%]
1. [NCIT:C8409](markdown/NCIT_C8409.md) (Malignant Sebaceous Neoplasm) [6][60.00%]
1. [NCIT:C8417](markdown/NCIT_C8417.md) (Benign Ear Neoplasm) [7][51.96%]
1. [NCIT:C8420](markdown/NCIT_C8420.md) (Diffuse Malignant Mesothelioma) [8][52.26%]
1. [NCIT:C8429](markdown/NCIT_C8429.md) (Papillary Epithelial Neoplasm) [172][57.14%]
1. [NCIT:C8430](markdown/NCIT_C8430.md) (Ovarian Papillary Tumor) [3][55.00%]
1. [NCIT:C8431](markdown/NCIT_C8431.md) (Ovarian Serous Tumor) [16][53.57%]
1. [NCIT:C8460](markdown/NCIT_C8460.md) (Acute Myeloid Leukemia with Minimal Differentiation) [2][54.24%]
1. [NCIT:C8484](markdown/NCIT_C8484.md) (Stage III Aggressive Adult Non-Hodgkin Lymphoma) [2][53.85%]
1. [NCIT:C8487](markdown/NCIT_C8487.md) (Stage IV Aggressive Adult Non-Hodgkin Lymphoma) [2][53.85%]
1. [NCIT:C8490](markdown/NCIT_C8490.md) (Recurrent Aggressive Adult Non-Hodgkin Lymphoma) [3][52.89%]
1. [NCIT:C8491](markdown/NCIT_C8491.md) (Indolent Adult Non-Hodgkin Lymphoma) [6][52.77%]
1. [NCIT:C8492](markdown/NCIT_C8492.md) (Aggressive Adult Non-Hodgkin Lymphoma) [22][52.77%]
1. [NCIT:C8493](markdown/NCIT_C8493.md) (Hereditary Breast and Ovarian Cancer Syndrome) [2][60.36%]
1. [NCIT:C8494](markdown/NCIT_C8494.md) (Lynch Syndrome) [2][53.20%]
1. [NCIT:C8501](markdown/NCIT_C8501.md) (Brain Stem Glioma) [15][53.10%]
1. [NCIT:C8504](markdown/NCIT_C8504.md) (Indolent Non-Hodgkin Lymphoma) [89][52.66%]
1. [NCIT:C8511](markdown/NCIT_C8511.md) (Refractory Carcinoma) [2][52.40%]
1. [NCIT:C8513](markdown/NCIT_C8513.md) (Stage I Colorectal Cancer AJCC v6 and v7) [3][54.46%]
1. [NCIT:C8514](markdown/NCIT_C8514.md) (Stage II Colorectal Cancer AJCC v6) [3][54.38%]
1. [NCIT:C8515](markdown/NCIT_C8515.md) (Stage III Colorectal Cancer AJCC v6) [3][54.38%]
1. [NCIT:C8516](markdown/NCIT_C8516.md) (Stage IV Colorectal Cancer AJCC v6) [3][54.00%]
1. [NCIT:C8517](markdown/NCIT_C8517.md) (Stage I Hodgkin Lymphoma) [6][54.17%]
1. [NCIT:C8518](markdown/NCIT_C8518.md) (Stage II Hodgkin Lymphoma) [6][54.17%]
1. [NCIT:C8519](markdown/NCIT_C8519.md) (Stage IV Hodgkin Lymphoma) [5][54.17%]
1. [NCIT:C8520](markdown/NCIT_C8520.md) (Stage I Non-Hodgkin Lymphoma) [34][54.55%]
1. [NCIT:C8521](markdown/NCIT_C8521.md) (Stage II Non-Hodgkin Lymphoma) [34][54.55%]
1. [NCIT:C8522](markdown/NCIT_C8522.md) (Stage III Non-Hodgkin Lymphoma) [34][54.55%]
1. [NCIT:C8523](markdown/NCIT_C8523.md) (Stage IV Non-Hodgkin Lymphoma) [34][54.55%]
1. [NCIT:C8525](markdown/NCIT_C8525.md) (Benign Sebaceous Neoplasm) [2][53.49%]
1. [NCIT:C8528](markdown/NCIT_C8528.md) (Metastatic Malignant Neoplasm in the Neck) [7][62.50%]
1. [NCIT:C8531](markdown/NCIT_C8531.md) (Benign Respiratory Tract Neoplasm) [18][75.00%]
1. [NCIT:C8536](markdown/NCIT_C8536.md) (Benign Pericardial Neoplasm) [2][52.66%]
1. [NCIT:C8537](markdown/NCIT_C8537.md) (Benign Blood Vessel Neoplasm) [54][55.56%]
1. [NCIT:C8538](markdown/NCIT_C8538.md) (Malignant Blood Vessel Neoplasm) [76][55.00%]
1. [NCIT:C8547](markdown/NCIT_C8547.md) (Metastatic Malignant Neoplasm in the Nervous System) [14][60.00%]
1. [NCIT:C8548](markdown/NCIT_C8548.md) (Benign Cerebral Neoplasm) [6][58.33%]
1. [NCIT:C8559](markdown/NCIT_C8559.md) (Malignant Paraganglioma) [9][53.57%]
1. [NCIT:C8562](markdown/NCIT_C8562.md) (Ocular Melanoma) [5][55.56%]
1. [NCIT:C8563](markdown/NCIT_C8563.md) (Undifferentiated High Grade Pleomorphic Sarcoma of Bone) [6][53.49%]
1. [NCIT:C8567](markdown/NCIT_C8567.md) (Visual Pathway Glioma) [9][52.77%]
1. [NCIT:C8578](markdown/NCIT_C8578.md) (Childhood Ependymoma) [4][53.84%]
1. [NCIT:C8586](markdown/NCIT_C8586.md) (Stage IV Soft Tissue Sarcoma AJCC v7) [3][53.85%]
1. [NCIT:C8588](markdown/NCIT_C8588.md) (Childhood Ovarian Germ Cell Tumor) [2][53.57%]
1. [NCIT:C8591](markdown/NCIT_C8591.md) (Testicular Germ Cell Tumor) [14][58.33%]
1. [NCIT:C8592](markdown/NCIT_C8592.md) (Benign Chondrogenic Neoplasm) [9][62.50%]
1. [NCIT:C8594](markdown/NCIT_C8594.md) (Leukemic Phase of Lymphoma) [2][53.10%]
1. [NCIT:C8602](markdown/NCIT_C8602.md) (Pleomorphic Adenoma) [7][52.66%]
1. [NCIT:C8603](markdown/NCIT_C8603.md) (Renal Pelvis Papillary Urothelial Neoplasm) [4][56.67%]
1. [NCIT:C8609](markdown/NCIT_C8609.md) (Malignant Hepatobiliary Neoplasm) [213][66.67%]
1. [NCIT:C8610](markdown/NCIT_C8610.md) (Metastatic Malignant Neoplasm in the Adrenal Gland) [2][62.50%]
1. [NCIT:C8612](markdown/NCIT_C8612.md) (Benign Peritoneal Neoplasm) [2][66.67%]
1. [NCIT:C8615](markdown/NCIT_C8615.md) (Metastatic Malignant Neoplasm in the Abdominal Cavity) [3][66.67%]
1. [NCIT:C8625](markdown/NCIT_C8625.md) (Recurrent Colorectal Carcinoma) [3][53.92%]
1. [NCIT:C8644](markdown/NCIT_C8644.md) (B Acute Lymphoblastic Leukemia) [12][54.60%]
1. [NCIT:C8663](markdown/NCIT_C8663.md) (Recurrent T-Cell Non-Hodgkin Lymphoma) [9][53.00%]
1. [NCIT:C8664](markdown/NCIT_C8664.md) (Refractory T-Cell Non-Hodgkin Lymphoma) [9][53.00%]
1. [NCIT:C8665](markdown/NCIT_C8665.md) (Stage I T-Cell Non-Hodgkin Lymphoma) [8][53.57%]
1. [NCIT:C8666](markdown/NCIT_C8666.md) (Stage II T-Cell Non-Hodgkin Lymphoma) [8][53.57%]
1. [NCIT:C8667](markdown/NCIT_C8667.md) (Stage III T-Cell Non-Hodgkin Lymphoma) [8][53.57%]
1. [NCIT:C8668](markdown/NCIT_C8668.md) (Stage IV T-Cell Non-Hodgkin Lymphoma) [8][53.57%]
1. [NCIT:C8688](markdown/NCIT_C8688.md) (Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma) [8][53.30%]
1. [NCIT:C8689](markdown/NCIT_C8689.md) (Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma) [7][53.30%]
1. [NCIT:C8690](markdown/NCIT_C8690.md) (Stage I Mature T- and NK-Cell Lymphoma) [7][53.30%]
1. [NCIT:C8691](markdown/NCIT_C8691.md) (Stage II Mature T- and NK-Cell Lymphoma) [7][53.30%]
1. [NCIT:C8692](markdown/NCIT_C8692.md) (Stage III Mature T- and NK-Cell Lymphoma) [7][53.30%]
1. [NCIT:C8693](markdown/NCIT_C8693.md) (Stage IV Mature T- and NK-Cell Lymphoma) [7][53.30%]
1. [NCIT:C8694](markdown/NCIT_C8694.md) (T Lymphoblastic Leukemia/Lymphoma) [18][54.87%]
1. [NCIT:C8701](markdown/NCIT_C8701.md) (Refractory Non-Hodgkin Lymphoma) [26][52.66%]
1. [NCIT:C8711](markdown/NCIT_C8711.md) (Non-Cutaneous Melanoma) [25][57.14%]
1. [NCIT:C8768](markdown/NCIT_C8768.md) (Stage I Pharyngeal Cancer) [12][53.57%]
1. [NCIT:C8769](markdown/NCIT_C8769.md) (Stage II Pharyngeal Cancer) [11][53.57%]
1. [NCIT:C8770](markdown/NCIT_C8770.md) (Stage III Pharyngeal Cancer) [13][53.57%]
1. [NCIT:C8771](markdown/NCIT_C8771.md) (Stage IV Pharyngeal Cancer) [13][53.57%]
1. [NCIT:C8776](markdown/NCIT_C8776.md) (Peripheral Primitive Neuroectodermal Tumor of Bone) [3][54.53%]
1. [NCIT:C8810](markdown/NCIT_C8810.md) (Extraskeletal Osteosarcoma) [10][53.84%]
1. [NCIT:C8836](markdown/NCIT_C8836.md) (Refractory Hodgkin Lymphoma) [5][52.77%]
1. [NCIT:C8841](markdown/NCIT_C8841.md) (Recurrent B-Cell Non-Hodgkin Lymphoma) [25][53.00%]
1. [NCIT:C8842](markdown/NCIT_C8842.md) (Refractory B-Cell Non-Hodgkin Lymphoma) [15][53.00%]
1. [NCIT:C8843](markdown/NCIT_C8843.md) (Stage II B-Cell Non-Hodgkin Lymphoma) [18][53.57%]
1. [NCIT:C8844](markdown/NCIT_C8844.md) (Stage III B-Cell Non-Hodgkin Lymphoma) [18][53.57%]
1. [NCIT:C8845](markdown/NCIT_C8845.md) (Stage IV B-Cell Non-Hodgkin Lymphoma) [18][53.57%]
1. [NCIT:C8848](markdown/NCIT_C8848.md) (Stage I Burkitt Lymphoma) [2][54.46%]
1. [NCIT:C8849](markdown/NCIT_C8849.md) (Stage II Burkitt Lymphoma) [2][54.46%]
1. [NCIT:C8850](markdown/NCIT_C8850.md) (Stage III Burkitt Lymphoma) [2][54.46%]
1. [NCIT:C8851](markdown/NCIT_C8851.md) (Diffuse Large B-Cell Lymphoma) [88][53.58%]
1. [NCIT:C8852](markdown/NCIT_C8852.md) (Recurrent Diffuse Large B-Cell Lymphoma) [8][53.75%]
1. [NCIT:C8853](markdown/NCIT_C8853.md) (Refractory Diffuse Large B-Cell Lymphoma) [3][53.75%]
1. [NCIT:C8854](markdown/NCIT_C8854.md) (Stage I Diffuse Large B-Cell Lymphoma) [3][53.75%]
1. [NCIT:C8855](markdown/NCIT_C8855.md) (Stage II Diffuse Large B-Cell Lymphoma) [3][53.75%]
1. [NCIT:C8856](markdown/NCIT_C8856.md) (Stage III Diffuse Large B-Cell Lymphoma) [3][53.75%]
1. [NCIT:C8857](markdown/NCIT_C8857.md) (Stage IV Diffuse Large B-Cell Lymphoma) [3][53.75%]
1. [NCIT:C8859](markdown/NCIT_C8859.md) (Stage I Follicular Lymphoma) [3][54.60%]
1. [NCIT:C8860](markdown/NCIT_C8860.md) (Stage II Follicular Lymphoma) [3][54.60%]
1. [NCIT:C8861](markdown/NCIT_C8861.md) (Stage III Follicular Lymphoma) [3][54.60%]
1. [NCIT:C8863](markdown/NCIT_C8863.md) (Nodal Marginal Zone Lymphoma) [7][54.24%]
1. [NCIT:C8868](markdown/NCIT_C8868.md) (B Lymphoblastic Lymphoma) [9][54.24%]
1. [NCIT:C8880](markdown/NCIT_C8880.md) (Extragonadal Embryonal Carcinoma) [2][56.21%]
1. [NCIT:C8881](markdown/NCIT_C8881.md) (Malignant Extragonadal Germ Cell Tumor) [26][52.02%]
1. [NCIT:C8884](markdown/NCIT_C8884.md) (Immature Extragonadal Teratoma) [4][54.16%]
1. [NCIT:C8885](markdown/NCIT_C8885.md) (Malignant Extragonadal Non-Seminomatous Germ Cell Tumor) [14][56.25%]
1. [NCIT:C8923](markdown/NCIT_C8923.md) (Acute Erythroid Leukemia) [2][53.49%]
1. [NCIT:C8925](markdown/NCIT_C8925.md) (Metastatic Melanoma) [2][56.25%]
1. [NCIT:C8932](markdown/NCIT_C8932.md) (Stage 0 Colorectal Cancer AJCC v6 and v7) [4][54.38%]
1. [NCIT:C8936](markdown/NCIT_C8936.md) (B Lymphoblastic Leukemia/Lymphoma) [33][53.75%]
1. [NCIT:C8946](markdown/NCIT_C8946.md) (Metastatic Prostate Carcinoma) [4][52.77%]
1. [NCIT:C8953](markdown/NCIT_C8953.md) (Recurrent Lung Carcinoma) [5][53.00%]
1. [NCIT:C8962](markdown/NCIT_C8962.md) (Digestive System Intraepithelial Neoplasia) [38][56.25%]
1. [NCIT:C8964](markdown/NCIT_C8964.md) (Synovial Neoplasm) [5][62.50%]
1. [NCIT:C8965](markdown/NCIT_C8965.md) (Lymphangioma) [11][55.00%]
1. [NCIT:C8968](markdown/NCIT_C8968.md) (Grade 2 Follicular Lymphoma) [6][54.80%]
1. [NCIT:C8971](markdown/NCIT_C8971.md) (Embryonal Rhabdomyosarcoma) [3][54.16%]
1. [NCIT:C8973](markdown/NCIT_C8973.md) (Endometrioid Stromal Sarcoma) [7][53.49%]
1. [NCIT:C8975](markdown/NCIT_C8975.md) (Malignant Mixed Mesodermal (Mullerian) Tumor) [7][54.55%]
1. [NCIT:C8978](markdown/NCIT_C8978.md) (Mucinous Adenofibroma) [3][55.56%]
1. [NCIT:C8984](markdown/NCIT_C8984.md) (Female Reproductive System Adenofibroma) [29][53.20%]
1. [NCIT:C8985](markdown/NCIT_C8985.md) (Cystadenofibroma) [11][53.30%]
1. [NCIT:C8986](markdown/NCIT_C8986.md) (Papillary Adenofibroma) [2][53.30%]
1. [NCIT:C8987](markdown/NCIT_C8987.md) (Clear Cell Adenofibroma) [6][53.30%]
1. [NCIT:C8988](markdown/NCIT_C8988.md) (Clear Cell Cystadenofibroma) [2][53.40%]
1. [NCIT:C8990](markdown/NCIT_C8990.md) (Oral Cavity Carcinoma) [53][52.89%]
1. [NCIT:C8991](markdown/NCIT_C8991.md) (Malignant Mastocytosis) [4][52.66%]
1. [NCIT:C8993](markdown/NCIT_C8993.md) (Ureter Carcinoma) [16][52.66%]
1. [NCIT:C8997](markdown/NCIT_C8997.md) (Blastoma) [7][51.13%]
1. [NCIT:C9003](markdown/NCIT_C9003.md) (Adrenal Cortex Adenoma) [3][54.08%]
1. [NCIT:C9004](markdown/NCIT_C9004.md) (Benign Adrenal Cortex Neoplasm) [4][57.14%]
1. [NCIT:C9005](markdown/NCIT_C9005.md) (Malignant Pancreatic Neoplasm) [50][75.00%]
1. [NCIT:C9011](markdown/NCIT_C9011.md) (Dermoid Cyst) [4][54.17%]
1. [NCIT:C9013](markdown/NCIT_C9013.md) (Adult Teratoma) [4][54.55%]
1. [NCIT:C9014](markdown/NCIT_C9014.md) (Cystic Teratoma) [6][54.55%]
1. [NCIT:C9015](markdown/NCIT_C9015.md) (Mature Teratoma) [8][54.17%]
1. [NCIT:C9022](markdown/NCIT_C9022.md) (Childhood Astrocytic Tumor) [41][53.00%]
1. [NCIT:C9023](markdown/NCIT_C9023.md) (Sarcoma by FNCLCC Grade) [47][57.14%]
1. [NCIT:C9024](markdown/NCIT_C9024.md) (FNCLCC Sarcoma Grade 1) [5][57.14%]
1. [NCIT:C9028](markdown/NCIT_C9028.md) (FNCLCC Sarcoma Grade 2) [8][57.14%]
1. [NCIT:C9029](markdown/NCIT_C9029.md) (FNCLCC Sarcoma Grade 3) [31][57.14%]
1. [NCIT:C9039](markdown/NCIT_C9039.md) (Cervical Carcinoma) [40][53.58%]
1. [NCIT:C9042](markdown/NCIT_C9042.md) (Childhood Brain Stem Glioma) [5][53.20%]
1. [NCIT:C9045](markdown/NCIT_C9045.md) (Recurrent Childhood Central Nervous System Neoplasm) [33][75.00%]
1. [NCIT:C9055](markdown/NCIT_C9055.md) (Bartholin Gland Carcinoma) [6][52.77%]
1. [NCIT:C9061](markdown/NCIT_C9061.md) (Penile Carcinoma) [21][52.53%]
1. [NCIT:C9062](markdown/NCIT_C9062.md) (Adult Burkitt Lymphoma) [5][54.46%]
1. [NCIT:C9063](markdown/NCIT_C9063.md) (Malignant Testicular Germ Cell Tumor) [9][52.66%]
1. [NCIT:C9087](markdown/NCIT_C9087.md) (Kaposi Sarcoma) [30][54.24%]
1. [NCIT:C9091](markdown/NCIT_C9091.md) (Adult Brain Stem Glioma) [3][53.20%]
1. [NCIT:C9092](markdown/NCIT_C9092.md) (Adult Ependymoma) [2][53.84%]
1. [NCIT:C9093](markdown/NCIT_C9093.md) (Adult Meningioma) [6][53.20%]
1. [NCIT:C9094](markdown/NCIT_C9094.md) (Adult Glioblastoma) [5][54.74%]
1. [NCIT:C9095](markdown/NCIT_C9095.md) (Childhood Burkitt Lymphoma) [5][54.46%]
1. [NCIT:C9096](markdown/NCIT_C9096.md) (Stage IV Cutaneous Melanoma AJCC v6 and v7) [2][53.57%]
1. [NCIT:C9099](markdown/NCIT_C9099.md) (Stage 0 Nasopharyngeal Carcinoma AJCC v6, v7, and v8) [2][54.38%]
1. [NCIT:C9104](markdown/NCIT_C9104.md) (Stage 0 Non-Small Cell Lung Cancer AJCC v6 and v7) [3][54.16%]
1. [NCIT:C9105](markdown/NCIT_C9105.md) (Oropharyngeal Carcinoma) [27][53.10%]
1. [NCIT:C9106](markdown/NCIT_C9106.md) (Urethral Carcinoma) [21][52.53%]
1. [NCIT:C9118](markdown/NCIT_C9118.md) (Sarcoma) [451][57.14%]
1. [NCIT:C9120](markdown/NCIT_C9120.md) (Pancreatic Ductal Adenocarcinoma) [9][55.94%]
1. [NCIT:C9124](markdown/NCIT_C9124.md) (Childhood Lymphoblastic Lymphoma) [7][53.58%]
1. [NCIT:C9133](markdown/NCIT_C9133.md) (Adenosquamous Lung Carcinoma) [7][54.08%]
1. [NCIT:C9134](markdown/NCIT_C9134.md) (Papillary Breast Carcinoma) [3][54.53%]
1. [NCIT:C9145](markdown/NCIT_C9145.md) (Osteosarcoma) [38][53.57%]
1. [NCIT:C9151](markdown/NCIT_C9151.md) (Lentigo Maligna Melanoma) [5][54.55%]
1. [NCIT:C9152](markdown/NCIT_C9152.md) (Superficial Spreading Melanoma) [4][53.33%]
1. [NCIT:C9154](markdown/NCIT_C9154.md) (Adult Acute Myeloid Leukemia) [17][53.00%]
1. [NCIT:C9159](markdown/NCIT_C9159.md) (Diffuse Gastric Adenocarcinoma) [2][54.00%]
1. [NCIT:C9160](markdown/NCIT_C9160.md) (Childhood Acute Myeloid Leukemia) [17][53.00%]
1. [NCIT:C9161](markdown/NCIT_C9161.md) (Anal Squamous Cell Carcinoma) [5][53.40%]
1. [NCIT:C9166](markdown/NCIT_C9166.md) (Gallbladder Adenocarcinoma) [8][54.31%]
1. [NCIT:C9182](markdown/NCIT_C9182.md) (Desmoid-Type Fibromatosis) [4][53.58%]
1. [NCIT:C9231](markdown/NCIT_C9231.md) (Merkel Cell Carcinoma) [9][54.16%]
1. [NCIT:C9234](markdown/NCIT_C9234.md) (Childhood Spinal Cord Neoplasm) [2][66.67%]
1. [NCIT:C9235](markdown/NCIT_C9235.md) (Systemic Mastocytosis) [7][52.53%]
1. [NCIT:C9240](markdown/NCIT_C9240.md) (Recurrent Nasopharynx Carcinoma) [2][54.53%]
1. [NCIT:C9242](markdown/NCIT_C9242.md) (Malignant Colon Neoplasm) [52][62.50%]
1. [NCIT:C9244](markdown/NCIT_C9244.md) (Aggressive Non-Hodgkin Lymphoma) [137][52.66%]
1. [NCIT:C9245](markdown/NCIT_C9245.md) (Invasive Breast Carcinoma) [46][53.00%]
1. [NCIT:C9251](markdown/NCIT_C9251.md) (Recurrent Non-Hodgkin Lymphoma) [42][52.66%]
1. [NCIT:C9252](markdown/NCIT_C9252.md) (Stage I Aggressive Adult Non-Hodgkin Lymphoma) [2][53.85%]
1. [NCIT:C9262](markdown/NCIT_C9262.md) (Recurrent Malignant Oral Neoplasm) [8][75.00%]
1. [NCIT:C9264](markdown/NCIT_C9264.md) (Recurrent Hepatocellular Carcinoma) [2][56.40%]
1. [NCIT:C9265](markdown/NCIT_C9265.md) (Mycosis Fungoides and Sezary Syndrome) [15][53.67%]
1. [NCIT:C9266](markdown/NCIT_C9266.md) (Recurrent Malignant Bladder Neoplasm) [4][75.00%]
1. [NCIT:C9268](markdown/NCIT_C9268.md) (Recurrent Malignant Nasopharyngeal Neoplasm) [3][75.00%]
1. [NCIT:C9272](markdown/NCIT_C9272.md) (Salivary Gland Carcinoma) [70][52.66%]
1. [NCIT:C9280](markdown/NCIT_C9280.md) (Mediastinal (Thymic) Large B-Cell Lymphoma) [6][55.00%]
1. [NCIT:C9283](markdown/NCIT_C9283.md) (Lymphocyte-Depleted Classical Hodgkin Lymphoma) [8][54.80%]
1. [NCIT:C9287](markdown/NCIT_C9287.md) (Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11) [4][54.60%]
1. [NCIT:C9290](markdown/NCIT_C9290.md) (Myeloid Neoplasm) [178][51.79%]
1. [NCIT:C9291](markdown/NCIT_C9291.md) (Anal Carcinoma) [37][52.77%]
1. [NCIT:C9292](markdown/NCIT_C9292.md) (Solid Neoplasm) [6][75.00%]
1. [NCIT:C9294](markdown/NCIT_C9294.md) (Histiocytic and Dendritic Cell Neoplasm) [26][61.11%]
1. [NCIT:C9295](markdown/NCIT_C9295.md) (Mast Cell Neoplasm) [14][52.12%]
1. [NCIT:C9300](markdown/NCIT_C9300.md) (Acute Leukemia) [140][51.96%]
1. [NCIT:C9301](markdown/NCIT_C9301.md) (Central Nervous System Lymphoma) [18][53.00%]
1. [NCIT:C9303](markdown/NCIT_C9303.md) (Mastocytoma) [2][52.40%]
1. [NCIT:C9306](markdown/NCIT_C9306.md) (Soft Tissue Sarcoma) [279][52.53%]
1. [NCIT:C9308](markdown/NCIT_C9308.md) (Lymphoproliferative Disorder) [774][60.00%]
1. [NCIT:C9309](markdown/NCIT_C9309.md) (Seminoma) [4][52.26%]
1. [NCIT:C9311](markdown/NCIT_C9311.md) (Malignant Cervical Neoplasm) [60][75.00%]
1. [NCIT:C9312](markdown/NCIT_C9312.md) (Bone Sarcoma) [51][52.66%]
1. [NCIT:C9313](markdown/NCIT_C9313.md) (Testicular Non-Seminomatous Germ Cell Tumor) [5][56.25%]
1. [NCIT:C9315](markdown/NCIT_C9315.md) (Lip and Oral Cavity Carcinoma) [86][52.66%]
1. [NCIT:C9317](markdown/NCIT_C9317.md) (Malignant Gingival Neoplasm) [10][53.87%]
1. [NCIT:C9318](markdown/NCIT_C9318.md) (Malignant Floor of the Mouth Neoplasm) [5][75.00%]
1. [NCIT:C9319](markdown/NCIT_C9319.md) (Floor of the Mouth Carcinoma) [4][53.00%]
1. [NCIT:C9320](markdown/NCIT_C9320.md) (Malignant Buccal Mucosa Neoplasm) [2][75.00%]
1. [NCIT:C9325](markdown/NCIT_C9325.md) (Adrenal Cortex Carcinoma) [7][54.31%]
1. [NCIT:C9327](markdown/NCIT_C9327.md) (Malignant Adrenal Cortex Neoplasm) [9][75.00%]
1. [NCIT:C9328](markdown/NCIT_C9328.md) (Malignant Duodenal Neoplasm) [6][62.50%]
1. [NCIT:C9329](markdown/NCIT_C9329.md) (Malignant Cecum Neoplasm) [5][60.00%]
1. [NCIT:C9330](markdown/NCIT_C9330.md) (Appendix Carcinoma) [22][52.77%]
1. [NCIT:C9331](markdown/NCIT_C9331.md) (Malignant Gastric Neoplasm) [62][75.00%]
1. [NCIT:C9333](markdown/NCIT_C9333.md) (Malignant Appendix Neoplasm) [26][66.67%]
1. [NCIT:C9336](markdown/NCIT_C9336.md) (Nasal Cavity Carcinoma) [10][53.30%]
1. [NCIT:C9341](markdown/NCIT_C9341.md) (Peripheral Primitive Neuroectodermal Tumor) [11][54.38%]
1. [NCIT:C9344](markdown/NCIT_C9344.md) (Pineoblastoma) [3][54.46%]
1. [NCIT:C9345](markdown/NCIT_C9345.md) (Malignant Tongue Neoplasm) [7][75.00%]
1. [NCIT:C9346](markdown/NCIT_C9346.md) (Malignant Tracheal Neoplasm) [6][75.00%]
1. [NCIT:C9347](markdown/NCIT_C9347.md) (Tracheal Carcinoma) [3][52.77%]
1. [NCIT:C9349](markdown/NCIT_C9349.md) (Plasmacytoma) [4][53.30%]
1. [NCIT:C9351](markdown/NCIT_C9351.md) (Pleural Mesothelioma) [19][56.25%]
1. [NCIT:C9353](markdown/NCIT_C9353.md) (Recurrent Malignant Hypopharyngeal Neoplasm) [2][66.67%]
1. [NCIT:C9357](markdown/NCIT_C9357.md) (Hodgkin Lymphoma) [75][52.66%]
1. [NCIT:C9360](markdown/NCIT_C9360.md) (Lymphoblastic Lymphoma) [28][53.49%]
1. [NCIT:C9361](markdown/NCIT_C9361.md) (Adult Lymphoblastic Lymphoma) [7][53.67%]
1. [NCIT:C9377](markdown/NCIT_C9377.md) (Brain Oligodendroglioma) [2][54.74%]
1. [NCIT:C9382](markdown/NCIT_C9382.md) (Rectal Carcinoma) [33][53.84%]
1. [NCIT:C9383](markdown/NCIT_C9383.md) (Rectal Adenocarcinoma) [8][54.53%]
1. [NCIT:C9384](markdown/NCIT_C9384.md) (Kidney Carcinoma) [46][52.77%]
1. [NCIT:C9385](markdown/NCIT_C9385.md) (Renal Cell Carcinoma) [28][53.67%]
1. [NCIT:C9387](markdown/NCIT_C9387.md) (Sarcoma by NCI Grade) [62][57.14%]
1. [NCIT:C9388](markdown/NCIT_C9388.md) (Sarcoma NCI Grade 1) [5][56.25%]
1. [NCIT:C9400](markdown/NCIT_C9400.md) (Sarcoma NCI Grade 2) [4][56.25%]
1. [NCIT:C9415](markdown/NCIT_C9415.md) (Sarcoma NCI Grade 3) [50][55.56%]
1. [NCIT:C9429](markdown/NCIT_C9429.md) (Conventional Fibrosarcoma) [2][56.67%]
1. [NCIT:C9431](markdown/NCIT_C9431.md) (Childhood Hematopoietic Neoplasm) [94][66.67%]
1. [NCIT:C9446](markdown/NCIT_C9446.md) (Grade 1 Colorectal Adenocarcinoma) [2][54.80%]
1. [NCIT:C9447](markdown/NCIT_C9447.md) (Grade 2 Colorectal Adenocarcinoma) [2][54.80%]
1. [NCIT:C9448](markdown/NCIT_C9448.md) (Grade 3 Colorectal Adenocarcinoma) [2][54.80%]
1. [NCIT:C9465](markdown/NCIT_C9465.md) (Hypopharyngeal Carcinoma) [23][53.00%]
1. [NCIT:C9466](markdown/NCIT_C9466.md) (Pharyngeal Carcinoma) [100][52.89%]
1. [NCIT:C9470](markdown/NCIT_C9470.md) (Systemic Anaplastic Large Cell Lymphoma) [4][54.08%]
1. [NCIT:C9474](markdown/NCIT_C9474.md) (Adenosarcoma) [5][52.89%]
1. [NCIT:C9475](markdown/NCIT_C9475.md) (Cerebellar Astrocytoma) [4][53.49%]
1. [NCIT:C9477](markdown/NCIT_C9477.md) (Anaplastic Astrocytoma) [14][55.00%]
1. [NCIT:C9480](markdown/NCIT_C9480.md) (Invasive Carcinoma) [96][52.40%]
1. [NCIT:C9481](markdown/NCIT_C9481.md) (Primary Carcinoma) [44][52.40%]
1. [NCIT:C9482](markdown/NCIT_C9482.md) (Soft Tissue Chondroma) [3][55.00%]
1. [NCIT:C25765](markdown/NCIT_C25765.md) (Secondary Acute Myeloid Leukemia) [4][53.20%]
1. [NCIT:C26712](markdown/NCIT_C26712.md) (Mucinous Adenocarcinoma) [41][55.88%]
1. [NCIT:C26749](markdown/NCIT_C26749.md) (VIP-Producing Neuroendocrine Tumor) [3][53.33%]
1. [NCIT:C26952](markdown/NCIT_C26952.md) (Trigeminal Nerve Disorder) [2][75.00%]
1. [NCIT:C26954](markdown/NCIT_C26954.md) (Hypoglossal Nerve Disorder) [2][75.00%]
1. [NCIT:C27004](markdown/NCIT_C27004.md) (Sarcomatoid Carcinoma) [25][52.66%]
1. [NCIT:C27007](markdown/NCIT_C27007.md) (Spitz Nevus) [3][53.57%]
1. [NCIT:C27031](markdown/NCIT_C27031.md) (Pancreatic Neuroendocrine Neoplasm) [31][54.55%]
1. [NCIT:C27084](markdown/NCIT_C27084.md) (Sarcomatoid Squamous Cell Carcinoma) [5][53.30%]
1. [NCIT:C27093](markdown/NCIT_C27093.md) (Stage 0 Squamous Cell Carcinoma) [11][53.84%]
1. [NCIT:C27094](markdown/NCIT_C27094.md) (Cylindroma) [2][53.49%]
1. [NCIT:C27127](markdown/NCIT_C27127.md) (Benign Cutaneous Vascular Neoplasm) [6][54.17%]
1. [NCIT:C27132](markdown/NCIT_C27132.md) (Trichoblastoma) [2][53.58%]
1. [NCIT:C27134](markdown/NCIT_C27134.md) (Hematopoietic and Lymphoid Cell Neoplasm) [1009][75.00%]
1. [NCIT:C27207](markdown/NCIT_C27207.md) (Vestibulocochlear Nerve Disorder) [3][75.00%]
1. [NCIT:C27210](markdown/NCIT_C27210.md) (Olfactory Nerve Disorder) [8][75.00%]
1. [NCIT:C27223](markdown/NCIT_C27223.md) (Infection-Related Malignant Neoplasm) [97][51.13%]
1. [NCIT:C27235](markdown/NCIT_C27235.md) (Gastric Non-Hodgkin Lymphoma) [5][53.00%]
1. [NCIT:C27255](markdown/NCIT_C27255.md) (Eccrine Carcinoma) [7][56.00%]
1. [NCIT:C27262](markdown/NCIT_C27262.md) (Myelodysplastic/Myeloproliferative Neoplasm) [10][52.66%]
1. [NCIT:C27268](markdown/NCIT_C27268.md) (Lymphoma by Stage) [170][52.40%]
1. [NCIT:C27269](markdown/NCIT_C27269.md) (Glandular Cell Intraepithelial Neoplasia) [46][53.57%]
1. [NCIT:C27273](markdown/NCIT_C27273.md) (Poroma) [4][53.49%]
1. [NCIT:C27280](markdown/NCIT_C27280.md) (Secondary Myelodysplastic Syndrome) [3][52.89%]
1. [NCIT:C27291](markdown/NCIT_C27291.md) (Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor) [30][53.40%]
1. [NCIT:C27292](markdown/NCIT_C27292.md) (Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor) [4][53.58%]
1. [NCIT:C27293](markdown/NCIT_C27293.md) (Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor) [5][53.84%]
1. [NCIT:C27294](markdown/NCIT_C27294.md) (Localized Primitive Neuroectodermal Tumor) [3][54.84%]
1. [NCIT:C27295](markdown/NCIT_C27295.md) (Recurrent Primitive Neuroectodermal Tumor) [5][54.02%]
1. [NCIT:C27308](markdown/NCIT_C27308.md) (Stage I B-Cell Non-Hodgkin Lymphoma) [18][53.57%]
1. [NCIT:C27357](markdown/NCIT_C27357.md) (Refractory Hematologic Malignancy) [51][66.67%]
1. [NCIT:C27358](markdown/NCIT_C27358.md) (Recurrent Hematologic Malignancy) [73][66.67%]
1. [NCIT:C27367](markdown/NCIT_C27367.md) (Adult Anaplastic Large Cell Lymphoma) [2][53.84%]
1. [NCIT:C27368](markdown/NCIT_C27368.md) (Childhood Liver and Intrahepatic Bile Duct Neoplasm) [12][62.50%]
1. [NCIT:C27380](markdown/NCIT_C27380.md) (Thyroid Gland Adenocarcinoma) [24][54.00%]
1. [NCIT:C27408](markdown/NCIT_C27408.md) (Metastatic Carcinoma in the Lung) [3][53.00%]
1. [NCIT:C27423](markdown/NCIT_C27423.md) (Esophageal Squamous Intraepithelial Neoplasia) [3][53.49%]
1. [NCIT:C27424](markdown/NCIT_C27424.md) (Esophageal Glandular Intraepithelial Neoplasia) [4][53.49%]
1. [NCIT:C27425](markdown/NCIT_C27425.md) (Esophageal High Grade Intraepithelial Neoplasia) [6][54.17%]
1. [NCIT:C27438](markdown/NCIT_C27438.md) (Benign Gastric Soft Tissue Neoplasm) [4][55.56%]
1. [NCIT:C27439](markdown/NCIT_C27439.md) (Malignant Gastric Soft Tissue Neoplasm) [3][58.33%]
1. [NCIT:C27456](markdown/NCIT_C27456.md) (Colorectal Tubular Adenoma) [2][53.30%]
1. [NCIT:C27462](markdown/NCIT_C27462.md) (Small Intestinal Intraepithelial Neoplasia) [2][53.49%]
1. [NCIT:C27467](markdown/NCIT_C27467.md) (Stage 0 Lung Cancer AJCC v6 and v7) [4][53.75%]
1. [NCIT:C27469](markdown/NCIT_C27469.md) (Disseminated Carcinoma) [2][52.66%]
1. [NCIT:C27470](markdown/NCIT_C27470.md) (Disseminated Malignant Neoplasm) [3][66.67%]
1. [NCIT:C27508](markdown/NCIT_C27508.md) (Intra-Abdominal Lymphangioma) [2][54.55%]
1. [NCIT:C27520](markdown/NCIT_C27520.md) (Benign Hair Follicle Neoplasm) [17][57.14%]
1. [NCIT:C27529](markdown/NCIT_C27529.md) (Malignant Cutaneous Vascular Neoplasm) [6][54.55%]
1. [NCIT:C27531](markdown/NCIT_C27531.md) (Pre-Malignant Skin Epithelial Lesion) [4][52.77%]
1. [NCIT:C27591](markdown/NCIT_C27591.md) (Vagus Nerve Disorder) [2][75.00%]
1. [NCIT:C27632](markdown/NCIT_C27632.md) (Transplant-Related Malignant Neoplasm) [23][60.82%]
1. [NCIT:C27633](markdown/NCIT_C27633.md) (Transplant-Related Carcinoma) [5][52.89%]
1. [NCIT:C27639](markdown/NCIT_C27639.md) (Transplant-Related Hematologic Malignancy) [15][54.55%]
1. [NCIT:C27673](markdown/NCIT_C27673.md) (Virus-Related Malignant Neoplasm) [84][51.39%]
1. [NCIT:C27674](markdown/NCIT_C27674.md) (Human Papillomavirus-Related Carcinoma) [18][52.77%]
1. [NCIT:C27675](markdown/NCIT_C27675.md) (Human Papillomavirus-Related Cervical Carcinoma) [5][54.00%]
1. [NCIT:C27676](markdown/NCIT_C27676.md) (Human Papillomavirus-Related Cervical Squamous Cell Carcinoma) [3][54.74%]
1. [NCIT:C27683](markdown/NCIT_C27683.md) (Human Papillomavirus-Related Squamous Cell Carcinoma) [13][53.30%]
1. [NCIT:C27689](markdown/NCIT_C27689.md) (EBV-Related Malignant Neoplasm) [24][62.50%]
1. [NCIT:C27690](markdown/NCIT_C27690.md) (EBV-Related Carcinoma) [8][52.77%]
1. [NCIT:C27691](markdown/NCIT_C27691.md) (EBV-Related Lymphoma) [14][52.89%]
1. [NCIT:C27693](markdown/NCIT_C27693.md) (EBV-Related Non-Hodgkin Lymphoma) [9][53.00%]
1. [NCIT:C27695](markdown/NCIT_C27695.md) (EBV-Related Clonal Post-Transplant Lymphoproliferative Disorder) [2][54.00%]
1. [NCIT:C27696](markdown/NCIT_C27696.md) (EBV-Related Post-Transplant Lymphoproliferative Disorder) [3][55.56%]
1. [NCIT:C27697](markdown/NCIT_C27697.md) (HHV8-Related Malignant Neoplasm) [33][62.50%]
1. [NCIT:C27698](markdown/NCIT_C27698.md) (Virus-Related Carcinoma) [30][52.66%]
1. [NCIT:C27699](markdown/NCIT_C27699.md) (Virus-Related Lymphoma) [17][52.77%]
1. [NCIT:C27707](markdown/NCIT_C27707.md) (Virus-Related Sarcoma) [31][54.17%]
1. [NCIT:C27716](markdown/NCIT_C27716.md) (Extragastrointestinal Gastrointestinal Stromal Tumor) [3][53.40%]
1. [NCIT:C27718](markdown/NCIT_C27718.md) (Human Papillomavirus-Related Malignant Neoplasm) [19][62.50%]
1. [NCIT:C27720](markdown/NCIT_C27720.md) (Pancreatic Neuroendocrine Tumor) [25][53.30%]
1. [NCIT:C27721](markdown/NCIT_C27721.md) (Digestive System Neuroendocrine Neoplasm) [181][55.00%]
1. [NCIT:C27722](markdown/NCIT_C27722.md) (Therapy-Related Myelodysplastic Syndrome) [2][53.00%]
1. [NCIT:C27745](markdown/NCIT_C27745.md) (Non-Small Cell Adenocarcinoma) [20][53.10%]
1. [NCIT:C27753](markdown/NCIT_C27753.md) (Acute Myeloid Leukemia Not Otherwise Specified) [35][52.89%]
1. [NCIT:C27760](markdown/NCIT_C27760.md) (Bacterium-Related Malignant Neoplasm) [7][51.39%]
1. [NCIT:C27761](markdown/NCIT_C27761.md) (Helicobacter Pylori-Related Malignant Neoplasm) [4][62.50%]
1. [NCIT:C27766](markdown/NCIT_C27766.md) (Parasite-Related Malignant Neoplasm) [3][66.67%]
1. [NCIT:C27767](markdown/NCIT_C27767.md) (Parasite-Related Carcinoma) [2][52.66%]
1. [NCIT:C27813](markdown/NCIT_C27813.md) (Bile Duct Adenocarcinoma) [44][53.49%]
1. [NCIT:C27814](markdown/NCIT_C27814.md) (Bile Duct Carcinoma) [68][53.00%]
1. [NCIT:C27815](markdown/NCIT_C27815.md) (Malignant Endometrial Neoplasm) [32][75.00%]
1. [NCIT:C27816](markdown/NCIT_C27816.md) (Pigmented Nevus) [4][56.25%]
1. [NCIT:C27825](markdown/NCIT_C27825.md) (Mucin-Producing Carcinoma) [29][52.40%]
1. [NCIT:C27880](markdown/NCIT_C27880.md) (Intraurothelial Neoplasia) [15][53.20%]
1. [NCIT:C27881](markdown/NCIT_C27881.md) (Transitional Cell Intraepithelial Neoplasia) [17][55.00%]
1. [NCIT:C27883](markdown/NCIT_C27883.md) (Papillary Urothelial Neoplasm) [20][52.66%]
1. [NCIT:C27885](markdown/NCIT_C27885.md) (Infiltrating Bladder Urothelial Carcinoma) [14][55.49%]
1. [NCIT:C27891](markdown/NCIT_C27891.md) (Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions) [4][53.92%]
1. [NCIT:C27897](markdown/NCIT_C27897.md) (T-Cell Proliferation of Uncertain Malignant Potential) [7][53.67%]
1. [NCIT:C27898](markdown/NCIT_C27898.md) (Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor) [6][53.58%]
1. [NCIT:C27899](markdown/NCIT_C27899.md) (Recurrent Peripheral Primitive Neuroectodermal Tumor) [2][54.53%]
1. [NCIT:C27901](markdown/NCIT_C27901.md) (Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor) [5][53.49%]
1. [NCIT:C27903](markdown/NCIT_C27903.md) (Localized Peripheral Primitive Neuroectodermal Tumor) [2][54.46%]
1. [NCIT:C27907](markdown/NCIT_C27907.md) (B-Cell Neoplasm) [351][52.66%]
1. [NCIT:C27908](markdown/NCIT_C27908.md) (T-Cell and NK-Cell Neoplasm) [151][52.66%]
1. [NCIT:C27909](markdown/NCIT_C27909.md) (Mature T-Cell and NK-Cell Neoplasm) [120][53.00%]
1. [NCIT:C27910](markdown/NCIT_C27910.md) (Mature B-Cell Neoplasm) [308][52.89%]
1. [NCIT:C27911](markdown/NCIT_C27911.md) (Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma) [28][53.49%]
1. [NCIT:C27912](markdown/NCIT_C27912.md) (Therapy-Related Myeloid Neoplasm) [8][52.53%]
1. [NCIT:C27913](markdown/NCIT_C27913.md) (Alkylating Agent-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome) [2][54.24%]
1. [NCIT:C27915](markdown/NCIT_C27915.md) (Immunodeficiency-Related Burkitt Lymphoma) [2][54.46%]
1. [NCIT:C27927](markdown/NCIT_C27927.md) (Alcohol-Related Carcinoma) [3][52.40%]
1. [NCIT:C27939](markdown/NCIT_C27939.md) (Lobular Neoplasia) [2][54.17%]
1. [NCIT:C27942](markdown/NCIT_C27942.md) (Intraductal Proliferative Lesion of the Breast) [4][57.14%]
1. [NCIT:C27949](markdown/NCIT_C27949.md) (Metaplastic Carcinoma) [19][52.53%]
1. [NCIT:C28396](markdown/NCIT_C28396.md) (Pancreatic Delta Cell Neuroendocrine Tumor) [4][53.40%]
1. [NCIT:C28432](markdown/NCIT_C28432.md) (Nipple Carcinoma) [3][52.77%]
1. [NCIT:C34447](markdown/NCIT_C34447.md) (Head and Neck Squamous Cell Carcinoma) [94][53.10%]
1. [NCIT:C34448](markdown/NCIT_C34448.md) (Carcinosarcoma) [14][55.00%]
1. [NCIT:C34803](markdown/NCIT_C34803.md) (Primary Malignant Liver Neoplasm) [100][58.33%]
1. [NCIT:C35180](markdown/NCIT_C35180.md) (Digestive System Carcinoma In Situ) [28][53.20%]
1. [NCIT:C35416](markdown/NCIT_C35416.md) (Mixed Tumor of the Parotid Gland) [4][58.33%]
1. [NCIT:C35417](markdown/NCIT_C35417.md) (Intrahepatic Cholangiocarcinoma) [18][54.67%]
1. [NCIT:C35506](markdown/NCIT_C35506.md) (Throat Cancer) [136][52.77%]
1. [NCIT:C35562](markdown/NCIT_C35562.md) (Neuroepithelial, Perineurial, and Schwann Cell Neoplasm) [375][51.39%]
1. [NCIT:C35690](markdown/NCIT_C35690.md) (Eye Lymphoma) [3][52.66%]
1. [NCIT:C35691](markdown/NCIT_C35691.md) (Mixed Tumor of the Salivary Gland) [16][51.60%]
1. [NCIT:C35765](markdown/NCIT_C35765.md) (Histiocytoma) [8][52.40%]
1. [NCIT:C35778](markdown/NCIT_C35778.md) (Gastrointestinal Stromal Tumor of the Gastrointestinal Tract) [12][53.30%]
1. [NCIT:C35812](markdown/NCIT_C35812.md) (Malignant Lymph Node Neoplasm) [2][75.00%]
1. [NCIT:C35839](markdown/NCIT_C35839.md) (Salivary Gland Ductal Papilloma) [2][53.30%]
1. [NCIT:C35850](markdown/NCIT_C35850.md) (Head and Neck Carcinoma) [414][52.53%]
1. [NCIT:C35870](markdown/NCIT_C35870.md) (Conventional Osteosarcoma) [4][55.06%]
1. [NCIT:C35871](markdown/NCIT_C35871.md) (Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor of Bone) [8][53.75%]
1. [NCIT:C35873](markdown/NCIT_C35873.md) (Iatrogenic Kaposi Sarcoma) [2][54.31%]
1. [NCIT:C35876](markdown/NCIT_C35876.md) (Childhood Intracranial Neoplasm) [53][75.00%]
1. [NCIT:C36031](markdown/NCIT_C36031.md) (Papillary Neoplasm) [174][75.00%]
1. [NCIT:C36055](markdown/NCIT_C36055.md) (Acute Myeloid Leukemia with a Variant RARA Translocation) [4][53.49%]
1. [NCIT:C36077](markdown/NCIT_C36077.md) (Hilar Cholangiocarcinoma) [10][54.08%]
1. [NCIT:C36082](markdown/NCIT_C36082.md) (Metastatic Carcinoma in the Bone) [3][53.00%]
1. [NCIT:C36083](markdown/NCIT_C36083.md) (Intraductal Breast Neoplasm) [13][62.50%]
1. [NCIT:C36090](markdown/NCIT_C36090.md) (Intraductal Papillary Breast Neoplasm) [7][54.55%]
1. [NCIT:C36095](markdown/NCIT_C36095.md) (Cervical Mucinous Adenocarcinoma) [3][54.53%]
1. [NCIT:C36207](markdown/NCIT_C36207.md) (Digestive System Adenoma) [58][54.17%]
1. [NCIT:C36263](markdown/NCIT_C36263.md) (Metastatic Malignant Neoplasm) [141][75.00%]
1. [NCIT:C36310](markdown/NCIT_C36310.md) (Secondary Carcinoma) [53][52.40%]
1. [NCIT:C36312](markdown/NCIT_C36312.md) (B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1) [2][55.13%]
1. [NCIT:C37193](markdown/NCIT_C37193.md) (Anaplastic Large Cell Lymphoma, ALK-Positive) [2][55.13%]
1. [NCIT:C37194](markdown/NCIT_C37194.md) (Anaplastic Large Cell Lymphoma, ALK-Negative) [2][54.16%]
1. [NCIT:C37201](markdown/NCIT_C37201.md) (Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation) [2][53.84%]
1. [NCIT:C37204](markdown/NCIT_C37204.md) (Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene) [2][54.00%]
1. [NCIT:C37263](markdown/NCIT_C37263.md) (Mixed Epithelial Stromal Tumor of the Kidney) [2][53.85%]
1. [NCIT:C37266](markdown/NCIT_C37266.md) (Bladder Flat Intraepithelial Lesion) [2][53.40%]
1. [NCIT:C37290](markdown/NCIT_C37290.md) (Head and Neck Basaloid Carcinoma) [3][53.49%]
1. [NCIT:C37869](markdown/NCIT_C37869.md) (B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma) [3][52.77%]
1. [NCIT:C38161](markdown/NCIT_C38161.md) (Digestive System Non-Hodgkin Lymphoma) [41][52.89%]
1. [NCIT:C38162](markdown/NCIT_C38162.md) (Digestive System Lymphoma) [61][52.77%]
1. [NCIT:C38163](markdown/NCIT_C38163.md) (Digestive System Hodgkin Lymphoma) [5][53.00%]
1. [NCIT:C38342](markdown/NCIT_C38342.md) (Pancreatic Intraductal Papillary-Mucinous Neoplasm) [5][54.08%]
1. [NCIT:C38458](markdown/NCIT_C38458.md) (Traditional Serrated Adenoma) [4][53.67%]
1. [NCIT:C38936](markdown/NCIT_C38936.md) (Grade I Meningioma) [12][53.30%]
1. [NCIT:C38937](markdown/NCIT_C38937.md) (Grade II Meningioma) [6][53.30%]
1. [NCIT:C38938](markdown/NCIT_C38938.md) (Grade III Meningioma) [7][53.30%]
1. [NCIT:C39749](markdown/NCIT_C39749.md) (Type II Endometrial Adenocarcinoma) [4][54.08%]
1. [NCIT:C39750](markdown/NCIT_C39750.md) (Glioblastoma, IDH-Wildtype) [11][54.60%]
1. [NCIT:C39789](markdown/NCIT_C39789.md) (Hereditary Renal Cell Carcinoma) [2][53.92%]
1. [NCIT:C39824](markdown/NCIT_C39824.md) (Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant) [2][55.94%]
1. [NCIT:C39831](markdown/NCIT_C39831.md) (Non-Invasive Bladder Papillary Urothelial Neoplasm) [4][53.33%]
1. [NCIT:C39842](markdown/NCIT_C39842.md) (Bladder Urachal Carcinoma) [2][52.89%]
1. [NCIT:C39850](markdown/NCIT_C39850.md) (Stage 0 Renal Pelvis and Ureter Urothelial Carcinoma) [8][53.92%]
1. [NCIT:C39851](markdown/NCIT_C39851.md) (Bladder Urothelial Carcinoma) [23][53.58%]
1. [NCIT:C39852](markdown/NCIT_C39852.md) (Urothelial Neoplasm) [71][52.40%]
1. [NCIT:C39853](markdown/NCIT_C39853.md) (Infiltrating Urothelial Carcinoma) [20][53.40%]
1. [NCIT:C39854](markdown/NCIT_C39854.md) (Non-Invasive Urothelial Neoplasm) [27][52.53%]
1. [NCIT:C39857](markdown/NCIT_C39857.md) (Bladder Papillary Urothelial Neoplasm) [6][53.57%]
1. [NCIT:C39867](markdown/NCIT_C39867.md) (Male Urethral Malignant Neoplasm) [2][75.00%]
1. [NCIT:C39879](markdown/NCIT_C39879.md) (Infiltrating Renal Pelvis and Ureter Urothelial Carcinoma) [3][54.08%]
1. [NCIT:C39904](markdown/NCIT_C39904.md) (Tumor of Specialized Prostatic Stroma) [2][55.00%]
1. [NCIT:C39915](markdown/NCIT_C39915.md) (Testicular Pure Germ Cell Tumor) [6][57.14%]
1. [NCIT:C39950](markdown/NCIT_C39950.md) (Tumor of the Thecoma/Fibroma Group) [3][57.22%]
1. [NCIT:C39954](markdown/NCIT_C39954.md) (Brenner Tumor) [4][55.56%]
1. [NCIT:C39986](markdown/NCIT_C39986.md) (Ovarian Primitive Germ Cell Tumor) [25][52.40%]
1. [NCIT:C39990](markdown/NCIT_C39990.md) (Ovarian Polyembryoma) [4][52.89%]
1. [NCIT:C40022](markdown/NCIT_C40022.md) (Primary Peritoneal Carcinoma) [7][52.77%]
1. [NCIT:C40023](markdown/NCIT_C40023.md) (Primary Peritoneal Serous Adenocarcinoma) [3][54.35%]
1. [NCIT:C40025](markdown/NCIT_C40025.md) (Malignant Ovarian Serous Tumor) [6][54.55%]
1. [NCIT:C40026](markdown/NCIT_C40026.md) (Malignant Ovarian Epithelial Tumor) [33][54.17%]
1. [NCIT:C40033](markdown/NCIT_C40033.md) (Malignant Ovarian Mucinous Tumor) [3][53.92%]
1. [NCIT:C40035](markdown/NCIT_C40035.md) (Adenocarcinofibroma) [3][53.00%]
1. [NCIT:C40039](markdown/NCIT_C40039.md) (Benign Ovarian Mucinous Tumor) [3][54.00%]
1. [NCIT:C40051](markdown/NCIT_C40051.md) (Malignant Ovarian Endometrioid Tumor) [3][53.30%]
1. [NCIT:C40065](markdown/NCIT_C40065.md) (Ovarian Endometrioid Stromal and Related Neoplasms) [2][54.55%]
1. [NCIT:C40072](markdown/NCIT_C40072.md) (Benign Ovarian Endometrioid Tumor) [3][53.58%]
1. [NCIT:C40076](markdown/NCIT_C40076.md) (Ovarian Clear Cell Tumor) [11][54.55%]
1. [NCIT:C40077](markdown/NCIT_C40077.md) (Malignant Ovarian Clear Cell Tumor) [3][53.58%]
1. [NCIT:C40080](markdown/NCIT_C40080.md) (Borderline Ovarian Clear Cell Tumor) [3][53.33%]
1. [NCIT:C40081](markdown/NCIT_C40081.md) (Borderline Ovarian Clear Cell Adenofibroma) [2][54.31%]
1. [NCIT:C40084](markdown/NCIT_C40084.md) (Benign Ovarian Clear Cell Tumor) [2][53.58%]
1. [NCIT:C40089](markdown/NCIT_C40089.md) (Malignant Ovarian Transitional Cell Tumor) [2][53.20%]
1. [NCIT:C40099](markdown/NCIT_C40099.md) (Fallopian Tube Serous Adenocarcinoma) [3][54.76%]
1. [NCIT:C40101](markdown/NCIT_C40101.md) (Serous Adenocarcinoma) [25][55.88%]
1. [NCIT:C40102](markdown/NCIT_C40102.md) (Fallopian Tube Serous Neoplasm) [7][53.85%]
1. [NCIT:C40106](markdown/NCIT_C40106.md) (Borderline Fallopian Tube Neoplasm) [3][58.33%]
1. [NCIT:C40109](markdown/NCIT_C40109.md) (Fallopian Tube Mucinous Neoplasm) [2][53.85%]
1. [NCIT:C40111](markdown/NCIT_C40111.md) (Fallopian Tube Endometrioid Tumor) [3][55.56%]
1. [NCIT:C40126](markdown/NCIT_C40126.md) (Fallopian Tube Soft Tissue Neoplasm) [2][51.39%]
1. [NCIT:C40135](markdown/NCIT_C40135.md) (Uterine Ligament Adenocarcinoma) [7][53.20%]
1. [NCIT:C40136](markdown/NCIT_C40136.md) (Uterine Ligament Serous Adenocarcinoma) [3][54.76%]
1. [NCIT:C40144](markdown/NCIT_C40144.md) (Endometrial Mucinous Adenocarcinoma) [3][54.08%]
1. [NCIT:C40145](markdown/NCIT_C40145.md) (Type I Endometrial Adenocarcinoma) [16][53.84%]
1. [NCIT:C40176](markdown/NCIT_C40176.md) (Uterine Corpus Smooth Muscle Neoplasm) [15][53.33%]
1. [NCIT:C40179](markdown/NCIT_C40179.md) (Uterine Corpus Soft Tissue Neoplasm) [31][62.50%]
1. [NCIT:C40181](markdown/NCIT_C40181.md) (Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm) [7][53.85%]
1. [NCIT:C40192](markdown/NCIT_C40192.md) (Cervical Papillary Squamous Cell Carcinoma) [2][55.19%]
1. [NCIT:C40195](markdown/NCIT_C40195.md) (Cervical Squamous Neoplasm) [18][53.85%]
1. [NCIT:C40197](markdown/NCIT_C40197.md) (High Grade Cervical Squamous Intraepithelial Neoplasia) [2][53.49%]
1. [NCIT:C40210](markdown/NCIT_C40210.md) (Cervical Glandular Neoplasm) [20][54.17%]
1. [NCIT:C40216](markdown/NCIT_C40216.md) (Cervical Soft Tissue Neoplasm) [11][60.00%]
1. [NCIT:C40217](markdown/NCIT_C40217.md) (Uterine Corpus Endometrial Stromal and Related Neoplasms) [6][55.00%]
1. [NCIT:C40218](markdown/NCIT_C40218.md) (Endometrioid Stromal and Related Neoplasms of the Cervix) [2][54.55%]
1. [NCIT:C40219](markdown/NCIT_C40219.md) (Uterine Corpus Endometrial Stromal Sarcoma) [2][54.55%]
1. [NCIT:C40226](markdown/NCIT_C40226.md) (Cervical Mixed Epithelial and Mesenchymal Neoplasm) [6][53.57%]
1. [NCIT:C40227](markdown/NCIT_C40227.md) (Benign Cervical Mixed Epithelial and Mesenchymal Neoplasm) [2][53.49%]
1. [NCIT:C40228](markdown/NCIT_C40228.md) (Malignant Cervical Mixed Epithelial and Mesenchymal Neoplasm) [2][53.40%]
1. [NCIT:C40242](markdown/NCIT_C40242.md) (Vaginal Squamous Neoplasm) [8][54.17%]
1. [NCIT:C40250](markdown/NCIT_C40250.md) (Vaginal Glandular Neoplasm) [10][55.00%]
1. [NCIT:C40256](markdown/NCIT_C40256.md) (Vaginal Adenoma) [3][54.55%]
1. [NCIT:C40265](markdown/NCIT_C40265.md) (Vaginal Soft Tissue Neoplasm) [7][62.50%]
1. [NCIT:C40269](markdown/NCIT_C40269.md) (Endometrioid Stromal and Related Neoplasms of the Vagina) [2][55.00%]
1. [NCIT:C40283](markdown/NCIT_C40283.md) (Vulvar Squamous Neoplasm) [11][54.17%]
1. [NCIT:C40292](markdown/NCIT_C40292.md) (Vulvar Glandular Neoplasm) [13][55.00%]
1. [NCIT:C40303](markdown/NCIT_C40303.md) (Vulvar Neoplasm of Skin Appendage Origin) [12][60.00%]
1. [NCIT:C40304](markdown/NCIT_C40304.md) (Malignant Vulvar Sweat Gland Neoplasm) [6][56.25%]
1. [NCIT:C40310](markdown/NCIT_C40310.md) (Sebaceous Carcinoma) [5][54.17%]
1. [NCIT:C40315](markdown/NCIT_C40315.md) (Pilomyxoid Astrocytoma) [2][53.30%]
1. [NCIT:C40316](markdown/NCIT_C40316.md) (Vulvar Soft Tissue Neoplasm) [9][62.50%]
1. [NCIT:C40317](markdown/NCIT_C40317.md) (Vulvar Sarcoma) [4][54.17%]
1. [NCIT:C40347](markdown/NCIT_C40347.md) (Invasive Mixed Breast Carcinoma) [4][53.49%]
1. [NCIT:C40382](markdown/NCIT_C40382.md) (Breast Adenoma) [5][53.57%]
1. [NCIT:C40389](markdown/NCIT_C40389.md) (Breast Myoepithelial Tumor) [6][52.12%]
1. [NCIT:C40392](markdown/NCIT_C40392.md) (Myoepithelial Tumor) [15][51.79%]
1. [NCIT:C40393](markdown/NCIT_C40393.md) (Salivary Gland Myoepithelial Tumor) [2][51.96%]
1. [NCIT:C40405](markdown/NCIT_C40405.md) (Breast Fibroepithelial Neoplasm) [10][54.55%]
1. [NCIT:C40406](markdown/NCIT_C40406.md) (Breast Soft Tissue Neoplasm) [23][66.67%]
1. [NCIT:C40407](markdown/NCIT_C40407.md) (Kidney Wilms Tumor) [16][55.00%]
1. [NCIT:C40409](markdown/NCIT_C40409.md) (Salivary Gland Pleomorphic Adenoma) [2][53.67%]
1. [NCIT:C40410](markdown/NCIT_C40410.md) (Salivary Gland Carcinoma ex Pleomorphic Adenoma) [4][53.84%]
1. [NCIT:C40970](markdown/NCIT_C40970.md) (Angiocentric Immunoproliferative Lesion) [15][52.89%]
1. [NCIT:C41247](markdown/NCIT_C41247.md) (Pancreatic Mucinous-Cystic Neoplasm) [4][53.20%]
1. [NCIT:C41248](markdown/NCIT_C41248.md) (Pancreatic Serous Neoplasm) [6][53.40%]
1. [NCIT:C42080](markdown/NCIT_C42080.md) (Childhood Choroid Plexus Neoplasm) [2][53.33%]
1. [NCIT:C42690](markdown/NCIT_C42690.md) (Lip and Oral Cavity Squamous Cell Carcinoma) [29][53.20%]
1. [NCIT:C42700](markdown/NCIT_C42700.md) (Uterine Carcinosarcoma) [4][54.35%]
1. [NCIT:C43284](markdown/NCIT_C43284.md) (Primary Systemic Mastocytosis) [4][52.77%]
1. [NCIT:C43310](markdown/NCIT_C43310.md) (Malignant Hair Follicle Neoplasm) [5][58.33%]
1. [NCIT:C43311](markdown/NCIT_C43311.md) (Germinative Follicular Epithelium Neoplasm) [7][55.00%]
1. [NCIT:C43313](markdown/NCIT_C43313.md) (Pilar-Associated Mesenchyme Neoplasm) [5][55.56%]
1. [NCIT:C43315](markdown/NCIT_C43315.md) (Benign Outer Hair Sheath and Infundibulum Neoplasm) [5][53.40%]
1. [NCIT:C43316](markdown/NCIT_C43316.md) (Malignant Outer Hair Sheath and Infundibulum Neoplasm) [2][56.25%]
1. [NCIT:C43319](markdown/NCIT_C43319.md) (Benign Germinative Follicular Epithelium Neoplasm) [4][53.30%]
1. [NCIT:C43323](markdown/NCIT_C43323.md) (Benign Pilar-Associated Mesenchyme Neoplasm) [4][53.57%]
1. [NCIT:C43324](markdown/NCIT_C43324.md) (Outer Hair Sheath and Infundibulum Neoplasm) [10][58.33%]
1. [NCIT:C43345](markdown/NCIT_C43345.md) (Ductal Eccrine Adenocarcinoma) [2][55.56%]
1. [NCIT:C43527](markdown/NCIT_C43527.md) (Sporadic Gastric Adenocarcinoma) [13][54.38%]
1. [NCIT:C43541](markdown/NCIT_C43541.md) (Pituitary Gland Microadenoma) [2][53.58%]
1. [NCIT:C43542](markdown/NCIT_C43542.md) (Pituitary Gland Macroadenoma) [2][53.58%]
1. [NCIT:C43550](markdown/NCIT_C43550.md) (Appendix Adenoma) [5][53.33%]
1. [NCIT:C43558](markdown/NCIT_C43558.md) (Appendix Mucinous Adenocarcinoma) [4][54.00%]
1. [NCIT:C43584](markdown/NCIT_C43584.md) (Rectosigmoid Adenocarcinoma) [2][54.80%]
1. [NCIT:C43585](markdown/NCIT_C43585.md) (Colorectal Mucinous Adenocarcinoma) [3][55.00%]
1. [NCIT:C43586](markdown/NCIT_C43586.md) (Colorectal Signet Ring Cell Carcinoma) [3][54.80%]
1. [NCIT:C43587](markdown/NCIT_C43587.md) (Colorectal Small Cell Neuroendocrine Carcinoma) [2][55.55%]
1. [NCIT:C43588](markdown/NCIT_C43588.md) (Colorectal Squamous Cell Carcinoma) [3][54.46%]
1. [NCIT:C43589](markdown/NCIT_C43589.md) (Colorectal Adenosquamous Carcinoma) [2][54.31%]
1. [NCIT:C43590](markdown/NCIT_C43590.md) (Colorectal Medullary Carcinoma) [2][54.53%]
1. [NCIT:C43591](markdown/NCIT_C43591.md) (Colorectal Undifferentiated Carcinoma) [2][54.46%]
1. [NCIT:C45193](markdown/NCIT_C45193.md) (Primary Cutaneous Diffuse Large B-Cell Lymphoma) [7][53.92%]
1. [NCIT:C45194](markdown/NCIT_C45194.md) (Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type) [2][54.67%]
1. [NCIT:C45213](markdown/NCIT_C45213.md) (Primary Cutaneous Diffuse Large B-Cell Lymphoma, Other) [3][54.00%]
1. [NCIT:C45219](markdown/NCIT_C45219.md) (Diffuse Large B-Cell Lymphoma by Gene Expression Profile) [3][54.08%]
1. [NCIT:C45238](markdown/NCIT_C45238.md) (Cutaneous Precursor Lymphoid Neoplasm) [3][53.30%]
1. [NCIT:C45240](markdown/NCIT_C45240.md) (Cutaneous Hematopoietic and Lymphoid Cell Neoplasm) [63][66.67%]
1. [NCIT:C45249](markdown/NCIT_C45249.md) (Cutaneous Mature B-Cell Neoplasm) [19][53.20%]
1. [NCIT:C45250](markdown/NCIT_C45250.md) (Cutaneous Mature T-Cell and NK-Cell Neoplasm) [30][53.10%]
1. [NCIT:C45332](markdown/NCIT_C45332.md) (Primary Cutaneous Peripheral T-Cell Lymphoma, Rare Subtype) [2][54.00%]
1. [NCIT:C45474](markdown/NCIT_C45474.md) (Intermediate (Rarely Metastasizing) Blood Vessel Neoplasm) [5][54.55%]
1. [NCIT:C45540](markdown/NCIT_C45540.md) (Lung Sarcomatoid Carcinoma) [7][54.08%]
1. [NCIT:C45569](markdown/NCIT_C45569.md) (High Grade Lung Neuroendocrine Neoplasm) [6][53.33%]
1. [NCIT:C45612](markdown/NCIT_C45612.md) (Lung Soft Tissue Neoplasm) [11][62.50%]
1. [NCIT:C45625](markdown/NCIT_C45625.md) (Malignant Lung and Pleural Neoplasm) [4][60.00%]
1. [NCIT:C45749](markdown/NCIT_C45749.md) (Cardiac Hemangioma) [3][53.49%]
1. [NCIT:C45835](markdown/NCIT_C45835.md) (Pancreatic Neuroendocrine Tumor G2) [5][53.58%]
1. [NCIT:C45837](markdown/NCIT_C45837.md) (Non-Functional Pancreatic Neuroendocrine Tumor) [3][53.75%]
1. [NCIT:C45840](markdown/NCIT_C45840.md) (Functional Pancreatic Neuroendocrine Tumor) [6][53.49%]
1. [NCIT:C45841](markdown/NCIT_C45841.md) (Functional Pancreatic Neuroendocrine Tumor G2) [3][53.75%]
1. [NCIT:C45843](markdown/NCIT_C45843.md) (Pancreatic Carcinoma with Mixed Differentiation) [3][53.10%]
1. [NCIT:C45915](markdown/NCIT_C45915.md) (Gonadotropin-Producing Pituitary Gland Adenoma) [2][53.67%]
1. [NCIT:C45921](markdown/NCIT_C45921.md) (Anterior Pituitary Gland Neoplasm) [37][58.33%]
1. [NCIT:C47857](markdown/NCIT_C47857.md) (Paget Disease of the Breast) [4][53.49%]
1. [NCIT:C48306](markdown/NCIT_C48306.md) (Adrenal Gland Composite Pheochromocytoma) [2][54.31%]
1. [NCIT:C48314](markdown/NCIT_C48314.md) (Benign Paraganglioma) [2][53.85%]
1. [NCIT:C48576](markdown/NCIT_C48576.md) (Extra-Adrenal Sympathetic Paraganglioma) [3][53.30%]
1. [NCIT:C48596](markdown/NCIT_C48596.md) (Invasive Prostate Carcinoma) [19][53.20%]
1. [NCIT:C48873](markdown/NCIT_C48873.md) (Splenic Lymphoma) [10][52.66%]
1. [NCIT:C49166](markdown/NCIT_C49166.md) (Extracardiac Rhabdomyoma) [6][53.30%]
1. [NCIT:C53459](markdown/NCIT_C53459.md) (Chondroma) [6][58.33%]
1. [NCIT:C53553](markdown/NCIT_C53553.md) (Breast Carcinoma by Gene Expression Profile) [6][52.66%]
1. [NCIT:C53684](markdown/NCIT_C53684.md) (Benign Connective and Soft Tissue Neoplasm) [282][75.00%]
1. [NCIT:C53704](markdown/NCIT_C53704.md) (Secondary Osteosarcoma) [2][54.00%]
1. [NCIT:C53707](markdown/NCIT_C53707.md) (Bone Osteosarcoma) [22][53.49%]
1. [NCIT:C53972](markdown/NCIT_C53972.md) (Erdheim-Chester Disease) [2][55.26%]
1. [NCIT:C53994](markdown/NCIT_C53994.md) (Undifferentiated Stromal Sarcoma) [4][53.75%]
1. [NCIT:C53999](markdown/NCIT_C53999.md) (Malignant Gastrointestinal Stromal Tumor) [7][54.08%]
1. [NCIT:C54094](markdown/NCIT_C54094.md) (Gastric Granular Cell Tumor) [2][52.26%]
1. [NCIT:C54099](markdown/NCIT_C54099.md) (Malignant Central Nervous System Germ Cell Tumor) [10][56.25%]
1. [NCIT:C54244](markdown/NCIT_C54244.md) (Basaloid Squamous Cell Carcinoma) [10][53.20%]
1. [NCIT:C54262](markdown/NCIT_C54262.md) (Ear Carcinoma) [7][52.66%]
1. [NCIT:C54283](markdown/NCIT_C54283.md) (Keratinizing Head and Neck Squamous Cell Carcinoma) [12][53.30%]
1. [NCIT:C54293](markdown/NCIT_C54293.md) (Nasal Cavity and Paranasal Sinus Carcinoma) [47][52.66%]
1. [NCIT:C60310](markdown/NCIT_C60310.md) (Lung Mature B-Cell Neoplasm) [2][53.10%]
1. [NCIT:C60709](markdown/NCIT_C60709.md) (Appendix Neuroendocrine Neoplasm) [16][54.55%]
1. [NCIT:C60780](markdown/NCIT_C60780.md) (Brain Astrocytoma) [21][53.30%]
1. [NCIT:C60781](markdown/NCIT_C60781.md) (Astrocytoma) [72][53.00%]
1. [NCIT:C61574](markdown/NCIT_C61574.md) (Uterine Corpus Cancer) [34][57.14%]
1. [NCIT:C62282](markdown/NCIT_C62282.md) (Skin Nodular Basal Cell Carcinoma) [2][55.26%]
1. [NCIT:C62332](markdown/NCIT_C62332.md) (Central Nervous System Carcinoma) [2][52.66%]
1. [NCIT:C63622](markdown/NCIT_C63622.md) (Undifferentiated Carcinoma with Osteoclast-Like Giant Cells) [2][52.77%]
1. [NCIT:C65151](markdown/NCIT_C65151.md) (Non-Small Cell Carcinoma) [63][52.53%]
1. [NCIT:C65181](markdown/NCIT_C65181.md) (Non-Invasive Papillary Transitional Cell Carcinoma) [5][53.30%]
1. [NCIT:C65192](markdown/NCIT_C65192.md) (Tubular Adenocarcinoma) [6][53.33%]
1. [NCIT:C66717](markdown/NCIT_C66717.md) (Metastatic Signet Ring Cell Carcinoma) [2][53.30%]
1. [NCIT:C66745](markdown/NCIT_C66745.md) (Adenocarcinoma with Neuroendocrine Differentiation) [2][53.00%]
1. [NCIT:C66776](markdown/NCIT_C66776.md) (Gonadal Polyembryoma) [6][52.02%]
1. [NCIT:C66806](markdown/NCIT_C66806.md) (Intraocular Medulloepithelioma) [4][66.67%]
1. [NCIT:C66950](markdown/NCIT_C66950.md) (Hepatoid Adenocarcinoma) [4][53.33%]
1. [NCIT:C67090](markdown/NCIT_C67090.md) (Serous Adenofibroma) [8][54.17%]
1. [NCIT:C67155](markdown/NCIT_C67155.md) (Olfactory Neurogenic Tumor) [5][62.50%]
1. [NCIT:C67554](markdown/NCIT_C67554.md) (Stage I Nasal Cavity and Paranasal Sinus Cancer AJCC v6 and v7) [3][53.57%]
1. [NCIT:C67555](markdown/NCIT_C67555.md) (Stage II Nasal Cavity and Paranasal Sinus Cancer AJCC v6 and v7) [3][53.57%]
1. [NCIT:C67556](markdown/NCIT_C67556.md) (Stage III Nasal Cavity and Paranasal Sinus Cancer AJCC v6 and v7) [3][53.57%]
1. [NCIT:C68610](markdown/NCIT_C68610.md) (Oropharyngeal Undifferentiated Carcinoma) [5][53.67%]
1. [NCIT:C68611](markdown/NCIT_C68611.md) (Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma) [10][53.20%]
1. [NCIT:C68626](markdown/NCIT_C68626.md) (Childhood Teratoma) [6][54.55%]
1. [NCIT:C68627](markdown/NCIT_C68627.md) (Childhood Extracranial Germ Cell Tumor) [4][56.25%]
1. [NCIT:C68678](markdown/NCIT_C68678.md) (Stage I Marginal Zone Lymphoma) [2][53.84%]
1. [NCIT:C68679](markdown/NCIT_C68679.md) (Stage II Marginal Zone Lymphoma) [2][53.84%]
1. [NCIT:C68682](markdown/NCIT_C68682.md) (Stage III Marginal Zone Lymphoma) [2][53.84%]
1. [NCIT:C68683](markdown/NCIT_C68683.md) (Stage IV Marginal Zone Lymphoma) [2][53.84%]
1. [NCIT:C68684](markdown/NCIT_C68684.md) (Recurrent Marginal Zone Lymphoma) [3][53.84%]
1. [NCIT:C68686](markdown/NCIT_C68686.md) (Stage II Aggressive Adult Non-Hodgkin Lymphoma) [2][53.85%]
1. [NCIT:C68690](markdown/NCIT_C68690.md) (Adult Ependymal Tumor) [6][53.10%]
1. [NCIT:C68691](markdown/NCIT_C68691.md) (Adult Oligodendroglial Tumor) [3][53.20%]
1. [NCIT:C68700](markdown/NCIT_C68700.md) (Adult Acute Myeloid Leukemia with Recurrent Genetic Abnormalities) [5][53.30%]
1. [NCIT:C69138](markdown/NCIT_C69138.md) (Adult Classical Hodgkin Lymphoma) [3][54.74%]
1. [NCIT:C69142](markdown/NCIT_C69142.md) (Childhood Classical Hodgkin Lymphoma) [3][54.74%]
1. [NCIT:C69144](markdown/NCIT_C69144.md) (Recurrent Grade III Lymphomatoid Granulomatosis) [2][55.25%]
1. [NCIT:C71024](markdown/NCIT_C71024.md) (Adult Spinal Cord Neoplasm) [3][66.67%]
1. [NCIT:C71305](markdown/NCIT_C71305.md) (Adult Grade III Meningioma) [2][53.40%]
1. [NCIT:C71698](markdown/NCIT_C71698.md) (Recurrent Brain Neoplasm) [15][66.67%]
1. [NCIT:C71699](markdown/NCIT_C71699.md) (Recurrent Spinal Cord Neoplasm) [2][66.67%]
1. [NCIT:C71703](markdown/NCIT_C71703.md) (Refractory Spinal Cord Neoplasm) [2][66.67%]
1. [NCIT:C72074](markdown/NCIT_C72074.md) (Atypical Carcinoid Tumor) [3][53.85%]
1. [NCIT:C79698](markdown/NCIT_C79698.md) (Optic Nerve Disorder) [5][75.00%]
1. [NCIT:C79951](markdown/NCIT_C79951.md) (Papillary Adenoma) [7][53.57%]
1. [NCIT:C80280](markdown/NCIT_C80280.md) (Diffuse Large B-Cell Lymphoma, Not Otherwise Specified) [24][54.08%]
1. [NCIT:C80291](markdown/NCIT_C80291.md) (High Grade B-Cell Lymphoma, Not Otherwise Specified) [2][54.08%]
1. [NCIT:C80307](markdown/NCIT_C80307.md) (Waldenstrom Macroglobulinemia) [2][54.67%]
1. [NCIT:C80308](markdown/NCIT_C80308.md) (Splenic B-Cell Lymphoma/Leukemia, Unclassifiable) [2][53.20%]
1. [NCIT:C80328](markdown/NCIT_C80328.md) (B Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities) [16][53.84%]
1. [NCIT:C80331](markdown/NCIT_C80331.md) (B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1) [3][54.08%]
1. [NCIT:C80683](markdown/NCIT_C80683.md) (Therapy-Related Leukemia) [4][52.12%]
1. [NCIT:C82179](markdown/NCIT_C82179.md) (Mixed Phenotype Acute Leukemia) [7][53.10%]
1. [NCIT:C82338](markdown/NCIT_C82338.md) (Myeloid Proliferations Related to Down Syndrome) [2][52.40%]
1. [NCIT:C82426](markdown/NCIT_C82426.md) (Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM) [2][53.49%]
1. [NCIT:C82430](markdown/NCIT_C82430.md) (Acute Myeloid Leukemia with Gene Mutations) [2][53.00%]
1. [NCIT:C82591](markdown/NCIT_C82591.md) (Myelodysplastic Syndrome with Single Lineage Dysplasia) [3][53.00%]
1. [NCIT:C83176](markdown/NCIT_C83176.md) (Colorectal Sessile Serrated Adenoma/Polyp) [2][53.84%]
1. [NCIT:C84269](markdown/NCIT_C84269.md) (Mastocytosis) [10][52.26%]
1. [NCIT:C84270](markdown/NCIT_C84270.md) (Myeloid and Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2) [5][51.79%]
1. [NCIT:C87178](markdown/NCIT_C87178.md) (Stage I Bone Cancer  AJCC v7) [2][57.14%]
1. [NCIT:C87181](markdown/NCIT_C87181.md) (Stage II Bone Cancer  AJCC v7) [2][57.14%]
1. [NCIT:C87184](markdown/NCIT_C87184.md) (Stage III Bone Cancer  AJCC v7) [2][57.14%]
1. [NCIT:C87185](markdown/NCIT_C87185.md) (Stage IV Bone Cancer  AJCC v7) [2][57.14%]
1. [NCIT:C87498](markdown/NCIT_C87498.md) (Stage 0 Nasal Cavity and Paranasal Sinus Cancer AJCC v6, v7, and v8) [2][53.33%]
1. [NCIT:C87543](markdown/NCIT_C87543.md) (Stage I Differentiated Thyroid Gland Carcinoma) [2][54.16%]
1. [NCIT:C87544](markdown/NCIT_C87544.md) (Stage II Differentiated Thyroid Gland Carcinoma) [2][54.16%]
1. [NCIT:C87545](markdown/NCIT_C87545.md) (Stage III Differentiated Thyroid Gland Carcinoma) [2][54.16%]
1. [NCIT:C87797](markdown/NCIT_C87797.md) (Secondary Central Nervous System Lymphoma) [3][53.10%]
1. [NCIT:C88145](markdown/NCIT_C88145.md) (Ocular Adnexal Lymphoma) [2][52.89%]
1. [NCIT:C88156](markdown/NCIT_C88156.md) (Leukemia Cutis) [3][54.17%]
1. [NCIT:C88414](markdown/NCIT_C88414.md) (Stage I Cutaneous Melanoma AJCC v7) [2][53.85%]
1. [NCIT:C88415](markdown/NCIT_C88415.md) (Stage III Cutaneous Melanoma AJCC v7) [2][53.85%]
1. [NCIT:C88888](markdown/NCIT_C88888.md) (Stage I Lung Cancer AJCC v7) [5][53.33%]
1. [NCIT:C88889](markdown/NCIT_C88889.md) (Stage II Lung Cancer AJCC v7) [5][53.33%]
1. [NCIT:C88890](markdown/NCIT_C88890.md) (Stage III Lung Cancer AJCC v7) [5][53.33%]
1. [NCIT:C88891](markdown/NCIT_C88891.md) (Stage IV Lung Cancer AJCC v7) [9][53.33%]
1. [NCIT:C88981](markdown/NCIT_C88981.md) (Stage I Nasopharyngeal Carcinoma AJCC v7) [2][54.60%]
1. [NCIT:C88982](markdown/NCIT_C88982.md) (Stage II Nasopharyngeal Carcinoma AJCC v7) [2][54.60%]
1. [NCIT:C88983](markdown/NCIT_C88983.md) (Stage III Nasopharyngeal Carcinoma AJCC v7) [2][54.60%]
1. [NCIT:C88984](markdown/NCIT_C88984.md) (Stage IV Nasopharyngeal Carcinoma AJCC v7) [2][54.60%]
1. [NCIT:C89021](markdown/NCIT_C89021.md) (Stage III Oropharyngeal Carcinoma AJCC v7) [2][53.30%]
1. [NCIT:C89023](markdown/NCIT_C89023.md) (Stage IV Oropharyngeal Carcinoma AJCC v7) [2][53.30%]
1. [NCIT:C89117](markdown/NCIT_C89117.md) (Stage IV Nasal Cavity and Paranasal Sinus Cancer AJCC v7) [3][53.85%]
1. [NCIT:C89366](markdown/NCIT_C89366.md) (Stage IV Bladder Cancer) [3][53.85%]
1. [NCIT:C89550](markdown/NCIT_C89550.md) (Stage 0 Cervical Cancer) [2][54.31%]
1. [NCIT:C89771](markdown/NCIT_C89771.md) (Stage 0 Esophageal Cancer AJCC v7) [2][54.08%]
1. [NCIT:C89793](markdown/NCIT_C89793.md) (Stage I Esophageal Cancer AJCC v7) [2][53.33%]
1. [NCIT:C89794](markdown/NCIT_C89794.md) (Stage II Esophageal Cancer AJCC v7) [2][53.33%]
1. [NCIT:C89795](markdown/NCIT_C89795.md) (Stage III Esophageal Cancer AJCC v7) [2][53.33%]
1. [NCIT:C89804](markdown/NCIT_C89804.md) (Stage IV Esophageal Cancer AJCC v7) [2][53.33%]
1. [NCIT:C89989](markdown/NCIT_C89989.md) (Stage II Colorectal Cancer AJCC v7) [3][54.38%]
1. [NCIT:C89994](markdown/NCIT_C89994.md) (Stage III Colorectal Cancer AJCC v7) [3][54.38%]
1. [NCIT:C89998](markdown/NCIT_C89998.md) (Stage IV Colorectal Cancer AJCC v7) [5][54.00%]
1. [NCIT:C89999](markdown/NCIT_C89999.md) (Stage IV Colon Cancer AJCC v7) [2][54.46%]
1. [NCIT:C90344](markdown/NCIT_C90344.md) (Bladder Carcinoma by AJCC v6 Stage) [22][52.66%]
1. [NCIT:C90345](markdown/NCIT_C90345.md) (Vulvar Cancer by AJCC v6 Stage) [4][54.55%]
1. [NCIT:C90500](markdown/NCIT_C90500.md) (Esophageal Cancer by AJCC v6 Stage) [5][53.57%]
1. [NCIT:C90503](markdown/NCIT_C90503.md) (Gastric Cancer by AJCC v6 Stage) [8][53.57%]
1. [NCIT:C90506](markdown/NCIT_C90506.md) (Colorectal Cancer by AJCC v6 Stage) [24][53.84%]
1. [NCIT:C90507](markdown/NCIT_C90507.md) (Colon Cancer by AJCC v6 Stage) [6][53.92%]
1. [NCIT:C90508](markdown/NCIT_C90508.md) (Rectal Cancer by AJCC v6 Stage) [5][53.92%]
1. [NCIT:C90509](markdown/NCIT_C90509.md) (Rectosigmoid Cancer by AJCC v6 Stage) [5][54.00%]
1. [NCIT:C90510](markdown/NCIT_C90510.md) (Hepatocellular Carcinoma by AJCC v6 Stage) [6][56.40%]
1. [NCIT:C90512](markdown/NCIT_C90512.md) (Gallbladder Cancer by AJCC v6 Stage) [5][53.33%]
1. [NCIT:C90513](markdown/NCIT_C90513.md) (Breast Cancer by AJCC v6 Stage) [19][54.17%]
1. [NCIT:C90514](markdown/NCIT_C90514.md) (Cutaneous Melanoma by AJCC v6 Stage) [10][54.55%]
1. [NCIT:C90519](markdown/NCIT_C90519.md) (Lung Cancer by AJCC v6 Stage) [9][53.57%]
1. [NCIT:C90522](markdown/NCIT_C90522.md) (Nasopharyngeal Carcinoma by AJCC v6 Stage) [7][53.84%]
1. [NCIT:C90523](markdown/NCIT_C90523.md) (Oropharyngeal Carcinoma by AJCC v6 Stage) [10][53.20%]
1. [NCIT:C90524](markdown/NCIT_C90524.md) (Hypopharyngeal Carcinoma by AJCC v6 Stage) [7][53.33%]
1. [NCIT:C90525](markdown/NCIT_C90525.md) (Pharyngeal Carcinoma by AJCC v6 Stage) [27][53.57%]
1. [NCIT:C90527](markdown/NCIT_C90527.md) (Laryngeal Cancer by AJCC v6 Stage) [9][53.33%]
1. [NCIT:C90528](markdown/NCIT_C90528.md) (Nasal Cavity and Paranasal Sinus Cancer by AJCC v6 Stage) [16][54.17%]
1. [NCIT:C91202](markdown/NCIT_C91202.md) (Bladder Carcinoma by AJCC v7 Stage) [25][52.66%]
1. [NCIT:C91203](markdown/NCIT_C91203.md) (Vulvar Cancer by AJCC v7 Stage) [4][54.55%]
1. [NCIT:C91208](markdown/NCIT_C91208.md) (Cervical Carcinoma by AJCC v7 Stage) [4][53.58%]
1. [NCIT:C91221](markdown/NCIT_C91221.md) (Esophageal Cancer by AJCC v7 Stage) [17][53.57%]
1. [NCIT:C91222](markdown/NCIT_C91222.md) (Gastric Cancer by AJCC v7 Stage) [8][53.57%]
1. [NCIT:C91223](markdown/NCIT_C91223.md) (Colorectal Cancer by AJCC v7 Stage) [26][53.84%]
1. [NCIT:C91224](markdown/NCIT_C91224.md) (Colon Cancer by AJCC v7 Stage) [8][53.92%]
1. [NCIT:C91225](markdown/NCIT_C91225.md) (Rectal Cancer by AJCC v7 Stage) [5][53.92%]
1. [NCIT:C91226](markdown/NCIT_C91226.md) (Rectosigmoid Cancer by AJCC v7 Stage) [5][54.00%]
1. [NCIT:C91228](markdown/NCIT_C91228.md) (Hepatocellular Carcinoma by AJCC v7 Stage) [8][56.40%]
1. [NCIT:C91229](markdown/NCIT_C91229.md) (Gallbladder Cancer by AJCC v7 Stage) [5][53.33%]
1. [NCIT:C91230](markdown/NCIT_C91230.md) (Breast Cancer by AJCC v7 Stage) [19][54.17%]
1. [NCIT:C91231](markdown/NCIT_C91231.md) (Cutaneous Melanoma by AJCC v7 Stage) [14][54.55%]
1. [NCIT:C91232](markdown/NCIT_C91232.md) (Lung Cancer by AJCC v7 Stage) [40][53.57%]
1. [NCIT:C91234](markdown/NCIT_C91234.md) (Penile Carcinoma by AJCC v7 Stage) [7][52.53%]
1. [NCIT:C91244](markdown/NCIT_C91244.md) (Nasopharyngeal Carcinoma by AJCC v7 Stage) [15][53.84%]
1. [NCIT:C91248](markdown/NCIT_C91248.md) (Oropharyngeal Carcinoma by AJCC v7 Stage) [14][53.20%]
1. [NCIT:C91251](markdown/NCIT_C91251.md) (Hypopharyngeal Carcinoma by AJCC v7 Stage) [10][53.33%]
1. [NCIT:C91252](markdown/NCIT_C91252.md) (Pharyngeal Carcinoma by AJCC v7 Stage) [42][53.57%]
1. [NCIT:C91255](markdown/NCIT_C91255.md) (Nasal Cavity and Paranasal Sinus Cancer by AJCC v7 Stage) [19][54.17%]
1. [NCIT:C91256](markdown/NCIT_C91256.md) (Laryngeal Cancer by AJCC v7 Stage) [10][53.33%]
1. [NCIT:C92944](markdown/NCIT_C92944.md) (Central Nervous System Histiocytic and Dendritic Cell Neoplasm) [3][60.00%]
1. [NCIT:C93125](markdown/NCIT_C93125.md) (Radiation-Related Sarcoma) [3][56.25%]
1. [NCIT:C94540](markdown/NCIT_C94540.md) (Anterior Pituitary Gland Endocrine Neoplasm) [35][53.33%]
1. [NCIT:C94759](markdown/NCIT_C94759.md) (Functioning Endocrine Neoplasm) [11][57.14%]
1. [NCIT:C94760](markdown/NCIT_C94760.md) (Non-Functioning Endocrine Neoplasm) [11][57.14%]
1. [NCIT:C94791](markdown/NCIT_C94791.md) (Stage I Childhood Non-Hodgkin Lymphoma) [3][54.17%]
1. [NCIT:C94792](markdown/NCIT_C94792.md) (Stage II Childhood Non-Hodgkin Lymphoma) [3][54.17%]
1. [NCIT:C94793](markdown/NCIT_C94793.md) (Stage III Childhood Non-Hodgkin Lymphoma) [3][54.17%]
1. [NCIT:C94794](markdown/NCIT_C94794.md) (Stage IV Childhood Non-Hodgkin Lymphoma) [3][54.17%]
1. [NCIT:C95397](markdown/NCIT_C95397.md) (Intramucosal Adenocarcinoma) [3][53.20%]
1. [NCIT:C95404](markdown/NCIT_C95404.md) (Digestive System Neuroendocrine Tumor) [124][53.57%]
1. [NCIT:C95405](markdown/NCIT_C95405.md) (Digestive System Neuroendocrine Carcinoma) [39][53.92%]
1. [NCIT:C95406](markdown/NCIT_C95406.md) (Digestive System Mixed Adenoneuroendocrine Carcinoma) [15][52.89%]
1. [NCIT:C95470](markdown/NCIT_C95470.md) (Pancreatic Serous Adenoma) [4][53.84%]
1. [NCIT:C95488](markdown/NCIT_C95488.md) (Non-Invasive Pancreatic Mucinous-Cystic Neoplasm) [2][53.58%]
1. [NCIT:C95505](markdown/NCIT_C95505.md) (Pancreatic Intraductal Neoplasm) [8][53.00%]
1. [NCIT:C95542](markdown/NCIT_C95542.md) (Pancreatic Acinar Cell Neoplasm) [3][52.89%]
1. [NCIT:C95584](markdown/NCIT_C95584.md) (Pancreatic Neuroendocrine Tumor G1) [2][53.58%]
1. [NCIT:C95616](markdown/NCIT_C95616.md) (Esophageal Neuroendocrine Tumor) [2][53.20%]
1. [NCIT:C95619](markdown/NCIT_C95619.md) (Esophageal Neuroendocrine Carcinoma) [2][54.31%]
1. [NCIT:C95871](markdown/NCIT_C95871.md) (Gastric Neuroendocrine Tumor) [6][53.30%]
1. [NCIT:C95884](markdown/NCIT_C95884.md) (Gastric Neuroendocrine Carcinoma) [2][54.31%]
1. [NCIT:C95909](markdown/NCIT_C95909.md) (Preinvasive Neoplasm of the Ampullary Region) [8][53.57%]
1. [NCIT:C95913](markdown/NCIT_C95913.md) (Ampullary Noninvasive Papillary Neoplasm, Pancreatobiliary Type) [2][53.40%]
1. [NCIT:C95980](markdown/NCIT_C95980.md) (Ampulla of Vater Neuroendocrine Neoplasm) [12][54.55%]
1. [NCIT:C95981](markdown/NCIT_C95981.md) (Ampulla of Vater Neuroendocrine Tumor) [8][53.33%]
1. [NCIT:C95984](markdown/NCIT_C95984.md) (Ampulla of Vater Neuroendocrine Carcinoma) [2][54.16%]
1. [NCIT:C96053](markdown/NCIT_C96053.md) (Small Intestinal B-Cell Non-Hodgkin Lymphoma) [9][53.30%]
1. [NCIT:C96061](markdown/NCIT_C96061.md) (Small Intestinal Neuroendocrine Tumor) [14][53.40%]
1. [NCIT:C96062](markdown/NCIT_C96062.md) (Intestinal Neuroendocrine Tumor) [38][53.20%]
1. [NCIT:C96063](markdown/NCIT_C96063.md) (Intestinal Neuroendocrine Carcinoma) [8][54.24%]
1. [NCIT:C96064](markdown/NCIT_C96064.md) (Small Intestinal Neuroendocrine Carcinoma) [2][54.60%]
1. [NCIT:C96152](markdown/NCIT_C96152.md) (Colorectal Neuroendocrine Neoplasm) [27][54.17%]
1. [NCIT:C96156](markdown/NCIT_C96156.md) (Colorectal Neuroendocrine Carcinoma) [4][55.00%]
1. [NCIT:C96159](markdown/NCIT_C96159.md) (Colorectal Neuroendocrine Tumor) [19][53.30%]
1. [NCIT:C96160](markdown/NCIT_C96160.md) (Colorectal Neuroendocrine Tumor G1) [6][54.00%]
1. [NCIT:C96165](markdown/NCIT_C96165.md) (Intestinal Neuroendocrine Tumor G2) [2][53.40%]
1. [NCIT:C96166](markdown/NCIT_C96166.md) (Digestive System Neuroendocrine Tumor G2) [16][53.30%]
1. [NCIT:C96414](markdown/NCIT_C96414.md) (Sessile Serrated Adenoma/Polyp) [4][53.67%]
1. [NCIT:C96418](markdown/NCIT_C96418.md) (Appendix Intraepithelial Neoplasia) [2][55.56%]
1. [NCIT:C96422](markdown/NCIT_C96422.md) (Appendix Neuroendocrine Tumor) [12][53.20%]
1. [NCIT:C96425](markdown/NCIT_C96425.md) (Appendix Neuroendocrine Carcinoma) [2][54.16%]
1. [NCIT:C96478](markdown/NCIT_C96478.md) (Colorectal Adenomatous Polyp) [4][53.40%]
1. [NCIT:C96485](markdown/NCIT_C96485.md) (Colorectal Serrated Adenocarcinoma) [2][54.46%]
1. [NCIT:C96488](markdown/NCIT_C96488.md) (Colorectal Cribriform Comedo-Type Adenocarcinoma) [2][54.60%]
1. [NCIT:C96498](markdown/NCIT_C96498.md) (Colorectal Lymphoma) [17][52.89%]
1. [NCIT:C96499](markdown/NCIT_C96499.md) (Colorectal Non-Hodgkin Lymphoma) [11][53.00%]
1. [NCIT:C96503](markdown/NCIT_C96503.md) (Colorectal Diffuse Large B-Cell Lymphoma) [2][53.92%]
1. [NCIT:C96508](markdown/NCIT_C96508.md) (Colorectal Sarcoma) [10][52.77%]
1. [NCIT:C96509](markdown/NCIT_C96509.md) (Colorectal Leiomyosarcoma) [2][54.87%]
1. [NCIT:C96510](markdown/NCIT_C96510.md) (Colorectal Kaposi Sarcoma) [2][54.38%]
1. [NCIT:C96540](markdown/NCIT_C96540.md) (Anal Canal Neuroendocrine Tumor) [2][53.33%]
1. [NCIT:C96549](markdown/NCIT_C96549.md) (Anal Canal Neuroendocrine Carcinoma) [2][54.31%]
1. [NCIT:C96756](markdown/NCIT_C96756.md) (Benign Liver and Intrahepatic Bile Duct Epithelial Neoplasm) [5][55.56%]
1. [NCIT:C96767](markdown/NCIT_C96767.md) (Metastatic Carcinoma in the Liver) [3][53.20%]
1. [NCIT:C96786](markdown/NCIT_C96786.md) (Liver Neuroendocrine Neoplasm) [2][53.57%]
1. [NCIT:C96810](markdown/NCIT_C96810.md) (Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma) [2][53.84%]
1. [NCIT:C96849](markdown/NCIT_C96849.md) (Liver Germ cell Tumor) [2][54.55%]
1. [NCIT:C96881](markdown/NCIT_C96881.md) (Gallbladder Mucinous Cystic Neoplasm) [3][66.67%]
1. [NCIT:C96917](markdown/NCIT_C96917.md) (Gallbladder Neuroendocrine Neoplasm) [7][54.17%]
1. [NCIT:C96918](markdown/NCIT_C96918.md) (Gallbladder Neuroendocrine Tumor) [3][53.30%]
1. [NCIT:C96919](markdown/NCIT_C96919.md) (Gallbladder Neuroendocrine Carcinoma) [2][54.38%]
1. [NCIT:C96945](markdown/NCIT_C96945.md) (Bile Duct Biliary Intraepithelial Neoplasia) [2][53.40%]
1. [NCIT:C96954](markdown/NCIT_C96954.md) (Extrahepatic Bile Duct Neuroendocrine Neoplasm) [6][53.85%]
1. [NCIT:C96955](markdown/NCIT_C96955.md) (Extrahepatic Bile Duct Neuroendocrine Tumor) [2][53.40%]
1. [NCIT:C96956](markdown/NCIT_C96956.md) (Extrahepatic Bile Duct Neuroendocrine Carcinoma) [2][54.53%]
1. [NCIT:C96963](markdown/NCIT_C96963.md) (Digestive System Carcinoma) [560][52.66%]
1. [NCIT:C98291](markdown/NCIT_C98291.md) (Gonadal Teratoma) [6][54.55%]
1. [NCIT:C100093](markdown/NCIT_C100093.md) (Central Nervous System Nongerminomatous Germ Cell Tumor) [17][52.26%]
1. [NCIT:C102870](markdown/NCIT_C102870.md) (Ovarian Non-Dysgerminomatous Germ Cell Tumor) [18][52.53%]
1. [NCIT:C102872](markdown/NCIT_C102872.md) (Pharyngeal Squamous Cell Carcinoma) [25][53.40%]
1. [NCIT:C102897](markdown/NCIT_C102897.md) (High Grade Astrocytic Tumor) [51][53.40%]
1. [NCIT:C111691](markdown/NCIT_C111691.md) (Glioblastoma by Gene Expression Profile) [4][54.38%]
1. [NCIT:C114451](markdown/NCIT_C114451.md) (Rare Childhood Malignant Neoplasm) [23][75.00%]
1. [NCIT:C114483](markdown/NCIT_C114483.md) (Childhood Langerhans Cell Histiocytosis) [2][54.76%]
1. [NCIT:C114750](markdown/NCIT_C114750.md) (Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone) [2][53.58%]
1. [NCIT:C114777](markdown/NCIT_C114777.md) (Adult Germ Cell Tumor) [12][60.00%]
1. [NCIT:C114779](markdown/NCIT_C114779.md) (Central Nervous System Non-Hodgkin Lymphoma) [9][53.10%]
1. [NCIT:C114782](markdown/NCIT_C114782.md) (Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone) [2][53.58%]
1. [NCIT:C114801](markdown/NCIT_C114801.md) (Childhood Gonadal Germ Cell Tumor) [3][55.00%]
1. [NCIT:C114828](markdown/NCIT_C114828.md) (Mucosal Melanoma) [6][56.25%]
1. [NCIT:C114833](markdown/NCIT_C114833.md) (Childhood Central Nervous System Embryonal Neoplasm) [13][56.25%]
1. [NCIT:C114836](markdown/NCIT_C114836.md) (Recurrent Childhood Central Nervous System Embryonal Neoplasm) [2][55.00%]
1. [NCIT:C114940](markdown/NCIT_C114940.md) (Malignant Cardiovascular Neoplasm) [110][75.00%]
1. [NCIT:C114956](markdown/NCIT_C114956.md) (Recurrent Childhood Astrocytic Tumor) [17][53.10%]
1. [NCIT:C114967](markdown/NCIT_C114967.md) (Childhood Diffuse Astrocytoma) [8][54.24%]
1. [NCIT:C114968](markdown/NCIT_C114968.md) (Childhood Gliosarcoma) [2][55.13%]
1. [NCIT:C115192](markdown/NCIT_C115192.md) (Childhood Ependymal Tumor) [7][53.10%]
1. [NCIT:C115195](markdown/NCIT_C115195.md) (Childhood Mixed Glioma) [5][53.20%]
1. [NCIT:C115196](markdown/NCIT_C115196.md) (Childhood Pineal Parenchymal Cell Neoplasm) [3][53.00%]
1. [NCIT:C115203](markdown/NCIT_C115203.md) (Childhood Embryonal Tumor with Multilayered Rosettes, C19MC-Altered) [3][53.20%]
1. [NCIT:C115360](markdown/NCIT_C115360.md) (Recurrent Childhood Diffuse Astrocytoma) [3][54.31%]
1. [NCIT:C115364](markdown/NCIT_C115364.md) (Recurrent Childhood Glioblastoma) [2][54.74%]
1. [NCIT:C115369](markdown/NCIT_C115369.md) (Recurrent Childhood Non-Hodgkin Lymphoma) [4][52.77%]
1. [NCIT:C115385](markdown/NCIT_C115385.md) (Recurrent Malignant Extragonadal Germ Cell Tumor) [2][52.12%]
1. [NCIT:C115442](markdown/NCIT_C115442.md) (Recurrent Lip and Oral Cavity Squamous Cell Carcinoma) [2][53.30%]
1. [NCIT:C116342](markdown/NCIT_C116342.md) (Low Grade Astrocytic Tumor) [10][53.33%]
1. [NCIT:C118826](markdown/NCIT_C118826.md) (Childhood Malignant Small Intestinal Neoplasm) [2][60.00%]
1. [NCIT:C118827](markdown/NCIT_C118827.md) (Childhood Thyroid Gland Carcinoma) [3][53.10%]
1. [NCIT:C120083](markdown/NCIT_C120083.md) (Hereditary Nonpolyposis Colorectal Cancer) [4][75.00%]
1. [NCIT:C121583](markdown/NCIT_C121583.md) (Non-Cutaneous Leiomyosarcoma) [37][54.53%]
1. [NCIT:C121618](markdown/NCIT_C121618.md) (Germinomatous Germ Cell Tumor) [15][60.00%]
1. [NCIT:C121619](markdown/NCIT_C121619.md) (Nongerminomatous Germ Cell Tumor) [89][60.00%]
1. [NCIT:C121654](markdown/NCIT_C121654.md) (Spindle Cell/Sclerosing Rhabdomyosarcoma) [2][53.84%]
1. [NCIT:C121671](markdown/NCIT_C121671.md) (Angiosarcoma of Soft Tissue) [18][53.84%]
1. [NCIT:C121738](markdown/NCIT_C121738.md) (Intermediate Soft Tissue Tumor of Uncertain Differentiation) [7][62.50%]
1. [NCIT:C121793](markdown/NCIT_C121793.md) (Undifferentiated/Unclassified Sarcoma) [12][52.77%]
1. [NCIT:C121926](markdown/NCIT_C121926.md) (Intermediate Bone Neoplasm) [4][75.00%]
1. [NCIT:C121973](markdown/NCIT_C121973.md) (Acute Lymphoblastic Leukemia by Gene Expression Profile) [5][53.49%]
1. [NCIT:C121974](markdown/NCIT_C121974.md) (Ph-Like Acute Lymphoblastic Leukemia) [2][54.00%]
1. [NCIT:C122603](markdown/NCIT_C122603.md) (Infant Leukemia) [7][52.12%]
1. [NCIT:C122614](markdown/NCIT_C122614.md) (Infant Acute Lymphoblastic Leukemia) [3][53.67%]
1. [NCIT:C122625](markdown/NCIT_C122625.md) (Childhood Acute Myeloid Leukemia Not Otherwise Specified) [10][53.10%]
1. [NCIT:C123329](markdown/NCIT_C123329.md) (Multiple Endocrine Neoplasia Type 2) [2][54.55%]
1. [NCIT:C123392](markdown/NCIT_C123392.md) (Childhood Lymphomatoid Granulomatosis) [3][54.00%]
1. [NCIT:C123841](markdown/NCIT_C123841.md) (Childhood Nongerminomatous Germ Cell Tumor) [8][58.33%]
1. [NCIT:C123907](markdown/NCIT_C123907.md) (Childhood Malignant Kidney Neoplasm) [7][62.50%]
1. [NCIT:C124271](markdown/NCIT_C124271.md) (Childhood Ganglioneuroblastoma) [3][53.30%]
1. [NCIT:C124275](markdown/NCIT_C124275.md) (Childhood Astrocytoma) [32][53.10%]
1. [NCIT:C126306](markdown/NCIT_C126306.md) (Recurrent Glioblastoma) [4][54.53%]
1. [NCIT:C126324](markdown/NCIT_C126324.md) (Gastroesophageal Junction Neuroendocrine Carcinoma) [2][54.00%]
1. [NCIT:C126479](markdown/NCIT_C126479.md) (Broad Ligament Serous Adenocarcinoma) [2][54.55%]
1. [NCIT:C126493](markdown/NCIT_C126493.md) (Benign Uterine Ligament Neoplasm) [4][57.14%]
1. [NCIT:C126498](markdown/NCIT_C126498.md) (Malignant Uterine Ligament Neoplasm) [9][75.00%]
1. [NCIT:C126771](markdown/NCIT_C126771.md) (Uterine Corpus Neuroendocrine Neoplasm) [3][55.56%]
1. [NCIT:C127194](markdown/NCIT_C127194.md) (Growth Hormone and Prolactin-Producing Adenoma) [2][54.76%]
1. [NCIT:C127816](markdown/NCIT_C127816.md) (WHO Grade III Glioma) [28][53.20%]
1. [NCIT:C128041](markdown/NCIT_C128041.md) (Cervical Neuroendocrine Neoplasm) [5][55.56%]
1. [NCIT:C128045](markdown/NCIT_C128045.md) (Cervical Neuroendocrine Carcinoma) [2][54.00%]
1. [NCIT:C128054](markdown/NCIT_C128054.md) (Malignant Cervical Soft Tissue Neoplasm) [7][57.14%]
1. [NCIT:C128073](markdown/NCIT_C128073.md) (Vaginal Neuroendocrine Carcinoma) [2][53.30%]
1. [NCIT:C128112](markdown/NCIT_C128112.md) (Vaginal Germ Cell Tumor) [2][60.00%]
1. [NCIT:C128164](markdown/NCIT_C128164.md) (Vulvar Adenocarcinoma of Sweat Gland Type) [5][53.67%]
1. [NCIT:C128243](markdown/NCIT_C128243.md) (Vulvar Neuroendocrine Carcinoma) [4][53.10%]
1. [NCIT:C129325](markdown/NCIT_C129325.md) (Diffuse Glioma) [105][54.55%]
1. [NCIT:C129439](markdown/NCIT_C129439.md) (Medulloblastoma, Genetically Defined) [6][53.33%]
1. [NCIT:C129441](markdown/NCIT_C129441.md) (Medulloblastoma, SHH-Activated) [2][53.20%]
1. [NCIT:C129526](markdown/NCIT_C129526.md) (Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma) [5][53.10%]
1. [NCIT:C129600](markdown/NCIT_C129600.md) (Central Nervous System Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma) [3][53.67%]
1. [NCIT:C129828](markdown/NCIT_C129828.md) (Metastatic Transitional Cell Carcinoma) [2][52.77%]
1. [NCIT:C129857](markdown/NCIT_C129857.md) (Gingival Squamous Cell Carcinoma) [6][53.67%]
1. [NCIT:C131500](markdown/NCIT_C131500.md) (Recurrent Primary Malignant Neoplasm) [48][75.00%]
1. [NCIT:C131526](markdown/NCIT_C131526.md) (Ependymal Tumor of Spinal Cord) [5][53.30%]
1. [NCIT:C131610](markdown/NCIT_C131610.md) (Ependymal Tumor of Brain and Spinal Cord) [2][53.20%]
1. [NCIT:C131611](markdown/NCIT_C131611.md) (Supratentorial Ependymal Tumor) [2][53.30%]
1. [NCIT:C131873](markdown/NCIT_C131873.md) (Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma) [2][53.58%]
1. [NCIT:C132067](markdown/NCIT_C132067.md) (Low Grade Glioma) [60][54.17%]
1. [NCIT:C132146](markdown/NCIT_C132146.md) (Malignant Solid Neoplasm) [3][75.00%]
1. [NCIT:C132505](markdown/NCIT_C132505.md) (Grade II Glioma) [47][53.85%]
1. [NCIT:C132506](markdown/NCIT_C132506.md) (Recurrent Glioma) [31][54.55%]
1. [NCIT:C132728](markdown/NCIT_C132728.md) (Lip and Oral Cavity Cancer by AJCC v8 Stage) [4][54.17%]
1. [NCIT:C132736](markdown/NCIT_C132736.md) (Lip and Oral Cavity Cancer by AJCC v6 and v7 Stage) [37][53.85%]
1. [NCIT:C132778](markdown/NCIT_C132778.md) (Major Salivary Gland Cancer by AJCC v7 Stage) [6][53.85%]
1. [NCIT:C132779](markdown/NCIT_C132779.md) (Major Salivary Gland Cancer by AJCC v8 Stage) [5][53.85%]
1. [NCIT:C132814](markdown/NCIT_C132814.md) (Pharyngeal Carcinoma by AJCC v8 Stage) [15][53.57%]
1. [NCIT:C132816](markdown/NCIT_C132816.md) (Nasopharyngeal Carcinoma by AJCC v8 Stage) [7][53.84%]
1. [NCIT:C132853](markdown/NCIT_C132853.md) (Recurrent Germ Cell Tumor) [3][52.02%]
1. [NCIT:C133003](markdown/NCIT_C133003.md) (Hypopharyngeal Carcinoma by AJCC v8 Stage) [6][53.33%]
1. [NCIT:C133074](markdown/NCIT_C133074.md) (Nasal Cavity and Paranasal Sinus Cancer by AJCC v8 Stage) [7][54.17%]
1. [NCIT:C133156](markdown/NCIT_C133156.md) (Laryngeal Cancer by AJCC v8 Stage) [6][53.33%]
1. [NCIT:C133187](markdown/NCIT_C133187.md) (Mucosal Melanoma of the Head and Neck) [3][55.56%]
1. [NCIT:C133252](markdown/NCIT_C133252.md) (Cutaneous Squamous Cell Carcinoma of the Head and Neck) [7][53.49%]
1. [NCIT:C133253](markdown/NCIT_C133253.md) (Cutaneous Squamous Cell Carcinoma of the Head and Neck by AJCC v8 Stage) [5][53.58%]
1. [NCIT:C133254](markdown/NCIT_C133254.md) (Non-Small Cell Squamous Lung Carcinoma) [2][55.13%]
1. [NCIT:C133399](markdown/NCIT_C133399.md) (Esophageal Cancer by AJCC v8 Stage) [2][53.57%]
1. [NCIT:C133411](markdown/NCIT_C133411.md) (Esophageal Adenocarcinoma by AJCC v7 Stage) [5][54.60%]
1. [NCIT:C133442](markdown/NCIT_C133442.md) (Esophageal Squamous Cell Carcinoma by AJCC v7 Stage) [5][54.46%]
1. [NCIT:C133592](markdown/NCIT_C133592.md) (Recurrent Classical Hodgkin Lymphoma) [3][54.74%]
1. [NCIT:C133709](markdown/NCIT_C133709.md) (Recurrent Head and Neck Squamous Cell Carcinoma) [8][53.20%]
1. [NCIT:C133712](markdown/NCIT_C133712.md) (Metastatic Paraganglioma) [2][53.20%]
1. [NCIT:C133716](markdown/NCIT_C133716.md) (Small Intestinal Cancer by AJCC v7 Stage) [5][53.20%]
1. [NCIT:C133733](markdown/NCIT_C133733.md) (Appendix Carcinoma by AJCC v7 Stage) [2][53.85%]
1. [NCIT:C133736](markdown/NCIT_C133736.md) (Refractory Classical Hodgkin Lymphoma) [2][54.74%]
1. [NCIT:C133787](markdown/NCIT_C133787.md) (Anal Canal Cancer by AJCC v6 and v7 Stage) [6][53.20%]
1. [NCIT:C133794](markdown/NCIT_C133794.md) (Anal Cancer by AJCC v8 Stage) [5][53.85%]
1. [NCIT:C133839](markdown/NCIT_C133839.md) (Metastatic Gastrointestinal Carcinoma) [5][52.89%]
1. [NCIT:C133893](markdown/NCIT_C133893.md) (Small Intestinal Adenocarcinoma by AJCC v8 Stage) [5][54.60%]
1. [NCIT:C134117](markdown/NCIT_C134117.md) (Appendix Carcinoma by AJCC v8 Stage) [6][53.85%]
1. [NCIT:C134154](markdown/NCIT_C134154.md) (Refractory Lymphoma) [37][52.53%]
1. [NCIT:C134157](markdown/NCIT_C134157.md) (Recurrent Lymphoma) [55][52.53%]
1. [NCIT:C134168](markdown/NCIT_C134168.md) (Refractory Histiocytic and Dendritic Cell Neoplasm) [2][60.00%]
1. [NCIT:C134180](markdown/NCIT_C134180.md) (Colorectal Cancer by AJCC v8 Stage) [19][53.84%]
1. [NCIT:C134182](markdown/NCIT_C134182.md) (Stage 0 Colorectal Cancer AJCC v8) [2][54.24%]
1. [NCIT:C134185](markdown/NCIT_C134185.md) (Stage I Colorectal Cancer AJCC v8) [2][53.92%]
1. [NCIT:C134186](markdown/NCIT_C134186.md) (Stage II Colorectal Cancer AJCC v8) [2][53.92%]
1. [NCIT:C134191](markdown/NCIT_C134191.md) (Stage III Colorectal Cancer AJCC v8) [2][53.92%]
1. [NCIT:C134195](markdown/NCIT_C134195.md) (Stage IV Colorectal Cancer AJCC v8) [4][53.92%]
1. [NCIT:C134251](markdown/NCIT_C134251.md) (Colon Cancer by AJCC v8 Stage) [7][53.92%]
1. [NCIT:C134258](markdown/NCIT_C134258.md) (Rectal Cancer by AJCC v8 Stage) [5][53.92%]
1. [NCIT:C134287](markdown/NCIT_C134287.md) (Stage IV Colon Cancer AJCC v8) [2][54.00%]
1. [NCIT:C134514](markdown/NCIT_C134514.md) (Intrahepatic Cholangiocarcinoma by AJCC v7 Stage) [4][54.74%]
1. [NCIT:C134515](markdown/NCIT_C134515.md) (Hepatocellular Carcinoma by AJCC v8 Stage) [4][56.40%]
1. [NCIT:C134604](markdown/NCIT_C134604.md) (Intrahepatic Bile Duct Cancer by AJCC v8 Stage) [11][53.58%]
1. [NCIT:C134660](markdown/NCIT_C134660.md) (Gallbladder Cancer by AJCC v8 Stage) [5][53.33%]
1. [NCIT:C134742](markdown/NCIT_C134742.md) (Hilar Cholangiocarcinoma by AJCC v7 Stage) [3][54.16%]
1. [NCIT:C134743](markdown/NCIT_C134743.md) (Hilar Cholangiocarcinoma by AJCC v8 Stage) [5][54.16%]
1. [NCIT:C134755](markdown/NCIT_C134755.md) (Intrahepatic Cholangiocarcinoma by AJCC v8 Stage) [5][54.80%]
1. [NCIT:C134810](markdown/NCIT_C134810.md) (Distal Bile Duct Cancer by AJCC v7 Stage) [3][54.08%]
1. [NCIT:C134811](markdown/NCIT_C134811.md) (Distal Bile Duct Cancer by AJCC v8 Stage) [5][54.08%]
1. [NCIT:C134863](markdown/NCIT_C134863.md) (Ampulla of Vater Cancer by AJCC v7 Stage) [5][53.85%]
1. [NCIT:C134864](markdown/NCIT_C134864.md) (Ampulla of Vater Cancer by AJCC v8 Stage) [5][53.85%]
1. [NCIT:C134902](markdown/NCIT_C134902.md) (Pancreatic Cancer by AJCC v6 and v7 Stage) [5][53.57%]
1. [NCIT:C134909](markdown/NCIT_C134909.md) (Pancreatic Cancer by AJCC v8 Stage) [5][53.85%]
1. [NCIT:C135045](markdown/NCIT_C135045.md) (Gastric Neuroendocrine Tumor by AJCC v8 Stage) [4][53.40%]
1. [NCIT:C135075](markdown/NCIT_C135075.md) (Duodenal Neuroendocrine Tumor by AJCC v8 Stage) [4][53.58%]
1. [NCIT:C135080](markdown/NCIT_C135080.md) (Duodenal Neuroendocrine Tumor) [8][53.49%]
1. [NCIT:C135081](markdown/NCIT_C135081.md) (Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage) [4][53.20%]
1. [NCIT:C135129](markdown/NCIT_C135129.md) (Digestive System Neuroendocrine Tumor by AJCC v7 Stage) [8][53.33%]
1. [NCIT:C135155](markdown/NCIT_C135155.md) (Appendix Neuroendocrine Tumor by AJCC v7 Stage) [4][53.30%]
1. [NCIT:C135156](markdown/NCIT_C135156.md) (Appendix Neuroendocrine Tumor by AJCC v8 Stage) [4][53.30%]
1. [NCIT:C135205](markdown/NCIT_C135205.md) (Colorectal Neuroendocrine Tumor by AJCC v8 Stage) [8][53.40%]
1. [NCIT:C135206](markdown/NCIT_C135206.md) (Stage I Colorectal Neuroendocrine Tumor AJCC v8) [2][53.49%]
1. [NCIT:C135211](markdown/NCIT_C135211.md) (Stage IV Colorectal Neuroendocrine Tumor AJCC v8) [2][53.49%]
1. [NCIT:C135212](markdown/NCIT_C135212.md) (Colon Neuroendocrine Tumor) [8][53.49%]
1. [NCIT:C135213](markdown/NCIT_C135213.md) (Rectal Neuroendocrine Tumor) [4][53.49%]
1. [NCIT:C135214](markdown/NCIT_C135214.md) (Colon Neuroendocrine Tumor by AJCC v8 Stage) [2][53.58%]
1. [NCIT:C135527](markdown/NCIT_C135527.md) (Rectal Neuroendocrine Tumor by AJCC v8 Stage) [2][53.58%]
1. [NCIT:C135560](markdown/NCIT_C135560.md) (Pancreatic Neuroendocrine Tumor by AJCC v8 Stage) [4][53.40%]
1. [NCIT:C136320](markdown/NCIT_C136320.md) (Thymus Epithelial Neoplasm by AJCC v8 Stage) [9][57.14%]
1. [NCIT:C136345](markdown/NCIT_C136345.md) (Thymoma by AJCC v8 Stage) [4][55.00%]
1. [NCIT:C136374](markdown/NCIT_C136374.md) (Pleural Malignant Mesothelioma by AJCC v7 Stage) [4][54.74%]
1. [NCIT:C136399](markdown/NCIT_C136399.md) (Pleural Malignant Mesothelioma by AJCC v8 Stage) [4][54.74%]
1. [NCIT:C136467](markdown/NCIT_C136467.md) (Lung Cancer by AJCC v8 Stage) [9][53.57%]
1. [NCIT:C136482](markdown/NCIT_C136482.md) (Stage IV Lung Cancer AJCC v8) [4][53.33%]
1. [NCIT:C136486](markdown/NCIT_C136486.md) (Lung Adenocarcinoma In Situ) [2][55.49%]
1. [NCIT:C136488](markdown/NCIT_C136488.md) (Refractory Acute Lymphoblastic Leukemia) [3][53.58%]
1. [NCIT:C136490](markdown/NCIT_C136490.md) (Lung Adenocarcinoma by AJCC v7 Stage) [5][55.13%]
1. [NCIT:C136491](markdown/NCIT_C136491.md) (Non-Small Cell Lung Cancer by AJCC v7 Stage) [23][53.49%]
1. [NCIT:C136492](markdown/NCIT_C136492.md) (Adenosquamous Lung Carcinoma by AJCC v7 Stage) [5][54.16%]
1. [NCIT:C136493](markdown/NCIT_C136493.md) (Large Cell Lung Carcinoma by AJCC v7 Stage) [5][53.92%]
1. [NCIT:C136494](markdown/NCIT_C136494.md) (Squamous Cell Lung Carcinoma by AJCC v7 Stage) [5][54.93%]
1. [NCIT:C136610](markdown/NCIT_C136610.md) (Bone Cancer by AJCC v7 Stage) [14][58.33%]
1. [NCIT:C136612](markdown/NCIT_C136612.md) (Bone Cancer by AJCC v8 Stage) [4][58.33%]
1. [NCIT:C136632](markdown/NCIT_C136632.md) (Bone Sarcoma by AJCC v7 Stage) [9][53.57%]
1. [NCIT:C136633](markdown/NCIT_C136633.md) (Osteosarcoma by AJCC v7 Stage) [4][53.84%]
1. [NCIT:C136693](markdown/NCIT_C136693.md) (Soft Tissue Sarcoma by AJCC v8 Stage) [16][54.55%]
1. [NCIT:C136694](markdown/NCIT_C136694.md) (Soft Tissue Sarcoma of the Trunk and Extremities by AJCC v8 Stage) [4][53.85%]
1. [NCIT:C136707](markdown/NCIT_C136707.md) (Soft Tissue Sarcoma by AJCC v7 Stage) [10][54.17%]
1. [NCIT:C136708](markdown/NCIT_C136708.md) (Uterine Corpus Sarcoma by AJCC v7 Stage) [4][53.85%]
1. [NCIT:C136767](markdown/NCIT_C136767.md) (Gastrointestinal Stromal Tumor by AJCC v8 Stage) [5][54.16%]
1. [NCIT:C136769](markdown/NCIT_C136769.md) (Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor by AJCC v8 Stage) [4][54.53%]
1. [NCIT:C136811](markdown/NCIT_C136811.md) (Retroperitoneal Sarcoma by AJCC v8 Stage) [4][54.17%]
1. [NCIT:C136869](markdown/NCIT_C136869.md) (Merkel Cell Carcinoma by AJCC v7 Stage) [5][54.24%]
1. [NCIT:C138195](markdown/NCIT_C138195.md) (High Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements) [2][53.92%]
1. [NCIT:C138211](markdown/NCIT_C138211.md) (High Grade B-Cell Lymphoma) [6][53.67%]
1. [NCIT:C139002](markdown/NCIT_C139002.md) (Recurrent Soft Tissue Sarcoma) [6][52.66%]
1. [NCIT:C139005](markdown/NCIT_C139005.md) (Nodal Peripheral T-Cell Lymphoma) [2][53.30%]
1. [NCIT:C139532](markdown/NCIT_C139532.md) (Breast Cancer by AJCC v8 Stage) [17][54.17%]
1. [NCIT:C139533](markdown/NCIT_C139533.md) (Breast Cancer by AJCC v8 Anatomic Stage) [16][53.85%]
1. [NCIT:C139534](markdown/NCIT_C139534.md) (Anatomic Stage 0 Breast Cancer AJCC v8) [4][53.40%]
1. [NCIT:C139545](markdown/NCIT_C139545.md) (Anatomic Stage IV Breast Cancer AJCC v8) [7][53.57%]
1. [NCIT:C139618](markdown/NCIT_C139618.md) (Vulvar Cancer by AJCC v8 Stage) [4][54.55%]

